Deep refactoring of central carbon metabolism in the soil bacterium Pseudomonas putida by Sánchez-Pascuala Jerez, Alberto
	UNIVERSIDAD AUTÓNOMA DE MADRID 
FACULTAD DE CIENCIAS 
DEPARTAMENTO DE BIOLOGÍA 
 
 
 
DEEP REFACTORING OF CENTRAL CARBON METABOLISM 
IN THE SOIL BACTERIUM PSEUDOMONAS PUTIDA 
TESIS DOCTORAL 
Memoria presentada para optar al título de Doctor en Microbiología 
Alberto Sánchez-Pascuala Jerez 
 
 
DIRECTORES DE TESIS 
 
Dr. Víctor de Lorenzo Prieto 
Dr. Pablo Iván Nikel 
 
Consejo Superior de Investigaciones Científicas (CSIC) 
Centro Nacional de Biotecnología (CNB) 
 
Madrid, 2017 
 
 
  
		
 
 
 
 
Víctor de Lorenzo Prieto, Profesor de Investigación del Consejo Superior de Investigaciones 
Científicas en el Centro Nacional de Biotecnología (CNB-CSIC) de Madrid (España) y 
Pablo Iván Nikel, Investigador Senior de Novo Nordisk Foundation Center for Biosustainability (DTU 
BIOSUSTAIN) de Copenhague (Dinamarca), 
CERTIFICAN que 
Don Alberto Sánchez-Pascuala Jerez, Licenciado en Biología por la Universidad de Alcalá 
(Madrid), ha realizado bajo su dirección el trabajo de investigación titulado: 
“DEEP REFACTORING OF CENTRAL CARBON METABOLISM IN THE SOIL BACTERIUM 
PSEUDOMONAS PUTIDA” 
y consideran que el trabajo realizado reúne todas las condiciones requeridas por la legislación 
vigente, así como la originalidad y calidad científica necesarias, para poder ser presentado y defendido 
con el fin de optar al grado de Doctor por la Universidad Autónoma de Madrid. 
Y para que así conste y surta los efectos oportunos, firman el presente certificado en Madrid a 1 de 
junio de 2017. 
 
 
Firman Directores de la Tesis Doctoral: 
 
 
 
 
 
Dr. Víctor de Lorenzo Prieto     Dr. Pablo Iván Nikel  
Prof. de Investigación del CSIC    Inv. Senior DTU BIOSUSTAIN 
 
 
  
	 
 
 
 
 
 
 
To my guiding stars… My aunt Maribel, and grandparents Simo and Maxi. 
We have not been able to share this way, but I know that you are always with me. 
 
A las estrellas que me guían… Mi tía Maribel, y mis abuelos Simo y Maxi. 
No hemos podido compartir este camino, pero siempre estaréis a mi lado.  
 
  
	ACKNOWLEDGMENTS 
 
This work would not have been possible without the support of many people. 
 
I would like to express my sincere gratitude and admiration to my advisor, Prof. Víctor de Lorenzo. Since I 
arrived to your laboratory, you have taught me the importance to carry out excellent science with ethic, 
passion and humility. At the same time, your personal and professional qualities transform the daily life in 
the laboratory in a wonderful experience. I will take your research lessons as an inspiration to conduct my 
future path. ¡Muchas gracias por darme la oportunidad de disfrutar de esta experiencia! 
 
I cannot forget the full support provided by my co-advisor, Dr. Pablo Iván Nikel. Your help during the creation 
of this Thesis has been crucial for its achievement. Your scientific and personal support have made the 
present manuscript possible, and at the same time, you have taught me all the necessary elements to face 
the future with confidence. You are a model to follow and encourage others to make science of quality. 
¡Eternamente agradecido por todo Doc!  
 
Thanks to Rafael Rivilla for being my tutor and helping me with all the bureaucratic problems. I have 
particularly appreciated the moments in which we forgot the paperwork and discussed about science. You 
should be proud of the wonderful educational work developed in your Master and PhD program. ¡Gracias! 
 
Thanks to Tobias Fuhrer at IMSB (ETH, Zürich) to make possible the 13C-based fluxomic analyses displayed 
in this Thesis. 
 
Thanks to Stefano Donati to provide the necessary knowledge in order to work with Flux Balance Analysis 
(FBA). You are an excellence person and you will be an excellent scientist. 
 
Thanks to my ex-labmates Chu, Ilaria, Aleyo and Ángel. I started my science adventure with your help and 
finished it with an amazing friendship! 
 
I am eternally grateful for the support and good times provided for the people that comprise the laboratory: 
A Sofía tengo que agradecerle gran parte del profesional que soy ahora. Desde el momento que llegué al 
laboratorio no he parado de aprender, y estaré siempre orgulloso de poder transmitir a quien me sea posible 
todo lo básico para ser un buen microbiólogo. ¡Gracias por tantos cafés y buenos momentos amiga!  
A Belén, mi eterna compañera de pasillo, le debo mucho del conocimiento que ahora tengo sobre Biología 
Molecular (enzimas, polimerasas, …). ¡Muchas gracias por todo! 
A Ángeles, mi compañera de poyata, un placer haber compartido estos años las penas predoctorales. ¡Tu 
tesis será genial! 
	A Elena, gracias por toda la ayuda prestada en este poco tiempo. Serás una gran científica, pero ya eres 
una gran persona. 
A mis queridísimos compañeros de café, Esteban y Tomás. Sois unos grandes profesionales y unas 
grandísimas personas. Gracias por todas las conversaciones compartidas. ¡De mayor quiero ser como 
vosotros! 
A David, muchas gracias por esas charlas “gamers” y no. Siempre pensaré que eres un cerebro y una 
buenísima persona. 
A Yamal, mi compañero en el mundo de las carreras, gracias por siempre llevar puesta una sonrisa y 
compartir toda tu energía con los demás. ¡Trabajar contigo es un placer! 
To Pavel and Huseyin, thanks a lot for your help in the laboratory. The chance to share the time with people 
from other country enrich the mind, and for sure, help me to write this enormous Thesis in English. ¡Gracias 
chicos! 
A Inés, muchísimas gracias por la ayuda administrativa. En ocasiones la burocracia es más compleja que 
la ciencia y siempre has podido solventar cualquier situación. Junto a ello, siempre has sabido escuchar 
cualquier penuria y tener unas palabras de ayuda. ¡Muchas gracias! 
 
A toda la gente que compone la familia del CNB: Carol, Santa, Lola, Inés, Ramón, Dani… Hacéis que ir a 
trabajar diariamente sea un placer. ¡Gracias a todos!   
 
A “los de la Uni”: Peli, Vir, Jesús, Majalí, Pablo, Rubén y Patri. Vuestra amistad es tan importante como el 
título que conseguimos en la universidad. Siempre habéis sabido añadir una nota de felicidad a mi vida. 
¡Gracias por vuestra amistad!  
 
A mis “cuñados” favoritos (y únicos) Carmen y Javi. Hemos generado una pequeña familia maravillosa. El 
apoyo que nos hemos dado diariamente me ha permitido llegar a donde estoy. ¡Gracias por esas pizzas y 
sushis! 
 
A mis “suegros” Carmen y Agustín, gracias por todos los buenos momentos vividos. Junto a ello, mi más 
eterna gratitud por haber traído al mundo a la persona que me hace ser feliz todos los días. ¡Gracias! 
 
A los “del barrio”: Alex, Carlos, Pablo, Víctor, Luis, Sergi y Jesús. Es una fortuna poder seguir contando con 
vuestra amistad después de tantos años. Siempre estáis cuando se os necesita, y hacéis revivir los 
maravillosos momentos que hemos vivido desde que íbamos al colegio. ¡Gracias amigos! 
 
A Sergio (mi sensei), el cual me ha demostrado que cuidar tu cuerpo es tan importante como tu mente. 
Eres un ejemplo de superación a la hora de afrontar las dificultades que plantea la vida. ¡Gracias!  
 
	A Alfredo, toda mi gratitud y cariño. Eres un ejemplo a seguir en lo profesional y lo personal. ¡Gracias por 
todos los consejos que me has dado! 
 
A mi tío Santi, una de las personas más inteligentes e íntegras que conozco. Siempre orgulloso de oír en 
ocasiones la frase: “como te pareces a tu tío”. 
 
A mis padres, Conchi y José. Es imposible recoger en estas líneas el amor y admiración que siento por 
vosotros. Soy lo que soy gracias a vuestra ayuda y cada día que pasa no hago más que agradecer la 
fantástica familia que me ha tocado disfrutar. ¡Gracias padres! 
 
A mi pareja, compañera, amiga, … María. La presente Tesis es en gran parte tuya, el apoyo que me has 
ofrecido desde que nos conocemos me ha hecho alcanzar todas las metas marcadas. Te admiro y quiero 
a partes iguales. ¡Gracias por compartir la maravillosa persona que eres conmigo! 
 
 
  
	 11 
GENERAL INDEX 
 
Index of Figures…………………………………………………………………………………………………...[15] 
Index of Tables…………………………………………………………………………………………………….[17] 
Abbreviations…………………………………………………………………………………………………......[19] 
Abstract…………………………………………………………………………………………………………….[21] 
Resumen…………………………………………………………………………………………………………...[23] 
 
I. Introduction……………………………………………………………………………………………….……..[25] 
	
 1. Conspectus of Pseudomonas putida……………………………………………………………….[27] 
  1.1. Pseudomonas in perspective: a bit of history…………………………………………[27] 
  1.2. Pseudomonas putida KT2440…………………………………………………………..[28] 
  1.3. Biotechnological potential of P. putida KT2440……………………………………….[29] 
 2. Central carbon metabolism in P. putida KT2440…………………………………………………..[30] 
  2.1. The energy-dependent glucose uptake system of P. putida KT2440………………[30] 
  2.2. The atypical glucose metabolism in P. putida KT2440……………………………….[31] 
  2.3. ED pathway vs. EMP pathway: reducing power vs. energy yield…………….……..[33] 
3. Synthetic Biology and Metabolic Engineering for refactoring the central carbon metabolism of P. 
putida KT2440……………………………………………………………………………………………[35] 
 3.1. Genetic tools in Metabolic Engineering………………………………………………..[36] 
 3.2. Bacterial chassis design in Metabolic Engineering…………………………………...[37] 
4. The issue at stake: de novo engineering of central carbon metabolism in P. putida KT2440..[39] 
 
II. Objectives……………………………………………………………………………………………………….[41] 
 
III. Materials & Methods……………………………………………………………………………………….....[45] 
 1. General procedures…………………………………………………………………………………..[47] 
1.1. Bacterial strains………………………………………………………………….……....[47] 
1.2. Plasmids…………………………………...……………………………………….….....[50] 
1.3. Culture conditions………………………………………………………………………..[52] 
1.4. Bacterial transformation…………………………………………………………………[53] 
1.5. DNA manipulation and sequencing…………………………………………………….[53] 
1.6. Design of oligonucleotides………………………………………………………………[53] 
1.7. Construction of P. putida mutant strains………………………………………………[56] 
1.8. Construction of E. coli mutant strains………………………………………………….[57] 
1.9. DNA delivering using mini-Tn5 transposons………………………………………….[57] 
1.10. In silico prediction of gene functions……………………………………………….…[57] 
	 12 
1.11. Statistical Analysis……………………………………………………………….….....[58] 
2. Biochemical characterization…………………………………………………………….……….....[58] 
 2.1. Preparation of bacterial cell-free extracts………………………………….…………..[58] 
  2.2. In vitro enzymatic assay…………………………………………………………………[59] 
 3. Analytical determinations…………………………………………………………………………….[61] 
  3.1. Measurement of poly(3-hydroxybutyrate) (PHB) content…………………………….[61] 
  3.2. Determination of intracellular concentration of acetyl-coenzyme A…………………[61] 
  3.3. Glucose concentration…………………………………………………………………...[62] 
 4. Determination of phenotypic parameters…………………………………………………………...[62] 
  4.1. Phenotypic MicroArray™ technology…………………………………………………..[62] 
  4.2. Stress resistance determination………………………………………………………...[62] 
  4.3. Biofilm formation assay………………………………………………………………….[63] 
 5. Metabolic flux analysis and LC-MS/MS…………………………………………………………….[63] 
  5.1. Quantitative physiology………………………………………………………………….[63] 
  5.2. Determination of metabolite concentration by LC-MS/MS……………….…………..[64] 
5.3. Metabolic flux ratio analysis by gas chromatography coupled to mass spectrometry 
(GC-MS)…………………………………………………………………………………….....[64] 
6. Constraint-based genome-scale metabolic models and flux balance analysis………….……..[65] 
 
IV. Results……………………………………..………………………………………………………….….........[67] 
 
Chapter 1. The GlucoBrick system: A genetic tool for à la carte engineering of glycolytic activities 
in Gram-negative bacteria.......................................................................................................................[69] 
1.1. Benchmarking the components of the EMP pathway as a guiding principle for the design of 
GlucoBricks………………………………………………………………………………………………[69] 
1.2. Testing the GlucoBrick system: activities encoded in the platform restore or enhance glucose-
dependent growth of glycolytic E. coli mutants………………………………….……………………[72] 
1.3. Portability of the GlucoBrick system: using Modules I and II to engineer glycolysis in two 
different Pseudomonas species………………………………………………………………………..[76] 
1.4. Enhancing heterologous PHB production by increasing glycolytic fluxes in recombinant             
E. coli……………………………………………………………………………..……………………....[81] 
 
Chapter 2. Design and construction of P. putida GC (Glycolytic Chassis): The starting point for deep 
refactoring of central carbon metabolism in environmental bacteria…………………………………..[87] 
2.1. Streamlining glucose uptake to avoid ATP consumption through the native system of P. putida 
KT2440…………………………………………………………………………………………………...[88] 
 2.1.1. Glucose uptake system in P. putida KT2440……………………………………….[88] 
	 13 
2.1.2. Recruitment of the glucose facilitator (glf) from Zymomonas mobilis as an 
alternative transport system for P. putida KT2440…………………………………………[90] 
2.2. The metabolic fate of glucose in P. putida KT2440: A key issue to solve in order to implement 
a functional EMP pathway………………………………………………………………………………[92] 
2.3. Removing the ED pathway of P. putida KT2440 to establish a linear glycolysis…………….[98] 
 
Chapter 3. Exploring the role of glucose-6-P isomerase in central carbon metabolism of P. putida 
KT2440………………………………………………………………………………………………………….…[101] 
3.1. Removing the Pgi activity from P. putida KT2440: a single step to block the EDEMP 
cycle……………………………………………………………………………………………………..[101] 
3.2. Phenotypic MicroArray™: Global view of the phenotypic consequences of eliminating the Pgi 
activity in P. putida KT2440…………………………………………………………………………...[105] 
 3.2.1. Decrease of NADPH availability…………………………………………………….[107] 
 3.2.2. F6P accumulation…………………………………………………………………….[108] 
3.3. Genetic and metabolic perturbations to explore NADPH availability and its relationship with 
oxidative stress resistance in strain KT2440……………………………………………….………..[109] 
3.3.1. Role of GntZ in NADPH formation upon the functional interruption of the EDEMP 
cycle in a Dpgi genetic background…………………………………………….………….[109] 
3.3.2. The metabolic imbalance of the Pgi mutant correlates with a high sensitivity to 
oxidative stress………………………………………………………………………………[110] 
3.3.3. F6P accumulation and its correlation with biofilm formation in Pgi mutants…...[113] 
3.4. Constraint-based flux analysis as an additional approach to verify substrate availability for the 
NADP+-dependent dehydrogenation catalyzed by Zwf…………………………………………….[115] 
 
Chapter 4. Functional replacement of the core carbon metabolism in P. putida: establishing a 
flawless linear glycolysis in strain GC2……………………………………………………………………..[119] 
4.1. Implementation of the GlucoBrick system in P. putida GC1: beta-testing phase to allow a linear 
EMP glycolysis……………………………………………………………………………….………...[119] 
4.1.1. Streamlining the central carbon metabolism of P. putida KT2440: design and 
construction of a suitable chassis for the implementation of a linear, EMP-based glycolytic 
pathway…………………………………...………………………………………………….[120] 
4.1.2. Introduction of the genes needed to activate a linear glycolysis in P. putida 
GC1…………………………………………………………………………………………...[120] 
4.2. P. putida GC2: implementing a stable linear glycolysis based on the EMP pathway……...[124] 
 4.2.1. Removal of the ED route……………………………………………………………..[125] 
 4.2.2. Elimination of the native glucose transport system……………………………….[125] 
4.3. Design of genetic elements for establishing a stable linear glycolysis in P. putida GC2….[125] 
	 14 
4.3.1. Implementation of the glucose facilitator (Glf) from Z. mobilis in strain 
GC2………………………...………………………………………………………………....[126] 
4.3.2. Introduction of the EMP pathway activities encoded by Modules I and II of the 
GlucoBrick system……………………………..…………………………………………....[126] 
4.3.3. Insertion workflow of different glycolytic modules in P. putida GC2, and phenotypic 
analysis of glucose-using exconjugants isolates………………………………………….[129] 
4.3.4. Biochemical landscape of P. putida GC2·T·GBI·GBII……………………….…....[131] 
4.4. Central carbon metabolism in glucose-grown P. putida GC2·T·GBI·GBII: Quantitative 
physiology parameters and 13C-based metabolic flux analysis……………………………………[132] 
 4.4.1. Glucose transport and hexose phosphorylation/oxidation…….………………….[136] 
4.4.2. Metabolic origin and fate of G6P and pathways leading to Pyr 
formation……………………...………………………………………………………………[136] 
 4.4.3. Anaplerotic pathways, TCA cycle, and glyoxylate shunt…………….……………[137] 
4.4.4. Impact of the engineered EMP route in the energy and redox balances of P. 
putida……………...……………………………………………………………………….....[139] 
 
V. Discussion…………………………………………………………………………………………………….[141] 
1. Metabolic Engineering meets Synthetic Biology standards: the GlucoBrick system as a tool to 
implement glycolytic capacities in Gram-negative bacteria…………………….………………….[143] 
2. Preparing P. putida KT2440 to host a linear EMP pathway: upgrading the potential of 
environmental bacteria as a useful Synthetic Biology chassis….…………………………………[145] 
3. Understanding P. putida KT2440 glucose metabolism as a key principle to the flawless design 
of P. putida GC: the relevance of blocking the EDEMP cycle……………………………….…….[148] 
4. Engineering of P. putida to employ the linear EMP glycolytic pathway……………………….[151] 
5. Outlook……………………………………………………………………………………………….[157] 
 
VI. Conclusions……………………...…………………………………………………………………………..[159] 
 Conclusions……………………………………………………………...…………………….…….....[161] 
 Conclusiones………………...………………………………………………………………….……...[163] 
 
VII. References………………………………………………………………………………….………......…...[165] 
 
VIII. Annexes……………...……………………………………………………………………………………...[185] 
Annex 1. Phenotypic MicroArray™ complete report………………………………………………..[187] 
Annex 2. Permission/License…………………………………………………………………………[193] 
 
 
 
 
	 15 
INDEX OF FIGURES 
 
Figure 1½Glucose metabolism of P. putida KT2440………………………………………….………………..[33] 
Figure 2½Structural differences and similarities between the ED and EMP catabolic routes……………..[35] 
Figure 3½Key concepts in Synthetic Biology-guided Metabolic Engineering…………………………….….[38] 
Figure 4½Schematic representation of the GlucoBrick platform layout and biochemical reactions 
thereof……………………………………………………………………………………………………………….[70] 
Figure 5½Genetic architecture of the GlucoBrick platform……………………………………………….……[71] 
Figure 6½ Characterization of physiological parameters in recombinant Pseudomonas putida and P. 
aeruginosa strains carrying Module I…………………………………………………………………………….[77] 
Figure 7½ Biochemical characterization of native and implanted enzyme activities in Pseudomonas 
species………………………………………………………………………………………………………………[79] 
Figure 8½ Enhanced poly(3-hydroxybutyrate) synthesis in recombinant Escherichia coli carrying Modules I 
and II…………………………………………………………………………………………………………….......[83] 
Figure 9½Glucose uptake in P. putida KT2440………………………………………………………....……...[88] 
Figure 10½Growth phenotype characterization of glucose transport mutants……………………………...[89] 
Figure 11½Glf functionality in a glucose transport-deficient derivative of P. putida KT2440………………[92] 
Figure 12½Schematic representation of central carbon metabolism in P. putida KT2440………………...[93] 
Figure 13½Characterization of the glk deletion in P. putida KT2440…………………………………………[94] 
Figure 14½Characterization of the gcd deletion in P. putida KT2440………………………………………..[95] 
Figure 15½Characterization of the Gad activity removal in P. putida KT2440………………………………[97] 
Figure 16½Interrupting the Entner-Doudoroff (ED) pathway of P. putida KT2440………………………….[99] 
Figure 17½Growth phenotype characterization of different glucose catabolism mutants of P. putida 
KT2440…….………………………………………………………………………………………………………[100] 
Figure 18½ Schematic representation of the EDEMP cycle in P. putida KT2440………………………...[102] 
Figure 19½ Characterization of the Pgi deletions in P. putida KT2440……………………………………..[103] 
Figure 20½ Phenomic analysis of the Pgi mutation in P. putida KT2440…………………………………..[106] 
Figure 21½Characterization of the gntZ deletion in P. putida KT2440……………………………………..[109] 
Figure 22½ Paraquat as an oxidative stressor agent: qualitative characterization of tolerance by Pgi and 
GntZ mutants of P. putida KT2440………………………………………………….…………………………..[111] 
Figure 23½ Stress resistance to paraquat in liquid cultures of P. putida KT2440 carrying different 
combinations of Pgi and GntZ mutations…………………………………………………………………….…[112] 
Figure 24½ Biofilm formation in P. putida mutants devoid of the Pgi and GntZ activity………………….[114] 
Figure 25½Influence of eliminating the Pgi activity on the distribution of central metabolic fluxes evaluated 
by constraint-based analysis…………………………………………………………………………………….[116] 
Figure 26½Outline for the beta-testing of a linear glycolysis in P. putida…………………………………..[121] 
Figure 27½Physiological and biochemical characterization of the implanted GlucoBrick activities in P. putida 
GC1…………………………………………………………...……………………………………………………[123] 
Figure 28½Construction of P. putida GC2 and transposon-based elements used for the stable 
implementation of a linear glycolysis…………………………………………………………………………....[127] 
Figure 29½Workflow of the construction and selection of P. putida GC2·T·GBI·GBII……………………[128] 
Figure 30½Expected glucose metabolism in P. putida GC2·T·GBI·GBII…………………………………..[131] 
Figure 31½Biochemical pathways for glucose catabolism in P. putida KT2440…………………………..[133] 
Figure 32½In vivo distribution of carbon fluxes under glycolytic growth conditions for P. putida KT2440 and 
P. putida GC2·T·GBI·GBII……………………………………………………………………………………….[138] 
	 16 
Figure 33½Net ATP, NADH, and NADPH formation under glycolytic growth conditions for P. putida KT2440 
and P. putida GC2·T·GBI·GBII………………………………………………………………………………….[140] 
 
 
  
	 17 
INDEX OF TABLES 
 
Table 1½Previous attempts to refactor the central carbon metabolism of different microorganisms..……[30] 
Table 2½Bacterial strains used in this Thesis…………………………………………………………………...[47] 
Table 3½Plasmids used in this study…………………………………………………………………………….[50] 
Table 4½Oligonucleotides employed in PCR reactions………………………………………………………..[54] 
Table 5½Functional validation of Module I and II in glycolytic mutants of E. coli BW25113……………….[73] 
Table 6½ Metabolomic determinations in glucose-grown Pseudomonas putida KT2440 carrying the 
glycolytic genes borne by Module I…………………………………………………………………………….…[81] 
Table 7½ Growth parameters and polymer synthesis of a PHB-accumulating Escherichia coli strain carrying 
different combinations of glycolytic genes……………………………………………………………………….[84] 
Table 8½Growth parameters of P. putida KT2440 and its Dpgi-I and Dpgi-II mutant derivatives in shaken-
flask cultures under glycolytic growth conditions…………………………………...………………………….[105] 
Table 9½Growth parameters of P. putida KT2440 and its P. putida GC2·T·GBI·GBII strain in shaken-flask 
cultures under glycolytic growth conditions…………………………………………………………………….[135] 
 
 
 
  
	 19 
ABBREVIATIONS 
 
2-KG 2-Ketoglutarate 
2-OX 2-Oxoglutarate 
2K6PG 2-Ketogluconate-6-P 
2KG 2-Ketogluconate 
2PG Glycerate-2-P 
3-mB 3-Methylbenzoate 
3PG Glycerate-3-P 
6PG 6-Phosphogluconate 
A Absorbance 
ABC ATP-binding cassette 
Acetyl-CoA Acetyl-coenzyme A 
Ap Ampicillin 
ATP Adenosine triphosphate 
BPG Glycerate-1,3-P2 
CDS Coding sequences 
CDW Cell dry weight 
Cm Chloramphenicol 
DCPIP Dichlorophenolindophenol 
DHAP Dihydroxyacetone-P 
DNA Deoxyribonucleic acid 
ED pathway Entner-Doudoroff pathway 
Eda 2-Keto-3-deoxy-6-phosphogluconate aldolase 
Edd 6-Phosphogluconate dehydratase 
EMP pathway Embden-Meyerhof-Parnas pathway 
EPS Extracellular polymeric substances 
F6P Fructose-6-P 
FAD Flavin adenine dinucleotide 
FBA Flux balance analysis 
FBP Fructose-1,6-P2 
Fbp Fructose-1,6-bisphospatase 
Fda Fructose-1,6-P2 aldolase 
G6P Glucose-6-P 
GA3P Glyceraldehyde-3-P 
Gad Gluconate 2-dehydrogenase 
Gap GA3P dehydrogenase 
GC-MS Gas chromatography coupled to mass spectrometry 
Gcd Glucose dehydrogenase 
Glk Glucokinase 
Gm Gentamicin 
GntZ 6-Phosphogluconate dehydrogenase 
GnuK Gluconate kinase 
GRAS Generally recognized as safe 
HPLC High-performance liquid chromatography 
IM Inner membrane 
IPTG Isopropyl-1-thio-b-galactopyranoside 
	 20 
kb 1,000 base pairs 
KDPG 2-Keto-3-deoxy-6-phosphogluconate 
Km Kanamycin 
LB Lysogeny Broth (Luria-Bertani) medium 
LC-MS Liquid chromatography coupled to mass spectrometry 
NAD+ Nicotinamide adenine dinucleotide 
NADH Nicotinamide adenine dinucleotide reduced form 
NADP+ Nicotinamide adenine dinucleotide phosphate 
NADPH Nicotinamide adenine dinucleotide phosphate reduced form 
OAA Oxaloacetate 
OD Optical density 
OM Outer membrane 
ORF Open reading frame 
PCR Polymerase chain reaction 
PEP Phosphoenolpyruvate 
Pfk 6-Phosphofructo-1-kinase 
Pgi Glucose-6-P isomerase 
Pgl 6-Phosphogluconolactonase 
PHB Poly(3-hydroxybutyrate) 
PP pathway Pentose phosphate pathway 
PQQ Pyrroloquinoline quinone 
PS Periplasmic space 
PTS Phosphoenolpyruvate (PEP):carbohydrate phosphotransferase system 
PtxD 2-Ketogluconate-6-P 
Pyk Pyruvate kinases 
Pyr Pyruvate 
R5P Ribose-5-P 
RBS Ribosome binding site 
Ri5P Ribulose-5-P 
RNA Ribonucleic acid 
S7P Sedoheptulose-7-P 
Sm Streptomycin 
Tc Tetracyclin 
TCA cycle Tricarboxylic acid cycle 
Tpi Triose-P isomerase 
WT Wild-type 
X5P Xylulose-5-P 
Zwf Glucose-6-P 1-dehydrogenase 
	 21 
ABSTRACT 
 
Pseudomonas putida KT2440 is currently one of the most appealing microorganisms to be used as a 
cell platform in biotechnological applications. Its high metabolic versatility, increased resistance to oxidative 
stress, and amenability to genetic manipulations, are some of the main reasons for which P. putida is gaining 
attention as a chassis for bioproduction. This soil bacterium displays an atypical structure in its very central 
carbon metabolism when growing on glucose as the carbon source, in which the supply of reducing power 
(i.e., NADPH) prevails over the formation of ATP. Strain KT2440 operates a glycolytic cycle based on the 
Entner-Doudoroff (ED) route, as opposed to a linear glycolysis (that prevails in Enterobacteria). Such a 
metabolic architecture enables growth and survival of P. putida KT2440 under stressful conditions, in which 
catabolic overproduction of NADPH would be advantageous (e.g., the natural environments this bacterium 
thrives in). However, the low energy efficiency limits the widespread use of P. putida in biotechnological 
processes that require a high level of ATP generation. 
 
The present Thesis aims at setting the basis to modify this state of affairs by undertaking a complete 
metabolic refactoring of P. putida KT2440 in order to increase its glucose-dependent energetic performance 
by de novo engineering of the bacterial metabolic lifestyle. The achievement of such goal comprised different 
steps in which Synthetic Biology approaches have been thoroughly incorporated. First, a powerful genetic 
tool for à la carte engineering of glycolytic activities in different Gram-negative bacteria (i.e., the GlucoBrick 
platform) has been designed and constructed. The adoption of this standardized tool allowed for the rational 
implementation of a functional Embden-Meyerhof-Parnas (EMP) pathway in P. putida KT2440, which 
substituted the native, less energy-efficient ED route. Furthermore, the central carbon metabolism of P. 
putida KT2440 was streamlined by introducing several mutations in key glycolytic steps to facilitate the 
accommodation of novel biochemical capacities; this approach resulted in the generation of a set of P. putida 
glycolytic chassis. Simultaneously, the impact generated by the disruption of the native metabolic regime 
was studied by eliminating the glucose-6-P isomerase (Pgi) activities of strain KT2440, that resulted in an 
overall perturbation of the response to exogenous oxidative stress. The physiological and metabolic 
characterization of the glycolytic mutants developed in this study has thereby increased the fundamental 
knowledge on central carbon metabolism in P. putida KT2440. 
 
Finally, the P. putida glycolytic chassis obtained in this Thesis, devoid of all the glycolytic steps in the 
upper catabolism along with the native glucose transport system, served as the biological container for 
hosting a functional, energy-efficient linear EMP pathway. This study tackles a novel aspect in terms of 
Metabolic Engineering, serving as a case example of network-wide metabolic refactoring of an 
environmental bacterium to increase its catalytic potential. As an evidence of this achievement, a complete 
13C-based fluxomic analysis was conducted in the engineered strain, in which the itinerary followed by 
carbon skeletons derived from glucose were exhaustively mapped throughout the novel metabolic network. 
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This approach demonstrated that the linear glycolytic pathway grafted into P. putida is functional, and that 
its ATP output was higher than that mediated by the native biochemical network.  
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RESUMEN 
 
En la actualidad, Pseudomonas putida KT2440 se considera como uno de los microorganismos más 
atractivos para su utilización como plataforma biológica en aplicaciones biotecnológicas. Su gran 
versatilidad metabólica, elevada resistencia a estrés oxidativo, y la facilidad a la hora de ser manipulada 
genéticamente, son algunas de las características que han propiciado el interés en P. putida KT2440 y su 
aplicación como chassis en bio-producción. Esta bacteria del suelo presenta una estructura atípica en su 
metabolismo central cuando se cultiva en glucosa como fuente de carbono, favoreciéndose la generación 
de poder reductor (es decir, NADPH) en detrimento de la formación de ATP. La cepa KT2440 lleva a cabo 
una glicólisis cíclica basada en la ruta de Entner-Doudoroff (ED), a diferencia de la glicólisis lineal típica 
(prevalente en Enterobacterias). Esta arquitectura metabólica ha permitido que P. putida KT2440 pueda 
sobrevivir y crecer bajo condiciones de estrés, en las cuales una sobre-producción catabólica de NADPH 
resulta ventajosa para incrementar la supervivencia en el medio ambiente natural. Sin embargo, el bajo 
rendimiento energético de esta bacteria repercute negativamente en su potencial biotecnológico en 
aquellos procesos que requieren de una demanda de ATP elevada. 
 
La presente Tesis Doctoral pretende asentar las bases para revertir esta situación, llevando a cabo 
una completa refactorización metabólica de P. putida KT2440 con el fin de incrementar el rendimiento 
energético de esta bacteria a partir de glucosa. Con el fin de alcanzar este objetivo, el presente estudio 
hace uso de un abordaje basado en la Biología Sintética. Primeramente, se creó y diseñó una potente 
herramienta genética (denominada sistema GlucoBrick) con la cual se pueden implementar actividades 
glicolíticas en diferentes bacterias Gram-negativas a la carta. La utilización de esta herramienta 
estandarizada permitió la implementación funcional de la ruta de Embden-Meyerhof-Parnas (EMP) en P. 
putida KT2440, sustituyendo de esta forma la ruta nativa ED, menos favorable energéticamente. Dicho 
proceso ha sido posible mediante la reducción genómica de P. putida KT2440, que facilitó la introducción 
de nuevas capacidades metabólicas mediante la eliminación de diversos elementos glicolíticos endógenos. 
Como resultado de esta operación, se ha generado un conjunto de chassis glicolíticos derivados de esta 
bacteria. Paralelamente, en este estudio se ha evaluado el impacto metabólico de interrumpir el 
funcionamiento normal del metabolismo de la cepa KT2440, mediante la eliminación de la actividad 
glucosa-6-P isomerasa (Pgi). Dicha manipulación resultó en una disminución significativa de la respuesta 
de esta bacteria al estrés oxidativo exógeno. En conjunto, la obtención de un gran número de mutantes 
glicolíticos de P. putida KT2440 permitió incrementar el conocimiento sobre el metabolismo central de 
carbono en este microorganismo. 
 
Finalmente, el chassis glicolítico basado en P. putida KT2440 construido en esta Tesis Doctoral, en el 
cual las vías nativas de transporte y utilización de glucosa han sido inhabilitadas, ha sido utilizado como el 
hospedador funcional de una ruta linear de EMP. El trabajo desarrollado en este estudio se enmarca en el 
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campo de la Ingeniería Metabólica, siendo un ejemplo en el que se ha modificado racional y completamente 
la utilización de glucosa como fuente de carbono en un microorganismo ambiental. A la hora de demostrar 
la eficacia de dicha reconversión metabólica, en el presente trabajo se planteó el análisis de flujos de 
carbono mediante sustratos que contienen 13C, con el que ha sido posible mapear el recorrido de los 
esqueletos de carbono a través de toda la red metabólica. Este enfoque experimental demostró que la ruta 
glicolítica lineal es funcional y activa, y que la generación de ATP en la cepa de P. putida modificada es 
mayor que el generado por las rutas metabólicas nativas. 
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I. INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
«Not to know what happened before you were born is to be a child forever» 
Marcus Tullius Cicero 
(106 BC-43 BC) 
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INTRODUCTION 
 
1. Conspectus of Pseudomonas putida 
 
1.1. Pseudomonas in perspective: a bit of history. Pseudomonas putida KT2440 is the bacterium that 
has been selected in this study for a deep refactoring of its central carbon metabolism, thereby bestowing a 
new metabolic identity onto it. The history of this microorganism is closely linked to the metabolic versatility 
displayed by the entire genus to which it belongs, that has prompted the biotechnological interest on this 
group of bacteria. 
	
The name Pseudomonas was coined in 1894 by Prof. Migula. Back then, the genus was described as 
a group of cells with polar organs of motility and formation of spores in some special cases (Migula, 1894; 
Migula, 1900). This description was obviously short and inaccurate, but at the end of the XIX century, it was 
accepted for publication. This unclear description transformed the genus Pseudomonas in an authentic 
jumble until the publication of the doctoral thesis defended by L. E. den Dooren de Jong in 1926. This 
publication revealed one of the features that would define (and classify) the entire genus more accurately: 
its remarkable ability to degrade a large variety of organic compounds (including relevant toxic substances) 
as a part of the process of carbon mineralization (den Dooren de Jong, 1926). The den Dooren de Jong’s 
thesis was however not widely used by contemporary scientists, given that the thesis was written in Dutch, 
but held out an inspirational vision for Stanier and collaborators, who went on creating the first accurate 
description of the Pseudomonas genus some forty years later (Stanier et al., 1966). The Stanier’s study 
proposed a set of differential tables based on nutritional characteristics, and occasionally on some 
morphological details, to classify the most relevant Pseudomonas species (including P. putida). This work 
provided a unifying definition of Pseudomonas that is currently valid for the most characteristic members of 
the group: «Unicellular rods, with the long axis straight or curved, but not helical. Motile by means of one or 
more polar flagella. Gram-negative. Do not form spores, stalks, or sheaths. The energy-yielding metabolism 
is respiratory, never fermentative or photosynthetic. All use molecular oxygen as a terminal oxidant; and 
some can use denitrification as an alternative, anaerobic respiratory mechanism. All are 
chemoorganotrophs; some are facultative chemolithotrophs that use H2 as an energy source» (Stanier et 
al., 1966). 
 
The confusing panorama became clearer thanks to new methodologies and technical approaches, 
based on the studies of macromolecular identifiers. The DNA/DNA and RNAr/DNA hybridization techniques 
(Doi & Igarashi, 1965; Johnson & Ordal, 1968; Palleroni et al., 1973) enabled the division of Pseudomonas 
species into five taxonomic groups (i.e., RNA-I to RNA-V). This was the key step towards the final phylogeny 
and taxonomy classification, which was possible upon obtaining the sequence of the 16S rRNA gene 
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(Palleroni et al., 1973). Based on this seminal publication, still valid at the present time, the genus 
Pseudomonas was limited to the previously described RNA-I group within the subclass of Gram-negative, 
aerobic g-Proteobacteria (Palleroni, 2003). 
 
Currently, the number of species assigned to the Pseudomonas genus encompasses a large number 
of members [>200 and still growing (Euzeby, 1997)]. These bacteria have been isolated from a large number 
of environments [e.g., plant rhizosphere, soil, and water (Jensen et al., 2004)], reflecting the enormous 
metabolic versatility that is characteristic of this group of microorganisms. The Genomic Era allowed to 
access the technologies needed for sequencing the entire genome of different bacteria of this group, thereby 
discovering an extensive collection of enzymes and metabolic pathways that can degrade a large number 
of organic compounds, including xenobiotic pollutants (Winsor et al., 2016). In order to be able to consume 
such variety of structurally unrelated carbon sources, bacteria of the Pseudomonas genus display a large 
set of diverse metabolic pathways. These features also indicate that Pseudomonas is a robust group of 
microorganisms with a great potential for biotechnological applications. This is the case of the subject of 
study in this Thesis, P. putida KT2440, a microorganism that has been largely employed in different areas 
of bioremediation and biocatalysis (Nikel et al., 2014b; Poblete-Castro et al., 2012; 2017) since its isolation 
and identification in the 70s. The biotechnological interest on this bacterium has served as an inspiration for 
the present Thesis, by proposing the possibility of refactoring its central carbon metabolism capacities and 
taking advantage of the physiological characteristics displayed by the genus. 
 
1.2. Pseudomonas putida KT2440. This bacterium is the best characterized saprophytic member of the 
Pseudomonads group. This situation partially stems from the fact that it has retained its ability to survive 
and function in the environment (Bagdasarian et al., 1981; Regenhardt et al., 2002). This bacterial strain is 
the plasmid-free derivative of a toluene-degrading bacterium, originally termed Pseudomonas arvilla strain 
mt-2 (Kojima et al., 1967), and subsequently re-classified as P. putida mt-2 (Williams & Murray, 1974). The 
biotechnological applicability of P. putida KT2440 is backed by its certification as a safety strain by the 
Recombinant DNA Advisory Committee (Federal Register. Appendix E, 1982). On top of that, this bacterium 
has been extensively used as a host for cloning and gene expression, considering its capability to degrade 
aromatic compounds (e.g., toluene or m-xylene), which makes it a promising microbial platform for 
biodegradation approaches (Jiménez et al., 2002; Martins dos Santos et al., 2004; Timmis, 2002). 
 
In terms of genomic knowledge, P. putida KT2440 has been the subject of a progressive updating over 
the last years. The first attempt to completely sequence its single chromosome was published in 2002 
(Nelson et al., 2002), and was recently updated by Belda and collaborators in 2016 (Belda et al., 2016). The 
revised genome of P. putida KT2440 is 6,181,873 bp long, with a G+C content of 61.5%. The updated 
genome profile encompasses 5,592 coding sequences (CDS), 1,151 of which encode hypothetical proteins, 
and 28 encode pseudogenes. This high level of knowledge allowed to predict 1,485 CDSs associated to 
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actual biochemical reactions, configuring a rather diverse biochemical map of the metabolism in this 
bacterium (Udaondo et al., 2016). 
 
1.3. Biotechnological potential of P. putida KT2440. The general description of P. putida KT2440 
exposed in the last section provides clues of its biotechnological potential. Taking into account that the main 
goal of this Thesis has been to increase the catalytic capability of strain KT2440 via refactoring of its central 
carbon metabolism, this section compiles and summarizes the metabolic and physiological features that 
served as source of inspiration for the present study. 
 
The fundamental knowledge gathered from genome analysis of P. putida has allowed to predict its 
biocatalytic potential. For example, strain mt-2 has a remarkable capacity to degrade aromatic compounds 
[e.g., toluene or m-xylene (Jiménez et al., 2002)], and displays high levels of solvent tolerance (Ramos et 
al., 2015). These features allow for the utilization of this bacterium as an agent in different bioremediation 
and bioproduction approaches (Loeschcke & Thies, 2015; Poblete-Castro et al., 2012). Additionally to these 
specific examples of physiological and metabolic robustness, the particular structure of its central carbon 
metabolism confers P. putida KT2440 a high tolerance to oxidative stress (Kim & Park, 2014), which is of 
interest for several biotechnological applications [e.g., biofuels production (Liao et al., 2016)]. This bacterial 
strain is also a well-established microbial host for cloning and heterologous gene expression, empowered 
by a steadily increasing number of genetic tools tailored for molecular manipulations (Durante-Rodríguez et 
al., 2014; Lieder et al., 2015; Martínez-García & de Lorenzo, 2011; Martínez-García et al., 2011; 2014a,b; 
Silva-Rocha et al., 2013). These advantageous traits are not limited to wet laboratory applications, as 
indicated by the availability of four genome-scale constraint-based metabolic models for in silico studies 
(Belda et al., 2016; Nogales et al., 2008; Puchałka et al., 2008; Sohn et al., 2010). 
 
In summary, the wide applicability of this soil bacterium in industrial bioprocesses [e.g., for the 
production of biopolymers (Linger et al., 2014; Prieto et al., 2016), natural products (Klein et al., 2017; 
Loeschcke & Thies, 2015), and metabolic building blocks such as adipic acid (Okamura-Abe et al., 2016; 
Vardon et al., 2015)] supports the scope of the present study to improve its central carbon metabolism in 
terms of energetic balance. In this regard, the glucose metabolism of P. putida KT2440 is an excellent 
example of a biochemical network evolutionary adapted to the environmental conditions (Chavarría et al., 
2013). Such metabolic organization enables this bacterium to obtain a high level of reducing power (in the 
form of NADPH), used not only in anabolism (Spaans et al., 2015), but also important to counteract oxidative 
stress (Kim & Park, 2014; Singh et al., 2007). This metabolic operation of the biochemical network of P. 
putida does not prioritize energy production (in terms of ATP) when the cells grow on hexose substrates, 
and thus somewhat limits the feasibility of this bacterium in applications for which this requirement is 
essential (Hara & Kondo, 2015; Schuster, 2000). For this reason, the entire transformation of the central 
carbon metabolism of P. putida KT2440 [based on the Entner-Doudoroff (ED) pathway] into an energy-
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efficient glucose catabolic network inspired in the Embden-Meyerhof-Parnas (EMP) pathway was 
systematically tackled as indicated below. 
 
2. Central carbon metabolism in P. putida KT2440 
 
Historically, the majority of Metabolic Engineering efforts have been focused on what could be considered 
peripheral aspects (Ajikumar et al., 2010; Raab et al., 2005; Stephanopoulos, 2012; Wu et al., 2016); e.g., 
the elimination of competing endogenous pathways, the fine-tuning of gene expression and substrate 
transport, and the rerouting of small molecules at given nodes of the target biochemical network. 
Approaches that target central carbon metabolism, which fuels microbial cell factories to obtain the energy 
and precursors needed for growth and bioproduction, are scarce (Jojima & Inui, 2015; Kern et al., 2007; 
Nikel et al., 2016a). This may be partially due to the difficulties of manipulating the core metabolism 
(Papagianni, 2012), which is extremely interconnected with the rest of the biochemical network. As indicated 
in Table 1, the literature reflects some of these partial attempts to carry out a deep metabolic transformation 
of industrially-relevant microorganisms (e.g., by replacing their main glycolytic pathways). Against this 
background, the present Thesis evaluates the possibility of refactoring the central carbon metabolism of P. 
putida KT2440 in terms of glucose utilization pathways as an attempt to improve its overall energy balance. 
As an introduction to this specific issue, an overall vision of the native glucose metabolism of P. putida 
KT2440 is discussed in the section below. 
 
Table 1½Previous attempts to refactor the central carbon metabolism of different microorganisms. 
Microorganism 
Pathwaya Phenotype on 
glucoseb Reference Targeted Added 
Saccharomyces cerevisiae EMP ED N.G. Benisch & Boles (2014) 
P. putida KT2440 ED EMP N.G. Chavarría et al. (2013) 
Zymomonas mobilis ED EMP 40% lower µ Chen et al. (2013) 
 
a In the case of Z. mobilis, the participation of the target pathway was not removed completely (i.e., by employing 
antisense inhibition). In the other examples, the target pathway was totally blocked (i.e., by deletion of the cognate 
genes). Abbreviations are as follows: EMP, Embden-Meyerhof-Parnas pathway; and ED, Entner-Doudoroff 
pathway. 
b General description of the growth phenotype under glycolytic conditions. Abbreviations are as follows: N.G., no 
growth; and µ, specific growth rate. 
 
2.1. The energy-dependent glucose uptake system of P. putida KT2440. One of the critical steps in the 
optimization of microbial cell factories using Metabolic Engineering approaches is the uptake of substrate(s). 
P. putida KT2440 is able to enter glucose in its central carbon metabolism by means of two different routes 
(Fig. 1): (i) phosphorylation of the hexose in the cytoplasm by glucokinase (Glk), or (ii) oxidation in the 
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periplasm to gluconate and/or 2-ketogluconate (2KG) through the activity of glucose dehydrogenase (Gcd) 
and gluconate 2-dehydrogenase, collectively referred to as Gad (del Castillo et al., 2007; 2008; Fuhrer et 
al., 2005; Latrach-Tlemçani et al., 2008). The transport of hexoses from the extracellular medium to the 
bacterial cytoplasm, crossing the outer and inner membrane, is carried out by an ATP-binding cassette 
(ABC) transport system coupled to the action of the OprB porins (Fig. 1a). The OprB porins [OprB-1 
(PP_1019) and OprB-2 (PP_1445)] facilitate the diffusion of glucose across the outer membrane (del Castillo 
et al., 2007; Wylie & Worobec, 1995). Then, the ABC transport system captures glucose from the periplasmic 
space with the aid of the periplasmic sugar-binding protein encoded by the gtsA gene (PP_1015). This 
complex, composed by the sugar and the periplasmic-binding protein, interacts with the core of the ABC 
transporter system encoded by the gtsB (PP_1016), gtsC (PP_1017), and gtsD (PP_1018) genes to finally 
introduce the carbohydrate into the cytoplasm (Schneider, 2001). This type of glucose transport systems is 
widely distributed in Gram-negative bacteria, in which the periplasmic-binding protein has a very high affinity 
for the specific substrate, i.e., glucose (Jensen et al., 2002). For example, the hexose transport system of 
Thermococcus litoralis, that exhibits a binding protein similar to that of strain KT2440, has a Km of 
approximately 20 nM, whereas the Km of the native glucose uptake system of Escherichia coli is around 1 
µM (Xavier et al., 1996). The high affinity of these transport systems come along with the investment of 
ATP, allowing for the efficient uptake of glucose even when the sugar concentrations are very low, as it is 
often the case in natural environments (Davidson & Chen, 2004). In terms of Metabolic Engineering 
purposes, however, such transport systems are to be avoided as they would use ATP that could be 
otherwise funneled into other biochemical processes. 
 
2.2. The atypical glucose metabolism in P. putida KT2440. As hinted above, the central carbon 
metabolism of P. putida KT2440 is an example of a biochemical network adapted to ensure bacterial survival 
under stressful conditions (Chavarría et al., 2013; Nikel et al., 2015a). In order to meet this environmental 
challenge, the genome of P. putida KT2440 contains all the genes encoding enzymes of the three prominent 
catabolic pathways for sugars in bacteria: the ED pathway, the EMP pathway, and the pentose phosphate 
(PP) pathway (Fig. 1b). An enzyme remarkably absent in the biochemical network of P. putida KT2440 is 
6-phosphofructo-1-kinase (Pfk), that enables the transformation of fructose-6-P (F6P) into fructose-1,6-P2 
(FBP) in many microorganisms (Chavarría et al., 2013). The absence of Pfk results in the inability of strain 
KT2440 to degrade glucose via the linear, downwards EMP pathway, a phenomenon recognized in other 
environmental microorganisms as well [e.g., Shewanella oneidensis (Tang et al., 2009)]. 
 
After being transported into the periplasmic space, glucose is transformed into 6-phosphogluconate 
(6PG) through a series of peripheral reactions (Daddaoua et al., 2009; del Castillo et al., 2007), and this 
metabolite is processed almost exclusively (96%) through the 6-phosphogluconate dehydratase (Edd) and 
2-keto-3-deoxy-6-phosphogluconate aldolase (Eda) enzymes (i.e., the ED pathway proper) with only a very 
small fraction (ca. 4%), entering the PP pathway. Edd transforms 6PG to 2-keto-3-deoxy-6-
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phosphogluconate (KDPG), and this metabolic intermediate is then split by Eda into pyruvate (Pyr) and 
glyceraldehyde-3-P (GA3P). Interestingly, the ED-based metabolism is far more distributed in Nature than 
previously thought (Bar-Even et al., 2012); the two ED enzymes being highly conserved among bacterial 
and even archaeal species. 
 
By adopting a multi-omic approach in cells grown on glucose, it was recently demonstrated that P. 
putida KT2440 operates a cyclic glycolysis (Nikel et al., 2015a). This particular architecture in central carbon 
metabolism was termed EDEMP cycle. The functionality of this biochemical device is based on the prevalent 
participation of the ED pathway, supported by the incomplete EMP pathway [operating as a gluconeogenic 
route (Nikel et al., 2014a; 2015b)], and the first two elements of the PP pathway (Nikel et al., 2014a; 2015b). 
By using this atypical metabolic configuration, P. putida KT2440 recycles part of the trioses-P pool back to 
glucose-6-P (G6P), as indicated in Fig. 1b. Under balanced growth conditions with glucose as the only 
carbon source, the EDEMP cycle recycles ca. 10-15% of the trioses-P generated by the ED pathway back 
to hexoses-P. The rest of carbon skeletons in the form of trioses-P is further metabolized into acetyl-
coenzyme A (acetyl-CoA) to enter into the tricarboxylic acid (TCA) cycle in order to produce biomass 
precursors and reducing equivalents. The study of mutants blocked at different steps of the EDEMP cycle 
highlighted the relevance of this sub-network for the survival and robustness of P. putida KT2440. For 
example, interrupting the cycle has proved to affect the overall redox balance of this bacterium, despite the 
fact that the core metabolism of strain KT2440 has been demonstrated to be quite robust to both redox and 
energy perturbations (Ebert et al., 2011). At the same time, the disruption of this metabolic cycle can 
compromise the synthesis of different precursors coming from the recycling of trioses-P [i.e., generation of 
FBP, which could not be obtained otherwise (Portais & Delort, 2002)]. 
 
The operation of the glycolytic cycle also results in a high endurance of P. putida to oxidative stress. 
This is one of the most important characteristic features displayed by this environmental bacterium, reflected 
in its capacity to inhabit polluted environments (Kim & Park, 2014). The activity of the major dehydrogenases 
in the EDEMP cycle of P. putida KT2440, such as glucose-6-P 1-dehydrogenase (Zwf), is directly coupled 
to the formation of NADPH (Nikel & Chavarría, 2016), with a relatively small degree of promiscuity in cofactor 
selectivity (Nikel et al., 2015a). In the case of the linear ED pathway, one NADPH molecule is generated per 
molecule of G6P entering the process through Zwf. In the EDEMP cycle, in contrast, the yield of NADPH 
can increase significantly depending on the extent of recycling (Fig. 1b). This is possible due to the formation 
of additional G6P from F6P via the glucose-6-P isomerase (Pgi) activity, feeding the Zwf activity with extra 
substrate molecules. The relevance of this network to P. putida KT2440 has been exposed by the material 
impossibility to obtain a complete Zwf mutant. At the same time, the essentiality of Zwf is hinted by the 
presence of three isoenzymes for the same biochemical reaction [i.e., Zwf (PP_5351), ZwfA (PP_1022), 
and ZwfB (PP_4042)], an example of redundancy associated to environmental adaptation (Bratlie et al., 
2010; Maleki et al., 2015). 
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Figure 1½Glucose metabolism of P. putida KT2440. (a) Schematic representation depicting the glucose 
uptake system of P. putida KT2440. The capital letters shown in the picture indicate the functional subunits 
of the ABC transporter. (b) Simplified representation of central carbon metabolism in P. putida KT2440. 
Glucose catabolism occurs mainly through the activity of the Entner-Doudoroff (ED) pathway, and part of 
the trioses-P thereby generated are recycled back to hexoses-P by means of the EDEMP cycle, that also 
encompasses activities from the (gluconeogenic) Embden-Meyerhof-Parnas (EMP) and pentose 
phosphate (PP) pathways. The scheme also depicts the conversion of pyruvate into acetyl-coenzyme A, 
that enters in the tricarboxylic acid (TCA) cycle. A set of peripheral reactions can oxidize glucose to 
gluconate and/or 2-ketogluconate (2KG) before any phosphorylation of the intermediates occurs. Each 
metabolic block is indicated with different colours, and the EDEMP cycle is shaded in blue in the diagram. 
Note that 6-phosphofructo-1-kinase (Pfk) activity is absent and this reaction is indicated as a dashed grey 
row. The abbreviations used in this picture are as follows: G6P, glucose-6-P; F6P, fructose-6-P; FBP, 
fructose-1,6-P2; DHAP, dihydroxyacetone-P; GA3P, glyceraldehyde-3-P; Pyr, pyruvate; 6PG, 6-
phosphogluconate; KDPG, 2-keto-3-deoxy-6-phosphogluconate; acetyl-CoA, acetyl-coenzyme A; 2K6PG, 
2-ketogluconate-6-P; OM, outer membrane; PS, periplasmic space; and IM, inner membrane. 
 
2.3. ED pathway vs. EMP pathway: reducing power vs. energy yield. As indicated above, the metabolic 
lifestyle of P. putida KT2440 enables this bacterium to survive under adverse environmental conditions 
(Chavarría et al., 2013), but at the same time it somewhat limits the use of this microorganism in 
biotechnological applications that require high rates of ATP formation (Hara & Kondo, 2015; Schuster, 2000). 
Taking into account this operational limitation, the objective of this Thesis is focused on the transformation 
of the native EDEMP cycle-based metabolism of P. putida KT2440 into an energy-efficient EMP-based 
biochemical network. Yet, what are the main differences of each catabolic lifestyle? 
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Microbial cells need to expend a great deal of energy to maintain their functional organization. The 
EMP and ED catabolic pathways satisfy this energy demand with the generation of ATP during glucose 
metabolism (Stettner & Segrè, 2013). However, the ATP yield in either pathway is certainly not the same. 
The stoichiometry of reactants and products in each case (Fig. 2) indicates that the EMP pathway produces 
twice as much ATP per glucose than the ED pathway does (Bar-Even et al., 2012). The first part of glycolysis 
is based on the investment of ATP to phosphorylate hexose sugars (i.e., the so-called preparatory phase). 
These phosphorylated intermediaries are then cleaved to generate two trioses intermediates. The 
investment in ATP is recovered in the second phase of glycolysis (termed pay-off phase), where the 
oxidation of trioses-P drives the generation of ATP. Despite that the two glycolytic pathways overlap in some 
reactions (Fig. 2), they differ in the number of three carbon intermediates in the pay-off phase. In the case 
of the EMP pathway, 2 ATP equivalents are consumed to phosphorylate glucose twice, and both trioses-P 
intermediates (i.e., GA3P) enter the pay-off phase to produce two ATP each (Fig. 2a). On the other hand, 
the ED pathway consumes one ATP to phosphorylate glucose once (as it was indicated in the previous 
section, see Fig. 1b), obtaining a unique GA3P molecule to be entered in the pay-off phase (Fig. 2b). This 
approach results in the production of 1 ATP equivalent per molecule of glucose. In summary, while the EMP 
pathway extracts two ATP molecules per glucose, the ED pathway only yields one. 
 
Why is the ED pathway so widely distributed in bacteria despite its low energy yield? Phylogenetic 
analysis indicate that the ED pathway predated the EMP pathway (which is rather common in eukaryotes) 
in the evolutionary timeline (Romano & Conway, 1996). This theory considered the EMP route to be a fine-
tuned adaptation of the ED-based biochemistry in order to optimize energy efficiency. However, a more 
recent study suggested a different scenario, in which the ED pathway should be considered as a 
thermodynamically favored network (Flamholz et al., 2013). In this case, the low ATP from the ED pathway 
yield is compensated by the low cost of the machinery employed in this route (i.e., just two enzymes needed 
to operate the ED route as opposed to the ten enzymes that compose the EMP pathway). In any case, it 
seems plausible that the evolutionary choice of one route over the other is based on the particular 
adaptations to the environment, a feature that is unique for each biological entity. 
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Figure 2½Structural differences and similarities between the ED and EMP catabolic routes. The 
scheme depicts the key aspects of (a) the Embden-Meyerhof-Parnas (EMP) pathway and (b) the Entner-
Doudoroff (ED) pathway. The EMP and ED reactions are indicated by colored arrows (blue and green, 
respectively). The carbon atoms and phosphate groups are shown in different colors to highlight the 
organization of the ATP consuming and producing steps. Other features (e.g., the stoichiometry of reducing 
cofactors, such as NADH and NADPH) have been removed to simplify the scheme. The abbreviations used 
in this scheme are as follows: G6P, glucose-6-P; FBP, fructose-1,6-P2; GA3P, glyceraldehyde-3-P; Pyr, 
pyruvate; 6PG, 6-phosphogluconate; and KDPG, 2-keto-3-deoxy-6-phosphogluconate. 
 
3. Synthetic Biology and Metabolic Engineering for refactoring the central carbon 
metabolism of P. putida KT2440 
 
Metabolic Engineering emerged as a discipline which employs the existing knowledge about living systems 
to generate biological entities that can be used as biofactories for the production of value-added products 
(Breitling & Takano, 2015; King et al., 2016; Nielsen & Keasling, 2016; Schuster et al., 2000). Currently, 
Synthetic Biology provides a large number of strategies and tools for the rational creation of predictable 
DNA circuits to be used in Metabolic Engineering (Stephanopoulos, 2012). DNA synthesis has been 
optimized during the last years by the use of automated instruments, allowing for the significant reduction in 
the operational prizes (i.e., 50 USD/bp some 20 years ago vs. <0.2 USD/bp nowadays). DNA 
democratization has enabled bottom-up approaches that facilitate the reconstruction of entire metabolic 
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networks à la carte (Jullesson et al., 2015). DNA synthesis is as important as the biological machinery that 
expresses and contains these nucleic acids. This basic idea of biological container leads to the important 
concept of chassis, which can be defined as the live platform able to host and sustain the molecular 
transactions necessary for expressing the information encoded in any DNA design (Danchin, 2012). In the 
present Thesis, both notions are exploited under the form of two key elements: (i) a set of standardized DNA 
elements (designed as a genetic tool), that encode the whole of the reactions needed to implement the 
linear EMP glycolytic pathway in virtually any Gram-negative host, and (ii) a deeply streamlined P. putida 
KT2440-based chassis, that allows for deep refactoring of central carbon metabolism. In the next sections, 
the principles at the basis of these key elements are discussed in detail (Fig. 3). 
 
3.1. Genetic tools in Metabolic Engineering. The post-Genomic Era we are living nowadays has changed 
the angle from which Metabolic Engineering endeavors are approached. The enormous volume of data on 
genes, proteins, and metabolites that has been accumulated thus far, together with the decrease in DNA 
synthesis costs, has made rational engineering attempts easier. Users are now able to design and quickly 
synthetize DNA constructs encoding practically any desired metabolic pathway. This situation has, in turn, 
gradually shifted away the focus of Metabolic Engineering from manipulating individual pathways to 
purposedly perturbing the entire biochemical network in the host cell (Lee & Kim, 2015; Park & Lee, 2008; 
Stafford & Stephanopoulos, 2001). Synthetic Biology devices are an essential part of the repertoire of tools 
currently available to reach such a purpose. 
 
The concept of tool is directly correlated with the term of portability (Fig. 3a). As it was mentioned 
before, the type of genetic tool designed in this Thesis is meant to be compatible with a wide variety of 
Gram-negative bacteria (including, but certainly not limited to, P. putida). This situation is relevant since 
many of the available tools used nowadays for manipulating microbial metabolism are not universally 
applicable. Usually, these tools are specific to only certain pathways or products. This lack of transferability 
of a majority of tools and techniques between hosts, in turn, can be attributed to an incomplete 
understanding of regulatory mechanisms in the cell (Yadav et al., 2012). Thus, the development of genetic 
tools should also consider an up-to-date knowledge of regulatory elements both in the DNA sequences 
employed for their construction and the regulatory network in the host. 
 
 Furthermore, the feasibility of cheaply synthetizing DNA à la carte allows for the introduction of another 
key notion in the process of genetic tool design: modularity, an important principle for the standardization 
sough after by Synthetic Biology approaches (Fig. 3a). A well-designed genetic tool must facilitate the 
manipulation of its basic component elements; e.g., with the introduction of a logic pattern of enzyme 
restriction sites (Yadav & Stephanopoulos, 2010). Modularization, especially in the form of one module-one 
source strategy, enables faster construction, testing, and identification of expression configurations that 
maximize product formation in different scenarios. 
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At the same time that the genetic tool is generated by sticking to the principle of modularity, functional 
components should be designed by taking into account the genomic containment that is going to host them. 
A versatile genetic tool must be easy to be cut-and-pasted into standardized plasmid vector/transposon 
systems, making the assembly of DNA both facile and affordable (Biggs et al., 2014). The Synthetic Biology 
community is constantly providing standards to follow during the implementation of these practices (Fig. 
3a); e.g., the SEVA (Standard European Vector Architecture) plasmid collection (Silva-Rocha et al., 2013), 
and the pBAM1/pBAMDs transposon platform (Martínez-García et al., 2011; 2014a). This set of plasmids 
appears as a promising asset to deploy Metabolic Engineering designs in Gram-negative bacteria. However, 
the use of plasmids should be considered as a beta-phase testing in terms of stable metabolic 
manipulations: plasmid segregation, imprecise control of plasmid-based gene expression, and metabolic 
burden are just a few drawbacks of adopting plasmid-based heterologous gene expression (Anthony et al., 
2009; Bentley et al., 1990; Jones et al., 2000). For this reason, stable chromosome-based expression via 
transposition events are an alternative to circumvent these challenging issues. This strategy avoids (or, at 
least, alleviates the effect of) some of the above-mentioned problems, such as asymmetric segregation and 
problems with plasmid maintenance, the associated metabolic stress, and the need of antibiotic 
supplementation (Tyo et al., 2009). Taking into account the principles detailed in this section (including the 
concepts of portability, modularity, and composable DNA assembly), a promising genetic tool for à la carte 
implementation of a flawless EMP glycolytic pathway in different Gram-negative bacteria is thoroughly 
presented in this Thesis. 
 
3.2. Bacterial chassis design in Metabolic Engineering. Once the coding DNA modules have been 
designed and generated, the next step comprises the selection (and, if necessary, the engineering) of an 
appealing biological container for the construct(s). The many qualities of P. putida, which have been already 
indicated in the first part of the Introduction, served as an inspiration to unleash the full catalytic potential of 
this bacterium as a case example of deep refactoring of the entire carbon metabolism. This task is, however, 
a rather challenging venture. As a first step, it is necessary to generate a well-designed chassis amenable 
to host the novel metabolic capacities to be implanted. 
 
The design of a hefty bacterial chassis needs to follow rules as strict as the ones indicated above for 
standard genetic tools (Kim et al., 2016a). An appealing microbial chassis must hold the minimal information 
(i) to operate autonomously, (ii) to complete the basic biological functions of growth and maintenance, and 
(iii) to properly run the necessary cellular machinery to withstand stressful conditions that can appear during 
catalytic processes (Danchin, 2012). Taking into account all this information, the chassis construction 
process often encompasses the removal of genes that encode non-essential functions for survival under 
specific conditions (Choe et al., 2016). The concept of a minimal bacterial genome needs to be discussed 
in the context in which it is meant to be applied, adapting the type and extent of genetic manipulations to 
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the main goal of the entire project (in our case, refactoring of central carbon metabolism using glucose as 
the carbon source). 
 
The idea of a minimal genomic chassis has been already exploited in the past in several industrially-
relevant microorganisms (Choe et al., 2016; Martínez-García & de Lorenzo, 2016). Genome reduction 
seems to be a promising approach to make bacterial hosts more predictable and easily controllable (Lieder 
et al., 2015; Martínez-García et al., 2014c). At the same time, the functional simplification of biochemical 
pathways and metabolic nodes in the engineered cells minimizes the interactions between the cellular 
machinery and the genetic construct(s) implanted (Fig. 3b), which can otherwise result in the appearance 
of undesired side reactions and difficult-to-predict phenotypes (Kim & Copley, 2012; Nielsen et al., 2013). 
In our particular case, the implementation of novel metabolic capacities in a complex biochemical network 
poses an additional issue to solve, i.e., the competition of extant pathways for the substrate (Fig. 3b). The 
elements involved in the core bacterial metabolism are highly interconnected through a large number of 
essential biochemical reactions (e.g., glycolysis, anabolic reactions, and TCA cycle, to mention just a few 
examples). The refactoring and manipulation of these central biochemical routes calls for a detailed 
knowledge of the substrate’s itineraries. The overall success of these approaches largely depends on the 
elimination of competing reactions diverting carbon intermediates from the pathway(s) of interest (Tepper & 
Shlomi, 2010; Wendisch et al., 2016). 
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Figure 3½Key concepts in Synthetic Biology-guided Metabolic Engineering. The large number of 
works developed under the discipline of Metabolic Engineering have allowed to identify the relevant 
elements in most endeavors: (a) the generation of standard genetic tools, and (b) the design and 
construction of a suitable bacterial chassis. (a) A well-designed genetic tool is characterized by its portability 
(i.e., allowing the user to be employ the tool in different, often unrelated, biological entities), modularity (i.e., 
facilitating the manipulation of its constituent components), and the facility to be assembled (i.e., making 
the assemblage of DNA comfortable). (b) The biological container for these constructs (chassis) must be 
streamlined to increase its predictability, minimizing the potential interactions between the cellular 
machinery and the implanted genetic construct, and removing the native pathways that can compete for 
the substrate of the desired reaction(s). 
 
4. The issue at stake: de novo engineering of central carbon metabolism in P. putida KT2440 
 
P. putida KT2440 displays a remarkable endurance to different types of exogenous stressors, holding the 
promise to outcompete other microbial cell platforms in specific biotechnological applications. These 
advantageous properties stem from an atypical central carbon metabolism, which is geared to obtain 
reducing power (i.e., NADPH). However, the central carbon metabolism of this bacterium does not prioritize 
the generation of ATP, an important requirement in a large number of biotechnological process. Taking into 
account this challenging scenario, the present work seeks to engineer the catabolic lifestyle of P. putida to 
unleash its catalytic potential in applications in which a high yield of ATP on substrate is desirable. For this 
reason, a complete refactoring of the central carbon metabolism of this bacterium was undertaken by 
adhering to the Synthetic Biology principles enumerated in the previous sections. This Synthetic Biology-
guided metabolic transformation is based on the substitution of the highly redox-efficient ED pathway by a 
synthetic ATP-generating EMP route transplanted into a heavily engineered P. putida chassis. The whole 
process is divided into individual steps, driven by independent objectives. Firstly, the design and creation of 
the GlucoBrick platform, a standard genetic tool capable of implementing the EMP pathway glycolytic 
activities into virtually any Gram-negative bacterium, is discussed in Chapter 1. The genomic streamlining 
process conducted to generate an appropriate P. putida glycolytic chassis is explained in Chapter 2. The 
native metabolic wiring of the EDEMP cycle is explored by interrupting the step catalyzed by Pgi in Chapter 
3. Finally, Chapter 4 discloses the results of combining the GlucoBrick platform into the final version of the 
P. putida glycolytic chassis, analyzing the physiological effects of such network-wide metabolic manipulation 
by means of a fluxomic strategy. 
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II. OBJECTIVES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
«No one knows what he can do till he tries» 
Publilius Syrus  
(85 BC-43 BC) 
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OBJECTIVES 
 
The general objective of this Thesis is: 
 
The de novo refactoring of the central carbon metabolism of Pseudomonas putida KT2440 to implement 
a functional linear glycolysis, based on the Embden-Meyerhof-Parnas (EMP) pathway, for enhanced 
energy balance from glucose. 
 
This general objective is implemented trough the execution of the following specific objectives: 
 
1. To design a broad-host-range genetic tool for à la carte implementation of the EMP pathway-based 
glycolytic activities in different Gram-negative bacteria. 
 
2. To construct a useful P. putida KT2440 glycolytic chassis, capable of accommodating novel 
catabolic pathways in its central carbon metabolism. 
 
3. To understand the metabolic wiring of native glycolytic pathways in strain KT2440, through the 
interruption of the biochemical step catalyzed by glucose-6-P isomerase (Pgi). 
 
4. To implement a flawless linear EMP pathway in a P. putida glycolytic chassis as the only way to 
process glucose, increasing, at the same time, the ATP output from hexoses as the carbon source. 
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III. MATERIALS & METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
«Help me to do it myself» 
Maria Tecla Artemisia Montessori  
(1870 AC-1952 AC) 
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MATERIALS & METHODS 
 
1. General procedures 
	
1.1. Bacterial strains 
The bacterial strains used in this Thesis are described in Table 2. 
  
Table 2½Bacterial strains used in this Thesis. 
Strain	 Relevant characteristicsa	 Reference or source	
Escherichia coli	 	 	
 
CC118	
 
Cloning host; D(ara-leu) araD DlacX174 galE galK phoA thiE1 
rpsE rpoB(RifR) argE(Am) recA1 
 
Manoil & 
Beckwith (1985)	
CC118 lpir	 Cloning host for plasmids containing an R6K origin of 
replication; Δ(ara-leu) araD ΔlacX174 galE galK phoA20 thi-1 
rpsE rpoB argE (Am) recA1, λpir lysogen 
Herrero et al. 
(1990) 
DH5a lpir	 Cloning host for plasmids containing an R6K origin of 
replication; F– l– endA1 glnX44(AS) thiE1 recA1 relA1 spoT1 
gyrA96(NalR) rfbC1 deoR nupG F80(lacZDM15) D(argF-
lac)U169 hsdR17(rK– mK+), lpir lysogen	
Hanahan & 
Meselson (1983) 
 
HB101	 Mating helper strain; F– λ– hsdS20(rB– mB–) recA13 leuB6(Am) 
araC14 Δ(gpt-proA)62 lacY1 galK2(Oc) xyl-5 mtl-1 thiE1 rpsL20 
glnX44B(AS)B	
Boyer & 
Roulland-Dussoix 
(1969)	
BW25113b	 Wild-type strain; F– l– D(araD-araB)567 DlacZ4787(::rrnB-3) 
rph-1 D(rhaD-rhaB)568 hsdR514 
Datsenko & 
Wanner (2000)	
JW3887-1b	 Same as BW25113, but DpfkA775::aphA; KmR	 Baba et al. 
(2006)	
JW5280-1b	 Same as BW25113, but DpfkB722::aphA; KmR	 Baba et al. 
(2006)	
BPfkAB	 Same as BW25113, but DpfkA775::FRT DpfkB722::aphA; KmR	 This study	
JW2385-1b	 Same as BW25113, but Dglk-726::aphA; KmR	 Baba et al. 
(2006)	
JW2409-1b	 Same as BW25113, but DptsI745::aphA; KmR	 Baba et al. 
(2006)	
BPG	 Same as BW25113, but Dglk-726::FRT DptsI745::aphA; KmR	 Nikel & de 
Lorenzo (2013b)	
JW3890-2b	 Same as BW25113, but DtpiA778::aphA; KmR	 Baba et al. 
(2006)	
W3110	 Wild-type strain; F– l– IN(rrnD-rrnE)1 rph-1	 Jensen (1993), 
Bachmann 
(1972)	
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DS121b	 Same as W3110, but Depd-11::erm; EryR	 Seta et al. (1997)	
DS122b	 Same as W3110, but DgapA12::cat; CmR	 Seta et al. (1997)	
DS123b	 Same as W3110, but DgapA12::cat Depd-11::erm; CmR EryR	 Seta et al. (1997)	
DS123PK	 Same as W3110, but DgapA12::cat Depd-11::erm 
DptsI745::aphA; CmR EryR KmR 
This study	
DS123P	 Same as W3110, but DgapA12::cat Depd-11::erm 
DptsI745::FRT; CmR EryR	
This study	
DF575 b	 F– l– glnX44(AS) relA1 eno-2 rpsL104 malA malT1(lR) xyl-7 
mtlA2 thiE1 
Thomson et al. 
(1979)	
DF576 b	 F– l– glnX44(AS) relA1 pgk-2 rpsL104 malA malT1(lR) xyl-7 
mtlA2 thiE1	
Thomson et al. 
(1979)	
 
Strain	 Relevant characteristicsa	 Reference or source	
Pseudomonas putida	
 
KT2440	
 
Wild-type strain, derived from P. putida mt-2 (Worsey & Williams, 
1975) cured of the TOL plasmid pWW0 
 
Bagdasarian 
et al. (1981)	
KT2440 Dglk 
	
Same as KT2440, but with an in-frame deletion of the glk gene 
(PP_1011) 
 
This study 
	
KT2440 Dgcd Same as KT2440, but with an in-frame deletion of the gcd gene 
(PP_1444) 
This study 
	
KT2440 
DPP_3382-4 
Same as KT2440, but with an in-frame deletion of the genes 
PP_3382, PP_3383 and PP_3384 by a single deletion event 
This study 
	
KT2440 
      DPP_3623	
Same as KT2440, but with an in-frame deletion of the PP_3623 
gene 
This study 
	
KT2440 
    DPP_4232 
Same as KT2440, but with an in-frame deletion of the PP_4232 
gene	
This study 
	
KT2440 Dgad Same as KT2440 DPP_3382-4, but with an in-frame deletion of the 
genes PP_3623 and PP_4232	
This study	
KT2440 
       Dglk Dgcd	
Same as KT2440 Dglk, but with an in-frame deletion of the gcd gene 
(PP_1444)	
This study	
KT2440 Dedd	 Same as KT2440, but with an in-frame deletion of the edd gene 
(PP_1010)	
This study	
KT2440 Deda	 Same as KT2440, but with an in-frame deletion of the eda gene 
(PP_1024)	
This study	
KT2440 Dgts	 Same as KT2440, but with an in-frame deletion of the genes that 
encode the sugar ABC transporter [DgtsA (PP_1015), DgtsB 
(PP_1016), DgtsC (PP_1017) and DgtsD (PP_1018)]	
This study	
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KT2440  
   Dgts Dgcd 
Same as KT2440 Dgts, but with an in-frame deletion of the gcd gene 
(PP_1444)	
This study	
KT2440  
   Dgts Dgcd·T 
	
Same as KT2440 Dgts Dgcd but PP_5SE::mini-Tn5(glf); 
(chromosomal insertion of the gene encoding the Glf glucose 
transporter from Zymomonas mobilis); KmR	
This study	
GC1 
	
Glycolytic chassis I; derivative of P. putida KT2440 with the 
deletions described for the mutants Dglk, Dgcd, Dgad and Dedd	
This study	
GC2 
	
Glycolytic chassis II; derivative of P. putida GC1 with the deletions 
described for the mutants Dgts and Deda	
This study 
	
GC2·T·GBI	 Same as P. putida GC2 but PP_0841::mini-Tn5(glf); chromosomal 
insertion of the gene encoding the Glf glucose transporter from 
Zymomonas mobilis and genome coordinate 6,005,012:mini-
Tn5(GBI); chromosomal insertion of the genes of Module I of the 
GlucoBrick platform; KmR SmR	
This study	
GC2·T·GBI·GBII 
	
Same as P. putida GC2·T·GBI but PP_0806:mini-Tn5(GBII); 
chromosomal insertion of the Module II of the GlucoBrick platform; 
KmR SmR GmR 
This study	
KT2440 Dpgi-I	 Same as KT2440, but with an in-frame deletion of the pgi-I gene 
(PP_1808)	
This study	
KT2440 Dpgi-II	 Same as KT2440, but with an in-frame deletion of the pgi-II gene 
(PP_4701) 
This study 
	
KT2440 
     Dpgi-I Dpgi-II	
Same as KT2440 Dpgi-I, but with an in-frame deletion of the pgi-II 
gene (PP_4701)	
This study 
KT2440 DgntZ Same as KT2440, but with an in-frame deletion of the gntZ gene 
(PP_4043) 
This study 
 
KT2440 
Dpgi-I Dpgi-II 
DgntZ 
 
Same as KT2440 Dpgi-I Dpgi-II, but with an in-frame deletion of the 
gntZ gene (PP_4043) 
This study 
Pseudomonas aeruginosa 
PAO1 Wild-type strain (PAO1001), original stock conserved by P. V. Phibbs 
Stover et al. 
(2000) 
 
a Antibiotic markers: Ap, ampicillin; Cm, chloramphenicol; Ery, erythromycin; Gm, gentamicin; Km, 
kanamycin; Nal, nalidixic acid; Rif, rifampicin; Sm, streptomycin; Sp, spectinomycin; and Tc, tetracycline. 
b  Strain obtained from the E. coli Genetic Stock Center (Yale University, New Haven, CT, USA). 
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1.2. Plasmids 
 
The plasmids used in this study are described in Table 3.  
 
Table 3½Plasmids used in this study. 
Plasmids	 Relevant characteristicsa	 Reference or source	
 
pKD46	
 
ApR; helper plasmid expressing the l-Red recombination 
functions	
 
Datsenko & 
Wanner (2000)	
pCP20	 ApR CmR; helper plasmid used for excision of FRT-aphA-FRT 
(KmR), Saccharomyces cerevisiae FLP lcI857 lPR repA(Ts)	
Cherepanov & 
Wackernagel 
(1995)	
pRK600	 CmR; Helper plasmid used for conjugation, oriV(ColE1), 
RK2(mob+ tra+); derivative of plasmid pRK2013 (Ditta et al., 
1980) 
Kessler et al. 
(1992)	
pEMG	 KmR; oriV(R6K), vector used for deletions, lacZa with two 
flanking I-SceI target sites 
Martínez-García & 
de Lorenzo (2011) 
 
pEMGDglk KmR; pEMG derivative bearing a 1.0-kb TS1-TS2 EcoRI-BamHI 
insert for deletion of the glk gene of P. putida KT2440	
This study	
pEMGDgcd KmR; pEMG derivative bearing a 1.0-kb TS1-TS2 EcoRI-BamHI 
insert for deletion of the gcd gene of P. putida KT2440	
This study	
pEMGD 
     PP_3382-4	
KmR; pEMG derivative bearing a 1.0-kb TS1-TS2 EcoRI-BamHI 
insert for deletion of the group of genes PP_3382, PP_3383 
and PP_3384 of P. putida KT2440	
This study	
pEMGD 
     PP_3623 
KmR; pEMG derivative bearing a 1.0-kb TS1-TS2 EcoRI-BamHI 
insert for deletion of the PP_3623 gene of P. putida KT2440	
This study	
pEMGD 
     PP_4232 
KmR; pEMG derivative bearing a 1.0-kb TS1-TS2 SacI-BamHI 
insert for deletion of the PP_4232 gene of P. putida KT2440	
This study 
	
pEMGDedd	 KmR; pEMG derivative bearing a 1.0-kb TS1-TS2 EcoRI-BamHI 
insert for deletion of the edd gene of P. putida KT2440	
This study	
pEMGDeddDglk KmR; pEMG derivative bearing a 1.0-kb TS1-TS2 EcoRI-BamHI 
insert for deletion of the edd gene of P. putida KT2440 Dglk	
This study	
pEMGDeda	 KmR; pEMG derivative bearing a 1.0-kb TS1-TS2 EcoRI-BamHI 
insert for deletion of the eda gene of P. putida KT2440	
This study	
pEMGDgts	 KmR; pEMG derivative bearing a 1.0-kb TS1-TS2 EcoRI-BamHI 
insert for deletion of the genes that encoded the sugar ABC 
transporter by a single deletion event: DgtsA (PP_1015), DgtsB 
(PP_1016), DgtsC (PP_1017) and DgtsD (PP_1018)	
This study	
pEMGDpgi-I	 KmR; pEMG derivative bearing a 1.2-kb TS1-TS2 EcoRI-BamHI 
insert for deletion of the pgi-I gene of P. putida KT2440	
This study	
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pEMGDpgi-II KmR; pEMG derivative bearing a 1.1-kb TS1-TS2 EcoRI-BamHI 
insert for deletion of the pgi-II gene of P. putida KT2440	
This study 
	
pEMGDgntZ	 KmR; pEMG derivative bearing a 1.0-kb TS1-TS2 SacI-BamHI 
insert for deletion of the gntZ gene of P. putida KT2440	
This study	
pSW-Ib	 ApR; oriV(RK2), xylS, Pm→I-SceI, transcriptional fusion of the 
gene encoding I-SceI to the Pm promoter	
Wong & 
Mekalanos (2000)	
pAeT41	 ApR; derivative of cloning vector pUC18 bearing a ca. 5-kb 
SmaI/EcoRI DNA fragment spanning the phaC1AB1 gene 
cluster from Cupriavidus necator	
Peoples & 
Sinskey (1989)	
pSEVA224	 KmR; standard SEVA expression vector, oriV(RK2) lacIQ, Ptrc	 Silva-Rocha et al. 
(2013)	
pS224·GPG	 KmR; pSEVA224 derivative bearing glk and pfkA from Module 
I, and gapA from Module II	
This study	
pS224·GBI	 KmR; pSEVA224 derivative bearing Module I as an AvrII-BamHI 
insert 
This study	
pS224·GBII	 KmR; pSEVA224 derivative bearing Module II as a BamHI-
HindIII insert 
This study	
pSEVA234	 KmR; standard SEVA expression vector, oriV(pBBR1) lacIQ, Ptrc	 Silva-Rocha et al. 
(2013)	
pS234·GBI	 KmR; pSEVA234 derivative bearing Module I as an AvrII-BamHI 
insert	
This study	
pSEVA434	 SmR/SpR; standard SEVA expression vector, oriV(pBBR1) 
lacIQ, Ptrc	
Silva-Rocha et al. 
(2013)	
pS434·GBI	 SmR/SpR; pSEVA434 derivative bearing Module I as an AvrII-
BamHI insert 
This study	
pSEVA424	 SmR/SpR; standard SEVA expression vector, oriV(RK2) lacIQ, 
Ptrc	
Silva-Rocha et al. 
(2013)	
pS424·gapA	 SmR/SpR; pSEVA424 bearing gapA from Module II This study	
pS424·GBI	 SmR/SpR; pSEVA424 derivative bearing Module I as an AvrII-
BamHI insert	
This study	
pSEVA438	 SmR/SpR; standard SEVA expression vector, oriV(pBBR1) xylS, 
Pm	
Silva-Rocha et al. 
(2013)	
pS438·GBI	 SmR/SpR; pSEVA438 derivative bearing Module I as an AvrII-
BamHI insert	
This study 
pS438·glf	 SmR/SpR; pSEVA438 derivative bearing glf (glucose facilitator) 
gene from Zymomonas mobilis as an EcoRI-KpnI insert 
This study	
pRK600 
	
Helper plasmid used for conjugation; ori(ColE1), RK2(mob+ 
tra+); CmR	
Kessler et al. 
(1992)	
pBAMD1-2 Mini-Tn5 delivery plasmid; ori(R6K); ApR KmR 
	
Martínez-García  
et al. (2014a)	
pBAMD1-2·glf Derivative of pBAMD1-2; delivery plasmid used to insert glf 
(glucose facilitator) gene from Zymomonas mobilis as an 
EcoRI-KpnI insert in the chromosome of recipient P. putida 
strains; ApR KmR	
This study	
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pBAMD1-4 Mini-Tn5 delivery plasmid; ori(R6K); ApR SmR/SpR	 Martínez-García  
et al. (2014a) 
pBAMD1-4·GBI Derivative of pBAMD1-4; delivery plasmid used to insert 
GlucoBrick Module I as an AvrII-BamHI insert in the 
chromosome of recipient P. putida strains; ApR SmR/SpR	
This study	
pBAMD1-6 Mini-Tn5 delivery plasmid; ori(R6K); ApR GmR	 Martínez-García  
et al. (2014a) 
pBAMD1-6·GBII Derivative of pBAMD1-2; delivery plasmid used to insert 
GlucoBrick Module II as a BamHI-HindIII insert in the 
chromosome of recipient P. putida strains; ApR GmR	
This study	
 
 
a Antibiotic markers: Ap, ampicillin; Cm, chloramphenicol; Km, kanamycin; Sm, streptomycin; Sp, 
spectinomycin; and Gm, gentamicin. Ts, temperature-sensitive origin of replication. 
b  This plasmid is the same as pSW(I-SceI) (Wong & Mekalanos, 2000), renamed here as pSW-I for 
simplicity. 
 
1.3. Culture conditions. P. putida cultures were incubated at 30ºC; E. coli and Pseudomonas aeruginosa 
were grown at 37ºC. In order to obtain cultures for the propagation and construction of plasmids, E. coli 
strains CC118 and DH5a lpir were grown in Lysogeny Broth (LB) medium (Green & Sambrook, 2012; 
Martínez-García et al., 2017). For physiology experiments and to obtain cell-free extracts for enzyme activity 
assays, bacterial cells were grown with rotatory shaking at 170 r.p.m. in 250-ml Erlenmeyer flasks filled with 
50 ml of M9 minimal medium, containing 6 g l−1 Na2HPO4, 3 g l−1 KH2PO4, 1.4 g l−1 (NH4)2SO4, 0.5 g l−1 NaCl, 
0.2 g l−1 MgSO4·7H2O, and 2.5 ml l−1 of a trace elements solution (Nikel & de Lorenzo, 2013a). In the case 
of E. coli strains grown in minimal media cultures, CaCl2 was added at 0.1 mM and vitamin B1 was added 
at 0.05% (w/v). Unless otherwise indicated, minimal medium cultures were added with glucose at 20 mM. 
In some cultures, isopropyl-1-thio-b-galactopyranoside (IPTG) was added at 1 mM. Some glycolytic mutants 
of E. coli are affected in their growth even in rich LB medium (Thomson et al., 1979); these mutants were 
grown in M9GCM semi-synthetic medium. This culture medium contains the same salts as M9 minimal 
medium, but also 0.75% (w/v) amino acids from casein hydrolyzate (Becton-Dickinson Diagnostics Co., 
Sparks, MD, USA), 10 mM glucose, 20 mM glycerol, 15 mM sodium malate, and 0.05% (w/v) vitamin B1. In 
the case of E. coli DgapA Depd and DgapA Depd DptsI mutants (i.e., deficient in the epd-encoded erythrose-
4-P dehydrogenase), pyridoxine hydrochloride was added to the culture medium at 5 µM (Yang et al., 1998). 
In order to adapt the cells to growth on glucose from rich LB medium, pre-inocula were prepared with a few 
isolated colonies from LB medium plates. Those pre-inocula were grown overnight (with the exception of 
the strains with a lower growth rate, where the pre-inocula were prepared well in advance to provide enough 
amount of cells) in 10 ml of M9 minimal medium with glucose or M9GCM semi-synthetic medium with the 
corresponding antibiotics in 100-ml Erlenmeyer flasks. In the case of solid media cultures needed to streak 
cells, the composition was the same than those applicable in liquid medium with the addition of 15 g l-1 of 
agar. The antibiotics employed for selection were added to the media when needed at the following final 
MATERIALS & METHODS 
	 53 
III 
concentrations: ampicillin (Ap), 150 µg ml−1 for E. coli strains or 500 µg ml−1 for P. putida strains; 
streptomycin (Sm), 50 µg ml−1 or 80 µg ml−1 for P. putida strains; gentamicin (Gm), 10 µg ml−1; and 
kanamycin (Km), 50 µg ml−1 with the exception of P. aeruginosa, for which 300 µg ml−1 Km was needed to 
select colonies after transformation of plasmids by electroporation. For the construction of P. putida mutants, 
3-methylbenzoate (3-mB) was used at 15 mM to induce the XylS-dependent Pm promoter. Experiments for 
poly(3-hydroxybutyrate) (PHB) accumulation were carried out in LB medium added with glucose at 10 g l-1 
and the antibiotics and inducers described in the text (in these experiments, 3-mB was used at 0.5 mM to 
induce the expression of the genes in Module II). In order to check the capability of some cultures to grow 
in gluconeogenic conditions, minimal medium cultures were added with succinate at 30 mM. This 
concentration was selected for the purpose of obtaining the same concentration of carbon atoms (120 mM) 
when the cultures were inoculated in glycolytic (glucose) or glunoneogenic (succinate) conditions. For long-
term preservation, bacteria (previously grown in LB medium plates) were frozen in LB medium containing 
20% (v/v) glycerol and kept at –80ºC. 
 
1.4. Bacterial transformation. The transformation of E. coli strains was carried out (i) chemically, by 
following the RbCl method (Green & Sambrook, 2012) to obtain competent cells, or (ii) by electroporation 
(Wirth et al., 1989), by following the method described by Datsenko and Wanner (Datsenko & Wanner, 
2000). In the case of P. putida transformation, electrocompetent cells were obtained by subsequent 
washings at room temperature with 300 mM sucrose (Choi et al., 2006). For all strains, when appropriate, 
the electroporation was performed in a Gene Pulser/Pulse Controller (Bio-Rad) system configured as 
follows: 2.5 kV, 25 µF, 200  W. 
 
1.5. DNA manipulation and sequencing. DNA manipulations were carried out following routine laboratory 
techniques (Green & Sambrook, 2012). Plasmid DNA purification was accomplished with the QIAprep Spin 
Miniprep kit (Qiagen Inc., Valencia, CA, USA) according to the manufacturer's instructions. Restriction and 
DNA modification enzymes employed in this study were purchased from New England Biolabs (Ipswich, 
MA, USA). Isolate colonies from fresh LB plates were the starting material for colony polymerase chain 
reaction (PCR) amplification in order to check the presence of plasmid or gene deletions/insertion. PCR 
products were purified with the NucleoSpin Extract II kit (Macherey-Nagel, Düren, Germany). Agarose gel 
visualization was possible with the use of VersaDoc™ apparatus (Bio-Rad Corp., Hercules, CA, USA). 
Sanger sequencing (Secugen SL, Madrid, Spain) was used in order to check the accuracy of all the DNA 
constructs. 
 
1.6. Design of oligonucleotides. Oligonucleotides employed in PCR reactions were designed from the 
DNA sequence of interest using the software DNASTAR Lasergene Suite v14 (DNASTAR, Inc. Madison, 
WI, USA). The oligonucleotides used in this study were obtained from Sigma-Aldrich Co. (St. Louis, MO, 
USA) and are described in Table 4. 
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Table 4½Oligonucleotides employed in PCR reactions. 
Name	 Sequence (5' → 3')	 Tm (ºC)	 Use	
 
PP_1011-TS1F- 
EcoRI	
 
GGA ATT CGA GGC CCC GGC GCG GGT GTT 
CCA GGA CCA G	
88	
Construction of 
P. putida Dglk	
PP_1011-TS1R	 CAT CGG GGC CGC AAA GCG CCC CCC TCA 
GTG GTG CTT CAT TTG AGG TGC TCC AGG GCC 
GAG 
92	
PP_1011-TS2F	 CAC TGA GGG GGG CGC TTT GCG GCC CCG 
ATG	
86	
PP_1011-TS2R-
BamHI	
CGG GAT CCC GCC AGT CGT CGA AGG CCA 
GCA CGG CGT TG	
88	
 
PP_1444-TS1F-
EcoRI	
 
GGA ATT CGC GGC AGT GCC GAG GTG TCG 
AAG TGG CGG TGG	
 
86	
Construction of 
P. putidaDgcd	
PP_1444-TS1R	 GGC CTG AAG ATC CAG AGC AGT TTC TAA CCC 
GCG ACA CCG CTC CCG CAG GCT CAA CCC TGA 
GG 
89	
PP_1444-TS2F	 GGG TTA GAA ACT GCT CTG GAT CTT CAG GCC	 74	
PP_1444-TS2R-
BamHI	
CGG GAT CCG TCA GCC GGC CGC CCT CAG 
CGG CGC CGC CT	
95	
 
PP_3382-4-TS1F- 
EcoRI	
 
GGA ATT CGT CGT CAG TAA AGG ACG TGA ACG 
ACT GGA C	
 
76	
Construction of 
P. putida 
DPP_3382-4 
PP_3382-4-TS1R	 CAA GGC CGC CCC ACA GCC GAT GAG GAT TCG 
CGT GTT TTT CAG CGC CCT CGC CCG TAG GAG 
91	
PP_3382-4-TS2F	 GGG TTA GAA ACT GCT CTG GAT CTT CAG GCC	 74	
PP_3382-4-TS2R-
BamHI	
CGG GAT CCG TCA GCC GGC CGC CCT CAG 
CGG CGC CGC CT	
95	
 
PP_3623-TS1F-
EcoRI	
 
GGA ATT CTT GTC CGG CGG CTG GAA GCG 
CGG ACC GTT C	
 
85	
Construction of 
P. putida 
DPP_3623 
PP_3623-TS1R	 CAG CCT CGC GTC GGT ACA TGT GCC ACT CCA 
AGG CGT CCC TTG TGC GAT CAG CTG AAG GTG	
89	
PP_3623-TS2F	 TGG AGT GGC ACA TGT ACC GAC GCG AGG CTG	 81	
PP_3623-TS2R-
BamHI	
CGG GAT CCT CAT CTG GGT GCG CCA GGA CAA 
TGC CTT TG	
83	
 
PP_4232-TS1F- 
SacI	
 
CGA GCT CGC CGA CAC GCA AGC GCA CCC 
GGG CAT TTT C	
 
87	
Construction of 
P. putida 
DPP_4232 
PP_4232-TS1R	 CGA TCT CGG CCT GGT CAA GGA GGG TTG AAC 
AGC GTG CAG CAT CTC GAT CTA CAG GTG ATC 
85	
PP_4232-TS2F	 GTT CAA CCC TCC TTG ACC AGG CCG AGA TCG	 78	
PP_4232-TS2R-
BamHI	
CGG GAT CCC CGG TCG GGC CGG TCG AGG 
TTC CCG CGG AC	
92	
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PP_1010-TS1F-
EcorRI	
 
GGA ATT CGC ACT GAC CGC GAT ACG GTC	 75	
Construction of 
P. putida Dedd 
PP_1010-TS1R	 CAC CAA CCA GCA GGT GCT TCA TGT ACT GGA 
CTC CAG GCT AAT TG 
80	
PP_1010-TS2F	 ATG AAG CAC CTG CTG GTT GGT G	 71	
PP_1010-TS2R-
BamHI	
CGG GAT CCC CTA CCG GCA GGT CAA CAT G	 79	
 
PP_1010(Dglk)-
TS1R	
 
GCA AAG CGC CCC CCT CAG TGG TAC TGG ACT 
CCA GGC TAA TTG 
 
83	
 
In combination 
with PP_1010-
TS1F-EcorRI and 
PP_1010-TS2R-
BamHI to remove 
edd gene in  
P. putida Dglk 
PP_1010(Dglk)-
TS2F	
CAC TGA GGG GGG CGC TTT GC	 75	
 
PP_1024-TS1F-
EcoRI	
 
GGA ATT CGT CAC TGT CAG CCT GGC TGA	
 
75	
Construction of 
P. putida Deda 
PP_1024-TS1R	 CGT AAA GCA CAC AAC TGT TTT CAT GGG CAC 
CAG TAG ATG T	
76	
PP_1024-TS2F	 AAA CAG TTG TGT GCT TTA CG	 61	
PP_1024-TS2R-
BamHI	
CGG GAT CCC AAG GGC AAC GGC GCC CTG G	 86	
 
PP_1015-8-TS1F-
EcoRI	
 
GGA ATT CGC ATT GTT CGA CAC AGC CTG	
 
72	
Construction of 
P. putida DGts	
PP_1015-8-TS1R	 TTA TTG ATG GTG TAG ACG AGC GGA GCA CCT 
TTC TTG TTG T	
76	
PP_1015-8-TS2F	 CTC GTC TAC ACC ATC AAT AA	 58	
PP_1015-8-TS2R-
BamHI	
CGG GAT CCG TCG AAG TAC TTC TGC TTG A	 74	
 
PP_1808-TS1F-
EcoRI 
 
ATT TGA ATT CAC ATC GAC GAC TTC CGC CAC	
 
64	
Construction of 
P. putida Dpgi-I	
PP_1808-TS1R	 AAG ATC CTT GAT ACG GGT AAA GCC AG 64 
PP_1808-TS2F	 CTG GCT TTA CCC GTA TCA AGG ATC TTC CCT 
GCT TGA TAC TGG CCC G 
66 
	
PP_1808-TS2R- 
BamHI 
ATT TGG ATC CCT CAG AGG GGT CTC GGC AGG 65	
 
PP_4701-TS1F-
EcoRI	
 
ATT TGA ATT CAC CTG AAT ATG CCG ATC CAG 
ATC ATC	
 
65 
	
Construction of 
P. putida Dpgi-II 
	PP_4701-TS1R	 GTG CGT GGT GAG GGC TTG G	 66	
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PP_4701-TS2F	 CCA AGC CCT CAC CAC GCA CTC GCG GGT AAA 
CCC GCC TAC 
67	
PP_4701-TS2R- 
BamHI	
ATT TGG ATC CCG CCT TTC TTC ACA CCG CG	 66	
 
PP_4043-TS1F-
SacI	
 
CGA GCT CCT GGC CAG GTC GGT GCC GAA	
 
83	
Construction of 
P. putida DgntZ	
PP_4043-TS1R	 CGA AAA GGG AGC ATT GGC TCA TGA CTA AAC 
AGA CCC TTG C 
78	
PP_4043-TS2F	 GAG CCA ATG CTC CCT TTT CG	 67	
PP_4043-TS2R- 
BamHI	
CGG GAT CCG ATG AAG GAC AGC CGC TTG C	 79	
 
pSW-F	
 
GGA CGC TTC GCT GAA AAC TA	 65	 Presence of  
pSW-I	pSW-R	 AAC GTC GTG ACT GGG AAA AC	 65	
 
Bold letters indicate recognition site for the restriction enzymes and the complementary sequences used 
in splicing-by-overlap extension (SOEing; Horton, 1995; Nikel & de Lorenzo, 2013b) PCR amplifications 
are shown in italics.  
 
1.7. Construction of P. putida mutant strains. Clean P. putida knock-out mutants were obtained following 
the protocol described by Martínez-García & de Lorenzo (2011). These mutants are listed and described in 
Table 2. The method is based on the use of the suicide pEMG vector, where long flanking regions are 
cloned upstream and downstream of the target gene(s) by PCR, using chromosomal DNA from strain 
KT2440 as the template. The oligonucleotides employed to amplify these ca. 500-bp long flanking regions 
(TS1, upstream; and TS2, downstream) are described in Table 4. A 1-kbp amplification product (i.e., 
spanning the TS1-TS2 regions flanking target gene or group of genes, indicated with “x”) were obtained 
using the two 500-bp amplicons mentioned above as the template and the external oligonucleotides (i.e., x-
TS1F and x-TS2R) by splicing-by-overlap extension (SOEing) PCR (Horton, 1995; Nikel & de Lorenzo, 
2013b). The TS1-TS2 DNA fragments were digested with EcoRI and BamHI (except in the cases indicated 
in Table 3), cloned into the I-SceI–bearing pEMG vector digested with the same enzymes (giving rise to 
plasmid pEMGDx) and verified by enzyme restriction and Sanger DNA sequencing. The resulting pEMGDx 
vectors were electroporated in P. putida KT2440 in order to force cointegration events (this plasmid lacks a 
compatible origin of replication for Pseudomonas species). Merodiploids were selected by plating bacteria 
in LB medium plates containing Km and subsequently isolating to check by PCR reaction using 
oligonucleotides x-TS1F and x-TS2R. Once a suitable cointegration event was obtained, the selected 
bacterial clone was transformed with plasmid pSW-I and selected in LB medium plates containing Ap. In 
order to facilitate the recombination process (mediated by the I-SceI endonuclease) that allows the deletion 
event, the mentioned strains were incubated for 6 h in 5 ml of LB medium containing 500 µg ml-1 Ap and 15 
mM 3-mB. The resulting cultures were plated onto LB medium plates to obtain individual colonies, that were 
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restreaked onto LB medium with or without Km to check for the loss of the cointegrated plasmid. The Km-
sensitive clones were analyzed by colony PCR (using the pair of oligonucleotides x-TS1F and x-TS2R) to 
distinguish between deletion or revertant [i.e., wild-type (WT)] events. As a final step, the pSW-I plasmid 
was eliminated from the treated strains after several consecutive passes in liquid LB medium. In order to 
verify the elimination of the plasmid pSW-I, all the candidates were plated onto LB medium plates with 500 
µg ml-1 Ap and checked by PCR using the oligonucleotides pSW-F and pSW-R, which hybridize in the 
sequence of the pSW-I plasmid (Martínez-García & de Lorenzo, 2011). 
 
1.8. Construction of E. coli mutant strains. Mutations in glycolytic genes were accumulated in E. coli 
derivatives via sequential transduction of individual alleles with bacteriophage P1 (Godoy et al., 2015; Nikel 
& de Lorenzo, 2013b) using individual mutants from the KEIO collection (Baba et al., 2006) as donors, 
followed by elimination of the antibiotic resistance marker using plasmid pCP20 (Cherepanov & 
Wackernagel, 1995). 
 
1.9. DNA delivering using mini-Tn5 transposons. The stable insertion of foreign DNA into the 
chromosome of different P. putida mutants was carried out with the mini-Tn5 transposon borne by the 
synthetic pBAMD plasmids (Martínez-García et al., 2014a). The method to deliver DNA between different 
strains involved tripartite conjugative mating. E. coli CC118 lpir (carrying the pBAMD construct) was used 
as the donor strain, along with the mating-helper strain E. coli HB101 (carrying pRK600), and the appropriate 
P. putida mutants as the recipients. The conjugative mating was conducted as described elsewhere 
(Martínez-García & de Lorenzo, 2012). Briefly, bacteria were grown in LB medium overnight with the 
appropriate combination of antibiotics, then the cells were diluted to obtain an optical density at 600 nm 
(OD600) of 1. These cultures were washed twice with 10 mM MgSO4 in order to remove the antibiotics from 
the culture medium, and each cell suspension was added to a 10-ml plastic tube with 5 ml of 10 mM MgSO4 
to obtain a final OD600 of ca. 0.03. After mixing these suspensions gently, the content of the tube was 
concentrated by filtration and the cells were laid onto a filter disk (0.45 µm pore-size, 23 mm diameter, EMD 
Millipore Corp., Billerica, MA, USA). The filter disks were placed onto a LB medium plate and the plates 
were incubated at 30ºC for 6 h. The filters were placed separately in 10-ml plastic tubes with 5 ml of 10 mM 
MgSO4, and the biomass was suspended by vortexing the contents 10 s. The suspensions were diluted 
appropriately and plated onto M9 minimal medium plates with 0.2% (w/v) citrate and the appropriate 
antibiotics to select P. putida over E. coli. 
 
1.10. In silico prediction of gene functions. In order to hypothesize about the function of genes without 
previous experimental validation, an in silico approach was employed based on the use of different well-
implemented genome databases. The web resources used in this Thesis were the MicroScope platform 
(Genoscope, Evry, France; http://www.genoscope.cns.fr/agc/microscope) and the Pseudomonas Genome 
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Database (Simon Fraser University, British Columbia, Canada; http://www.pseudomonas.com) (Vallenet et 
al., 2017; Winsor et al., 2016). 
 
1.11. Statistical Analysis. All the experiments reported were independently repeated at least twice (as 
indicated in the corresponding figure or table legend), and the mean value of the corresponding parameter 
± standard deviation is presented. In some cases, the level of significance of the differences when 
comparing results was evaluated by means of the Student's t test with a = 0.05. 
 
2. Biochemical characterization 
 
2.1. Preparation of bacterial cell-free extracts. Cell-free extracts of E. coli, P. putida, and P. aeruginosa 
were obtained by a modification of published protocols (Chavarría et al., 2016; Nikel et al., 2014a). Enzyme 
activity determinations were carried out in cell-free extracts obtained from bacterial cultures harvested during 
the mid-exponential phase of growth (corresponding to an OD600 of 0.5) or, in some specific experiments, 
after 24 h of incubation. Cell-free extracts were obtained from 50 ml of culture broth (in 250-ml Erlenmeyer 
flasks). Biomass was collected by centrifuging the cultures at 4,000 r.p.m. for 15 min at 4ºC. Cell pellets 
were washed twice with 25 ml of pre-cooled 67 mM potassium phosphate buffer (pH = 7.1) at 4ºC. From 
this step onwards, the protocol followed to obtain the cell-free extract was modified depending on the 
location of the enzyme (i.e., membrane-bound or cytoplasm). In the case of enzymes located or associated 
with the cell membrane (e.g., Gcd and Gad activities), the resulting pellets were suspended in 2-ml 
Eppendorf tubes with the appropriate volume of pre-cooled 60 mM glycylglycine buffer (pH = 7.1) to obtain 
a cell density of 0.2 g of cells (wet weight) per milliliter of buffer. The suspensions were sonicated in seven 
30-s intervals separated by 1.5 min rests in ice to avoid heating of the sample (18-20 kHz, 1.0-1.5 A). At this 
point, the mixtures were centrifuged at 13,000 r.p.m for 30 min at 4ºC to remove the insoluble cell debris. 
Cell-free extracts were stored at –20ºC until use. 
 
In the case of cytoplasmic enzymes, pellets were washed with 67 mM potassium phosphate buffer 
obtained as explained above, and bacteria were resuspended in 1 ml of the same buffer and centrifuged in 
2-ml Eppendorf tubes at 8,000 r.p.m. for 10 min at 4ºC. After carefully removing the supernatant, the cell 
wet weight was obtained for each pellet in order to calculate the volume of reagents needed for protein 
extraction using the Novagen BugBusterTM protocol (EMD Millipore Corp., Billerica, MA, USA). Pellets and 
cell-free extracts were kept on ice throughout the whole procedure. Bacterial lysis was achieved by using 5 
ml of BugBusterTM Protein Extraction Reagent per gram of cell paste. Afterwards, 1 µl of Lysonase™ 
Bioprocessing Reagent was added per 1 ml of BugBusterTM Protein Extraction Reagent used for re-
suspension of the cells. Bacteria were lysed by shaking for 20 min at room temperature in a Rotamax 120 
orbital shaker (Heidolph Instruments GmbH & Co. KG, Schwabach, Germany) at 150 r.p.m. The insoluble 
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cell debris was removed by centrifugation at 13,000 r.p.m. for 20 min at 4ºC and the supernatants (i.e., cell-
free extracts) were stored at –20ºC until use. 
 
2.2. In vitro enzymatic assay. In order to determine the activity of three key glycolytic enzymes (Glk, Pfk, 
and GA3P dehydrogenase), the in vitro assays were carried out at 30ºC when using cell-free extracts from 
P. putida or at 37ºC when using cell-free extracts from P. aeruginosa and E. coli. The remaining activities 
were measured at 25ºC as indicated by Sigma-Aldrich Co. (St. Louis, MO, USA) in the corresponding 
enzymatic assay protocols or by following previously described protocols (Ng & Dawes, 1973; Nikel et al., 
2014a). All the enzymes were assessed under the optimal reported conditions for pH, substrate, and 
cofactor concentration (Chavarría et al., 2013; Nikel & Chavarría, 2016; Nikel et al., 2014a; 2015a). In vitro 
assays were conducted in Nunc™ MicroWell™ 96-well microplates (Thermo Fisher Scientific Inc., Waltham, 
MA, USA) in a SpectraMaxTM M2e multi-mode microplate reader (Molecular Devices LLC, Sunnyvale, CA, 
USA). All the specific enzyme activities are reported as nmol substrate converted min-1 mg of protein-1. 
Protein concentration in cell-free extracts was assessed using the Bradford (Bradford, 1976) Protein 
Assay (Bio-Rad Laboratories Inc., Hercules, CA, USA). All the accessory enzymes (with the exceptions 
indicated below) were from Saccharomyces cerevisiae and they were purchased from Sigma-Aldrich Co. 
An extinction coefficient (eNADP/H) of 6.22 mM-1 cm-1, representing the difference between the extinction 
coefficients of NAD(P)H and NAD(P)+. In the case of dichlorophenolindophenol (DCPIP) the extinction 
coefficients were determined as 4.1 mM-1 cm-1 at 600 nm (pH = 5.5) and 9.1 mM-1 cm-1 at 576 nm (pH = 
5.5). The limit of detection for all the enzymatic assays was consistently below 2-5 nmol min-1 mgprotein-1. The 
specific protocols used for the determinations are detailed below. 
 
Aldolase. Fructose-1,6-P2 aldolase (EC 4.1.2.13). The reaction mixture contained 17.3 µl of 1 M Tris·HCl 
buffer (pH = 7.4), 6.7 µl of 58 mM fructose-1,6-P2, 1.9 µl of 14 mM NADH, 6.7 µl of a-glycerophosphate 
dehydrogenase/triosephosphate isomerase from rabbit muscle (50 units ml-1 each), 165.4 µl of water, and 
2 µl of cell-free extract (or an appropriate dilution in 67 mM potassium phosphate buffer, pH = 7.1). The 
decrease in absorbance at 340 nm (A340) was measured during the assay.  
 
Edd. 6-Phosphogluconate dehydratase (EC 4.2.1.12). The Edd activity was assayed in a two-step reaction 
protocol obtained by modification of previously published methods (Baumann & Baumann, 1975; Ponce et 
al., 2005; Vicente & Cánovas, 1973a). The assay mixture contained in a final volume of 0.1 ml: 50 mM 
Tris·HCl buffer (pH = 7.5), 10 mM MgCl2, 10 µM gluconate-6-P, and an appropriate dilution of cell-free 
extract. This mixture was incubated for 5 min at room temperature and diluted with the same reaction buffer 
up to 2 ml. The mixture was heated for 2 min at 95ºC and centrifuged at 14,000 r.p.m. during 10 min at room 
temperature. The supernatant solution was assayed for pyruvate formation by using a mixture that contained 
20 µl of the supernatant and 180 µl of a solution containing 50 mM Tris·HCl buffer (pH = 7.5), 10 mM MgCl2, 
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1mM EDTA, 0.1 mM NADH, and 0.5 U L-lactate dehydrogenase from bovine heart. The decrease in A340 
was measured during the assay at 37ºC. 
 
Gad. Gluconate 2-dehydrogenase (EC 1.1.99.3). The reaction mixture contained 40 µl of 100 mM sodium 
acetate buffer (pH = 5.5), 16.7 µl of 75 mM sodium gluconate, 6.7 µl of 15 mM KCN, 33.2 µl of DCPIP (0.5 
mg l-1), 96.7 µl of water, and 6.7 µl of cell-free extract (or an appropriate dilution in 100 mM sodium acetate 
buffer pH = 5.5). The decrease in absorbance at 576 nm (A576) was measured during the assay. 
 
Gcd. Glucose dehydrogenase (EC 1.1.1.47). The reaction mixture contained 66.7 µl of 100 mM sodium 
acetate buffer (pH = 5.5), 36.7 µl of 75 mM glucose, 6.7 µl of 15 mM KCN, 13.2 µl of DCPIP (0.5 mg l-1), 
70 µl of water, and 6.7 µl of cell-free extract (or an appropriate dilution in 100 mM sodium acetate buffer pH 
= 5.5). The decrease in absorbance at 600 nm (A600) was measured during the assay. 
 
Glk. ATP–D-Hexose 6-phosphotransferase or glucokinase (EC 2.7.1.1). The reaction mixture contained 67 
µl of 120 mM Tris·HCl buffer (pH = 8.2), 26 µl of 500 mM glucose, 8 µl of 250 mM MgCl2, 53 µl of 36 mM 
ATP, 10 µl of 20 mM NADP+, 13 µl of glucose-6-P dehydrogenase (15 units ml-1), 18 µl of water, and 5 µl 
of cell-free extract (or an appropriate dilution in 67 mM potassium phosphate buffer, pH = 7.1). The increase 
in A340 was measured during the assay. 
 
GntZ. 6-Phosphogluconate dehydrogenase (EC 1.1.1.44). The reaction mixture contained 188.4 µl of 100 
mM glycylglycine buffer (pH = 7.5), 3.4 µl of 100 mM 6-phosphogluconate, 6.9 µl of 60 mM NAD+, and 1.3 
µl of cell-free extract (or an appropriate dilution in 100 mM glycylglycine buffer, pH = 7.5). The increase in 
A340 was measured during the assay. 
 
Pgi. Glucose-6-P isomerase (EC 5.3.1.9). The reaction mixture contained 33.3 µl of 240 mM glycylglycine 
buffer (pH = 7.1), 6.7 µl of 100 mM D-fructose-6-P, 6.7 µl of 20 mM NADP+, 6.7 µl of 100 mM MgCl2, 6.7 
µl of glucose-6-P dehydrogenase (50 units ml-1), 133.2 µl of water, and 6.7 µl of cell-free extract (or an 
appropriate dilution in 67 mM potassium phosphate buffer, pH = 7.1). The increase in A340 was measured 
during the assay. 
 
Pfk. 6-Phosphofructo-1-kinase (EC 2.7.1.11). The reaction mixture contained 20 µl of 1 M Tris·HCl buffer 
(pH = 7.5), 2 µl of 100 mM fructose-6-P, 8 µl of 250 mM MgCl2, 4 µl of 100 mM NH4Cl, 4 µl of 10 mM 
NADH, 6 µl of 36 mM ATP, 4 µl of fructose-1,6-P2 aldolase (50 units ml-1), 1.5 µl of triosephosphate 
isomerase (500 units ml-1), 1.5 µl of glycerol-3-P dehydrogenase from rabbit muscle (170 units ml-1), 144 µl 
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of water, and 5 µl of cell-free extract (or an appropriate dilution in 67 mM potassium phosphate buffer, pH 
= 7.1). The decrease in A340 was measured during the assay. 
 
Tpi. Triose-P isomerase (EC 5.3.1.1). The reaction mixture contained 20 µl of 1 M triethanolamine buffer 
(pH = 7.9), 2 µl of 0.5 M EDTA, 4 µl of glycerol-3-P dehydrogenase from rabbit muscle (17 units ml-1), 2 µl 
of 40 mM D,L-glyceraldehyde-3-P, 2 µl of 14 mM NADH, 168 µl of water, and 2 µl of cell-free extract (or an 
appropriate dilution in 67 mM potassium phosphate buffer, pH = 7.1). The decrease in A340 was measured 
during the assay. 
 
3. Analytical determinations 
 
3.1. Measurement of poly(3-hydroxybutyrate) (PHB) content. The amount of PHB was obtained by 
means of gas chromatography following protocols described in the literature (Nikel et al., 2006). 
Approximately 10 mg of freeze-dried biomass (0.01 mPa; 8 h) was weighed and deposited in Teflon-
stoppered vials. Methanolysis was carried out by addition of 2 ml of CH3OH/H2SO4 (85:15 [v/v]) and 2 ml of 
CHCl3. These samples were heated at 100ºC for 150 min, cooled at room temperature, and mixed with 2 ml 
of 1 M NaHCO3. Then, the aqueous phase was discarded, and the organic phase was extracted twice with 
the use of deionized water. Once the sample settled all the layers, the lower phase was removed drying with 
anhydrous Na2SO4. The methyl esters of 3-hydroxybutyrate were quantified in a Hewlett Packard HP 5890 
gas chromatograph equipped with a Hewlett Packard FFAP column. Pure PHB (Sigma Aldrich Co.) was 
used as a standard for the calibration, and the PHB content was defined as the ratio of grams of PHB per 
grams of cell dry weight (CDW). 
 
3.2. Determination of intracellular concentration of acetyl-coenzyme A. The intracellular concentration 
of acetyl-coenzyme A (CoA) was determined by liquid chromatography coupled to mass spectrometry (LC-
MS) as previously described (Pflüger-Grau et al., 2011). To this end, the biomass content in 2 ml of cultures 
was harvested by fast centrifugation at 14,000 r.p.m. during 20 s and the pellets were immediately frozen in 
liquid N2 to quench the cell metabolome (Hajjaj et al., 1998). Acetyl-CoA was then extracted from biomass 
with 0.5 ml of 60% (v/v) ethanol buffered with 25 mM ammonium acetate (pH = 7.2) at 70ºC for 1 min (Fuhrer 
& Sauer, 2009). The liquid extracts were pooled in a new tube and dried at 120 µbar to obtain a dried sample 
which was resuspended in 100 µl of MilliQ water. Acetyl-CoA was measured in an Agilent model 1200 SL 
high-performance liquid chromatograph (HPLC) coupled with a hybrid triple-quadrupole/linear ion trap mass 
spectrometer, model 4000 Q TRAPTM (Applied Biosystems) equipped with a turbo ion spray source. The 
chromatographic interpretation was made possible by adopting the Gao’s method (Gao et al., 2007), and 
normalizing the results with a 1 µg ml-1 acetyl-CoA (Sigma Aldrich Co.) standard. 
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3.3. Glucose concentration. All the experiments requiring measurement of glucose concentration were 
performed by adapting a protocol based on the glucose (GO) assay kit (Sigma-Aldrich Co.). This method 
was used to quantify residual glucose in culture supernatants in 96-well microtiter plates (Nunclon™D 
Surface; Nunc A/S, Roskilde, Denmark). The assay reagent was prepared as indicated in the technical 
bulletin; the final mix per well contained 80 µl of the assay reagent, 40 µl of the sample (diluted with water 
to approximately 20-80 µg glucose ml-1), and 80 µl of 12 N H2SO4. The amount of the final pink-colored 
product (oxidized o-dianisidine) was quantified at 540 nm using a SpectraMax M2e plate reader (Molecular 
Devices, LLC., Sunnyvale, CA, USA). 
 
4. Determination of phenotypic parameters  
 
4.1. Phenotypic MicroArray™ technology. The Phenotypic MicroArray™ (PM) technology provided by 
Biolog Inc. (Biolog, Hayward, CA, USA) was used to obtain a global view of the physiological consequences 
of eliminating the Pgi activity in P. putida KT2440 (Bochner, 2009; Bochner et al., 2001). The set-up for this 
PM analysis was the full array, which evaluates a set of 20 different plates (i.e. PM1-PM20) to index 
metabolic and stress-related differences between the mutant and the WT strain. This approach allowed to 
test the influence of different carbon, nitrogen, phosphorous and sulphur sources, extreme pH conditions, 
nutrient supplements, osmolytes, and the sensitivity to a collection of stressors. PM registered the kinetics 
of bacterial respiration using the reduction of tetrazolium dye as a general physiological indicator. 
Respiration ratios, either negative or positive, depending on whether the mutant respiration decreased or 
increased with respect to the WT strain, were used to quantify the phenotypes of the Pgi mutant strain. 
 
4.2. Stress resistance determination. Paraquat was employed as an oxidative stressor agent. This 
molecule catalyzes the formation of reactive oxygen species and decreases the NADPH cellular pool (Bus 
& Gibson, 1984), allowing us to determine the amount of available reducing power in different strains. This 
stressor was use in two different experimental approaches: (i) quantitative, obtaining a survival ratio, or (ii) 
qualitative, determining the zone of inhibition in agar diffusion tests. The approach used to obtain survival 
ratios is based on a previously published method (Martínez-García et al., 2014d) and was performed in 
liquid cultures. Pre-inocula were grown overnight in M9 minimal medium containing glucose and 
subsequently diluted to an OD600 of 0.05 in the same medium with and without paraquat at 10 µM. Then, 
bacterial growth was monitored by measuring the OD600 in 96-well microtiter plates (Nunclon™D Surface; 
Nunc A/S, Roskilde, Denmark) for 24 h in a SpectraMaxTM M2e multi-mode microplate reader (Molecular 
Devices LLC, Sunnyvale, CA, USA). Finally, the survival ratio was calculated as the OD600 in cultures 
containing paraquat vs. the OD600 in cultures without the stressor. The second approach (i.e., qualitative) is 
based on zones of inhibition in agar diffusion test. These zones of inhibition were assessed by using the 
top-agar approach. To this end, M9 minimal medium plates, containing glucose as the carbon source, were 
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prepared as indicated in the section Culture conditions. On the other hand, 5 ml of M9 minimal medium 
containing glucose and 7 g l-1 of agar was prepared in a pool of tubes pre-heated at 40ºC. Cultures of the 
strains to be tested were diluted in these tubes to an OD600 of 0.05, and the suspensions were subsequently 
spread homogeneously in the surface of the previously prepared plates. When the two layers were 
completely solidified, a porous paper disc, soaked with a 10 µl of 100 µM paraquat, was placed in the middle 
of the plate. Inhibition zones were determined after incubation of the plates at 30°C during 24 h.     
 
4.3. Biofilm formation assay. Biofilm formation was measured by means of a crystal violet assay (Nikel et 
al., 2013; O'Toole & Kolter, 1998). The different strains were grown in 96-well microtiter plates (Nunclon™D 
Surface; Nunc A/S, Roskilde, Denmark) with M9 minimal medium containing glucose for 24 h at 30ºC without 
shaking. Then, the culture was removed from the wells and transferred in a new 96-well microtiter plate to 
calculate the OD600 for the planktonic amount of cells using a SpectraMaxTM M2e multi-mode microplate 
reader (Molecular Devices LLC, Sunnyvale, CA, USA). After washing the initial wells three times with H2O, 
200 µl of 0.1% (w/v) crystal violet was added to the plates, which were then incubated 30 min at room 
temperature. Once the solution was discarded, the crystal violet associated with the biofilm was dissolved 
by addition of 150 µl of 33% (v/v) acetic acid and gentle shaking during 1 h at room temperature. The amount 
of crystal violet associated to biofilm was measured in a SpectraMaxTM M2e multi-mode microplate reader 
at 560 nm, and the obtained data were normalized to the OD600 of each culture to obtain the biofilm indexes. 
 
5. Metabolic flux analysis and LC-MS/MS 
 
5.1. Quantitative physiology. Physiological parameters for metabolic flux analysis were calculated as 
previously indicated in the literature (Nikel & Chavarría, 2016). The strains under study were grown in 1000-
ml Erlenmeyer flasks with 200 ml of M9 minimal medium with glucose as the carbon source. Cell growth 
was monitored spectrophotometrically by measuring the OD600 and the concentration of glucose was 
obtained with the glucose (GO) assay kit (Sigma-Aldrich Co.) as indicated in the supplier’s manual. The 
following physiological parameters were determined by regression analysis during the exponential growth 
phase in batch cultures (Nikel & Chavarría, 2016): biomass yield on glucose (Yx/s), maximum specific growth 
rate (µ), and specific rate of glucose consumption (qS). The correlation factor (k) between OD600 and CDW 
were obtained from batch cultures of each strain. CDW concentration was calculated from at least four 
parallel 10-ml cell suspension by centrifugation at 4,000 r.p.m at 4 ºC for 10 min. Bacterial pellets were 
freeze-dried for 24 h and weighed. 
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5.2. Determination of metabolite concentration by LC-MS/MS. Bacterial cultures were grown until they 
reached mid-exponential phase (i.e. OD600 of ca. 0.5), at which point the biomass corresponding to 0.5-0.6 
mg of CDW was collected in triplicates by fast centrifugation (13,000 r.p.m., 30 s, –4 ºC). Cultures were 
grown on either 100% [1-13C]-glucose (Cambridge Isotope Laboratories, Inc.) or 100% [6-13C]-glucose 
(Cambridge Isotope Laboratories, Inc.) as the sole carbon source, harvested, and processed as described 
above. The 13C labelling patterns of free intracellular metabolites were determined on the system mentioned 
above for dihydroxyacetone-P (DHAP), F6P, FBP, G6P, 6PG, phosphoenolpyruvate (PEP), ribose-5-P 
(R5P), ribulose-5-P (Ri5P), sedoheptulose-7-P (S7P), xylulose-5-P (X5P), and Pyr as described previously 
(Rühl et al., 2012). Bacterial pellets were immediately frozen in liquid N2. Samples were extracted three 
times with 0.5 ml of 60% (v/v) ethanol buffered with 10 mM ammonium acetate (pH = 7.2) at 78ºC for 1 min. 
After each extraction step, the biomass was separated by centrifugation at 13,000 r.p.m. for 1 min. The three 
liquid extracts were pooled in a new tube and dried at 120 µbar, and finally stored at –80ºC. Samples were 
resuspended in 20 µl of Milli-Q water and injected into a Waters Acquity UPLC system (Waters Corp., 
Mildford, MA, USA) with a Waters Acquity T3 column (150 mm ´ 2.1 mm ´ 1.8 µm, Waters Corp.) coupled 
to a Thermo TSQ Quantum Ultra triple quadrupole instrument (Thermo Fisher Scientific Inc., Wattham, MA, 
USA) with electrospray ionization. The quantitative analysis of raw metabolic data and the normalization 
procedure were conducted as explained by Nikel et al. (2015a) and van der Werf et al. (2008). 
 
5.3. Metabolic flux ratio analysis by gas chromatography coupled to mass spectrometry (GC-MS). 
Either 100% [1-13C]-glucose (Cambridge Isotope Laboratories, Inc.), or a mixture of 20% (w/w) [U-13C]-
glucose (Cambridge Isotope Laboratories, Inc.) and 80% (w/w) natural glucose were added to the cultures 
used for metabolic flux ratio analysis. Culture aliquots of 5 ml were harvested in mid-exponential growth by 
centrifugation at 4,000 r.p.m at 4 ºC for 10 min. Bacterial pellets were washed twice with 1 ml of 0.9% (w/v) 
NaCl, then hydrolyzed in 1 ml of 6 M HCl for 24 h at 110 ºC in sealed 2-ml Eppendorf tubes, and desiccated 
overnight in a heating block at 85ºC under a constant air stream. The hydrolysate was dissolved in 50 µl of 
99.8% (w/v) dimethyl formamide and subsequently transferred into a new tube. For derivatization, 30 µl of 
N-methyl-N-(tert-butyldimethylsilyl)-trifluoroacetamide was added and the mixture was incubated at 85 ºC 
for 60 min. The 13C labelling patterns of proteinogenic amino acids were determined injecting 1 µl of the 
derivatized sample into a 6890N Network GC apparatus (Agilent Technologies) combined with a 5875 inert 
XL mass selective detector (Agilent Technologies) and analyzed as described previously (Dauner & Sauer, 
2000; Fischer & Sauer, 2003). The corrected mass distributions were correlated to the in vivo metabolic 
activities obtained by the previously described measured of physiological parameters and statistical-data 
treatment of metabolic-flux ratio analysis (Fischer & Sauer, 2003) using the program ratio FiatFlux software 
(Zamboni et al., 2005). 
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6. Constraint-based genome-scale metabolic models and flux balance analysis 
 
Flux balance analysis (FBA) was used to predict the distribution of metabolic fluxes based on the 
mathematical representation of different metabolic reactions. A numerical matrix was built, representing the 
stoichiometric coefficients for the enzymes in the upper catabolism of strain KT2440 (Edwards et al., 2002; 
Orth et al., 2010). The metabolic network employed by FBA can be represented as a stoichiometry matrix 
(!), in which each row represents a unique metabolite and each column represent a biochemical reaction. 
The values in the columns of the matrix indicate the stoichiometric coefficients of the metabolites in the 
reaction in such a way that if the metabolite is produced it has a positive value and, when the metabolite is 
consumed, the value is negative. The size of ! is "×$ for a network based on " metabolites and $ 
reactions. The vector % with length " then can be defined as the concentrations of all the metabolites and 
the vector & with length n contains the fluxes through each reaction. A mass balance can be represented: '(')  = !& or at steady state: 0 = !&. This equation was used to define the space of possible solutions for 
the flux distribution (&) in the network. An objective function was obtained as ,-&, where , are the objective 
concentrations of the metabolites. Finally, the canonical notation for such linear problem is ,-& subject to !& = 0 (./0123/4$5 < & < 477123/4$5). The FBA algorithm solves this objective function defining 
a maximum growth parameter. The COBRA toolkit (Schellenberger et al., 2011) employed linear 
programming to obtain &	, based on the constraints of the model. In the present Thesis, the P. putida model 
iJN746 was used as a backbone (Nogales et al., 2008), to simulate the Pgi mutation by adopting information 
from the literature (Burgard et al., 2003). The aerobic growth was modeled with an in silico M9 minimal 
medium (iM9) following data from the literature for external metabolites and oxygen uptake rate (Nogales et 
al., 2008). To construct condition-specific metabolic models, the glucose uptake rates experimentally 
determined (qS) for each strain were used as extra constraints. In addition, several reactions were 
constrained using 13C-based metabolic flux analysis from P. putida KT2440 (Nikel et al., 2015a). The units 
indicated in the fluxes are represented as mmolglucose gCDW-1 h-1. 
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CHAPTER 1 
 
The GlucoBrick system: A genetic tool for à la carte engineering of glycolytic 
activities in Gram-negative bacteria* 
 
* The contents of this chapter have been published as: 
	
Alberto Sánchez-Pascuala, Víctor de Lorenzo & Pablo I. Nikel (2017) Refactoring the Embden-
Meyerhof-Parnas Pathway as a whole of portable GlucoBricks for implantation of glycolytic modules in 
Gram-negative bacteria. ACS Synth. Bio., 2017, 6 (5), pp 793–805. DOI: 10.1021/acssynbio.6b00230. 
 
 
Background 
 
The EMP pathway is widely accepted to be the biochemical standard of glucose catabolism. The well-
characterized glycolytic route of Escherichia coli, based on the EMP catabolism, is an example of a very 
intricate pathway in terms of genomic organization and patterns of gene expression and regulation 
(Papenfort et al., 2013). This intrinsic metabolic complexity renders it difficult to engineer glycolytic activities 
and transfer them to other microorganisms, thus limiting the enormous biotechnological potential of this 
pathway in bacterial hosts that lack the route. Taking into account the potential applications of such a 
portable tool for targeted pathway engineering, the genes encoding all the enzymes of the linear EMP route 
have been individually recruited from the genome of E. coli K-12, edited in silico to remove their endogenous 
regulatory signals, and synthesized de novo following a standard (i.e., GlucoBrick) that facilitates their 
grouping in the form of functional modules that can be combine at the user’s will. A useful tool to implement 
novel metabolic capabilities into different Gram-negative bacteria (including, but not limited to, P. putida 
KT2440) was tested in a practical application: glucose-dependent accumulation of poly(3-hydroxybutyrate), 
a biodegradable polymer, in recombinant E. coli strains.  
 
1.1. Benchmarking the components of the EMP pathway as a guiding principle for the design 
of GlucoBricks 
 
The first step in this research was to design a set of genes to introduce (or, in some cases, increase), 
glycolytic capacities in different bacteria. The EMP pathway of E. coli, the main route for the transformation 
of glucose into Pyr through the sequential activity of 10 individual enzymes (Fig. 4a), was taken as the model 
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biochemical sequence for hexose breakdown. In their native context, these 10 genes are spread out along 
the bacterial genome or arranged in two operons (e.g., fbaA and pgk) under the transcriptional control of at 
least five regulators (Cra, SoxS, Crp, Fur, and FnrS) and an important number of post-transcriptional control 
devices (Papenfort et al., 2013). Considering such complex regulatory scenario, the minimal enzyme 
complement of the route was selected for the design to prevent carrying host-specific regulatory connections 
that may compromise the portability of the tool. Under these circumstances, the distribution of what is 
considered a GlucoBrick is sketched in Fig. 4b.  
 
 
 
Figure 4½Schematic representation of the GlucoBrick platform layout and biochemical reactions 
thereof. (a)	 Linear glycolytic pathway encoded by the GlucoBrick platform. The genes from Module I 
encode the necessary genes to transform glucose into glyceraldehyde-3-P (GA3P); in a similar way, 
Module II encodes the genes needed to transform GA3P into pyruvate (Pyr).	The two sets of glycolytic 
activities are indicated with blue and red arrows, representing the activities within Modules I and II, 
respectively. Other abbreviations used in this outline are as follows: G6P, glucose-6-P; F6P, fructose-6-P; 
FBP, fructose-1,6-P2; DHAP, dihydroxyacetone-P; BPG, glycerate-1,3-P2; 3PG, glycerate-3-P; 2PG, 
glycerate-2-P; and PEP, phosphoenolpyruvate. (b) The genes from E. coli K-12 deemed necessary to 
activate a functional and linear Embden-Meyerhof-Parnas pathway were edited following the Standard 
European Vector Architecture Vector rules and assembled into two synthetic operons. The first operon 
(Module I) encodes the genes for the upper catabolic block of the pathway, which comprises the 
preparatory phase of the glycolysis. The second operon (Module II) encodes the genes for the lower 
catabolic block of the pathway, which comprises the pay-off phase of glycolysis. Glycolytic reactions are 
shown below the gene encoding them. All genes are preceded by a synthetic regulatory element, indicated 
by a purple circle, composed of a ribosome binding site (sequence underlined) and a spacer sequence. 
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The individual components of the route were standardized according to some basic principles. For 
example, there are some reactions in the naturally-occurring EMP pathway encoded by more than one gene 
(i.e., pfkA/pfkB, fbaA/fbaB, gpmA/gpmM, and pykA/pykF). This redundancy was overcome by selecting the 
component reported to display the highest activity according to the information available in the literature. 
Once these candidates were selected, all the glycolytic genes of the system were assembled by following 
the same structure, starting with a leading ATG signal and finishing with an STOP codon. The whole DNA 
sequence was edited to eliminate restriction sites incompatible with the assembly standard, and any internal 
transcriptional signal was erased. As indicated in Fig. 4b, each open reading frame (ORF) was preceded 
by a standardized synthetic ribosome binding site (RBS) sequence and a short DNA spacer, and the whole 
segment was flanked upstream and downstream by restriction sites that match given positions of the default 
multiple cloning site of the SEVA format (Martínez-García et al., 2014b; Silva-Rocha et al., 2013); i.e., 
following the standard format Restriction Enzyme 1–RBS–glycolytic gene–Restriction Enzyme 2. SEVA 
vectors comprise a selection of plasmids with four compatible broad-host-range origins of replication (i.e., 
RK2, pBBR1, pRO1600/ColE1, and RSF1010) and six independent antibiotic markers [i.e., Ap, Km, 
chloramphenicol (Cm), Sm, tetracyclin (Tc), and Gm]. The adoption of this standard enables the effective 
propagation and maintenance of up to four plasmids in any given Gram-negative bacterial host, and it also 
allows for the simultaneous expression of several genes. The strategy adopted for the edition of glycolytic 
genes would allow for the direct sub-cloning or swapping of any gene combination by a simple digestion 
and ligation step. Moreover, the order of insertion of each of the ten GlucoBricks in the SEVA’s multiple 
cloning site reflects the biochemical sequence of operation in the EMP pathway, thereby allowing for 
whatever the combination of the parts within the route at stake (Fig. 5). 
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Figure 5½Genetic architecture of the GlucoBrick platform. (a) Physical maps of Modules I and II, 
indicating the topology of the different restriction enzyme sites. The enzyme targets are colored in the 
sequence of the multiple cloning site of all the plasmids belonging to the Standard European Architecture 
Vector to identify the DNA block they belong to (i.e., blue, Module I; and red, Module II). Other restriction 
targets that could be useful to implement different regulatory or structural elements are shown in gray. The 
abbreviations used in this outline are GA3P, glyceraldehyde-3-P; and Pyr, pyruvate. (b) Restriction analysis 
of Modules I and II. Plasmids pS224·GBI (upper panel) and pS224·GBII (lower panel) were digested with 
the appropriate enzymes indicated in the outline in order to individually release all the genes from the 
GlucoBrick system, and the products were separated by electrophoresis in a 0.7% (w/v) agarose gel. 
Plasmid pS224·GBI was digested with AvrII-BamHI (i, releases the whole Module I segment); AvrII-EcoRI 
(ii, releases glk); EcoRI-SacI (iii, releases pgi); SacI-KpnI (iv, releases pfkA); KpnI-SmaI (v, releases fbaA); 
and SmaI-BamHI (vi, releases tpiA). Plasmid pS224·GBII was digested with BamHI-HindIII (i, releases the 
whole Module II segment); BamHI-XbaI (ii, releases gapA); XbaI-SalI (iii, releases pgk); SalI-PstI (iv, 
releases gpmA); PstI-SphI (v, releases eno); and SphI-HindIII (vi, releases pykF). 
 
Two DNA modules were designed to encode all the necessary enzymes for the activation of a linear 
glycolysis based on the EMP pathway. This synthetic EMP pathway was divided into two different catabolic 
blocks: the upper catabolic block (Module I), comprising the activities of the preparatory phase; and the 
lower catabolic block (Module II), spans the activities of the pay-off phase (Fig. 4a). Module I thus encodes 
the enzymes necessary for glucose phosphorylation and conversion into trioses-P. Module II encodes the 
enzymes necessary to transform these trioses-P (more specifically, GA3P) into Pyr (Fig. 4b). A detailed 
physical map of the DNA architecture of this platform (Fig. 5a) indicates that the two DNA blocks can be 
also combined sequentially in a single SEVA vector if desired, and even in transposon vectors designed for 
chromosomal integration of large DNA segments (Martínez-García et al., 2014a), a feature that will be 
exploited further on in this Thesis. At the same time, the adoption of the SEVA architecture is not only useful 
to deliver the GlucoBrick system into target bacteria, but it also represents a pratical method to express the 
genes encoded in this system under the control of different constitutive and effector-responsive 
transcriptional devices (Calero et al., 2016; Kim et al., 2016b; Martínez-García et al., 2014b; 2015). As a 
preliminary experiment to test the modularity of the GlucoBrick system, Modules I and II were separately 
cloned in vector pSEVA224 (RK2, KmR), obtaining plasmids pS224·GBI and pS224·GBII, respectively. 
These low-copy-number plasmids were digested with the appropriate enzymes following the information of 
Fig. 5a to recover all the elements present in the GlucoBrick system (Fig. 5b). Every individual gene could 
be retrieved by following this procedure, indicating that the strategy used for the assembly of this standard 
tool enables the combination of all the functional elements within the system at the user’s will. 
 
1.2. Testing the GlucoBrick system: activities encoded in the platform restore or enhance 
glucose-dependent growth of glycolytic E. coli mutants 
 
Once the GlucoBrick system was generated, its functionality was tested under in vivo conditions. The first 
attempt in order to test the system was implemented in E. coli. The functional characterization of the 
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GlucoBrick system was carried out by assessing their phenotypic impact when the corresponding plasmids 
were introduced in different glycolytic E. coli mutants defective in either single or several activities of the 
EMP pathway (Table 5). E. coli BW25113, a WT K-12 strain (Datsenko & Wanner, 2000), was used as the 
positive control, and the final cell density and the specific growth rate was obtained for each strain in cultures 
supplemented with Km and IPTG. 
 
Table 5½Functional validation of Module I and II in glycolytic mutants of E. coli BW25113. 
 
E. coli straina Plasmidb 
Growth parametersc in: 
M9GCM semi-synthetic medium M9 minimal medium + 
20 mM glucose 
CDW (g l-1) Growth coefficient CDW (g l-1) Growth coefficient 
BW25113 
(wild-type strain) 
None 2.7 ± 0.3 ‒ 1.7 ± 0.1 ‒ 
Dglk DptsI 
pSEVA224 1.1 ± 0.2 
1.2 ± 0.1 
N.G. 
G.R. 
pS224·GBI 1.3 ± 0.3 1.3 ± 0.2 
DpfkA DpfkB 
pSEVA224 0.4 ± 0.1 
2.3 ± 0.3 
N.G. 
G.R. 
pS224·GBI 1.4 ± 0.2 1.9 ± 0.1 
DtpiA 
pSEVA224 0.6 ± 0.1 
1.4 ± 0.2 
N.G. 
G.R. 
pS224·GBI 1.7 ± 0.3 1.2 ± 0.3 
DgapA Depd DptsI 
pSEVA224 0.5 ± 0.1 
6.1 ± 0.5 
N.G. 
G.R. 
pS224·GBII 1.2 ± 0.1 0.9 ± 0.1 
Dpgk 
pSEVA224 0.3 ± 0.1 
2.9 ± 0.1 
N.G. 
G.R. 
pS224·GBII 1.4 ± 0.5 1.6 ± 0.4 
Deno 
pSEVA224 0.8 ± 0.2 
3.1 ± 0.4 
N.G. 
G.R. 
pS224·GBII 1.5 ± 0.2 0.9 ± 0.1 
 
a  The relevant genotype of the strains is described in the Materials and Methods section (Table 2).  
b  Plasmid pSEVA224 was used as the control vector; plasmids pS224·GBI and pS224·GBII are pSEVA224 derivatives 
carrying either Module I or II, respectively. IPTG was added to all cultures at 1 mM at the onset of the cultivation. 
c  M9GCM semi-synthetic medium contains the same salts as M9 minimal medium, casein hydrolyzate, glycerol, and 
sodium malate. CDW, cell dry weight after 48 h of aerobic incubation at 37ºC. N.G., no growth (defined as a change 
in the CDW < 0.05 g l-1). The growth coefficient is the ratio between the specific growth rate of a strain carrying either 
Module I or II and the specific growth rate of the same strain carrying pSEVA224; the cases in which the mutant did 
not grow (and hence, the growth coefficient could not be calculated) are indicated as G.R., growth restored. Results 
represent the mean value ± standard deviation from triplicate measurements in at least two independent 
experiments. All the differences in growth coefficients for the strains grown in M9GCM semi-synthetic medium were 
significant (P < 0.05, as evaluated by means of the Student's t test) in the pair-wise comparison of a given 
recombinant to the control strain carrying the empty pSEVA224 vector. 
 
The participation of the GlucoBrick system at the level of Glk (i.e., glucokinase) and PtsI [i.e., the EI 
component of the PEP:carbohydrate phosphotransferase (PTS) system] served as the first experimental 
validation of the whole system. No glucose phosphorylation is possible in a double Dglk DptsI mutant of E. 
Chapter 1 
	 74 
 
coli, as both Glk and the PTS-dependent transport of the hexose coupled to phosphorylation are blocked 
(Nikel & de Lorenzo, 2013b). Note, however, that glucose transport into the cytoplasm should not be totally 
blocked in this genetic background, since alternative transporters (e.g., the low-affinity galactose:H+ GalP 
symporter and the ATP-dependent MglABC system) are known to internalize non-phosphorylated hexoses 
when the PTS system is not active (Jahreis et al., 2008). The Dglk DptsI strain was able to grow in M9GCM 
semi-synthetic medium (formulated in such a way that all the glycolytic mutants tested could grow, albeit 
some of them grew poorly) but not in M9 minimal medium with glucose as the only carbon source. However, 
the addition of Module I restored the growth of the double mutant on glucose back to the levels observed in 
the semi-synthetic medium (Table 5). 
 
In the case of the Pfk (i.e., 6-phosphofructo-1-kinase) activity, which transforms F6P into FBP, the 
strain under study was a double DpfkA DpfkB mutant. This strain was unable to grow on glucose as the sole 
carbon source and its growth was severely affected when inoculated in M9GCM medium. The 
implementation of Module I in Pfk-deficient bacteria was enough to restore the growth deficiency in both 
culture media, and it also lead to a 2.3-fold increase in the specific growth rate of the recombinant in M9GCM 
medium (Table 5). Pfk was considered to be one of the most important metabolic nodes in the evaluation 
of the GlucoBrick platform as this is the activity missing in many Pseudomonas species (and thus a relevant 
target for manipulation within the overall objective of activating a linear glycolysis in P. putida KT2440). 
 
Another crucial step in the EMP pathway is the TpiA (i.e., triose-P isomerase) activity, which catalyzes 
the isomerization between GA3P and DHAP. This activity plays a central role not only in glycolysis but also 
in gluconeogenesis, especially in environmental bacteria (Fraenkel, 1986). Expectedly, and taking into 
account its physiological relevance, the growth of a DtpiA mutant was impaired among all the culture 
conditions tested, probably because of the build-up of methylglyoxal as a toxic intermediate (Velur 
Selvamani et al., 2014). The implementation of Module I in a TpiA-deficient metabolic background mitigated 
this phenomenon, restoring the growth of the mentioned strain on glucose. At the same time, the presence 
of Module I also enhanced the growth in the semi-synthetic medium tested (Table 5). 
 
Once the functionality of Module I was demonstrated with the practical examples discussed above, 
Module II was submitted to the same battery of experiments. This block carries the EMP activities from the 
pay-off phase, which comprises the reactions to transform GA3P into Pyr. The first biochemical step assayed 
in this case was GA3P dehydrogenase [represented by GapA, and possibly the GapB isozyme (Boschi-
Muller et al., 1997)], which catalyzes the transformation of GA3P into glycerate-1,3-P2 (BPG). Note that a 
simple DgapA mutant would not reveal if GapA encoded in Module I is enough to fulfil the cognate 
biochemical step, due to the capacity of the PTS system to transform PEP into Pyr. Considering this complex 
metabolic scenario (and in order to ensure that there is no Pyr formation), a triple E. coli mutant was 
constructed by eliminating gapA (encoding a NAD+-dependent GA3P dehydrogenase, and also the major 
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GA3P dehydrogenase prevalent in Enterobacteria), epd (known as gapB, encoding a NAD+-dependent 
erythrose-4-P dehydrogenase), and also ptsI. This strain is totally unable to grow on glucose as a carbon 
source and, at the same time, it only reaches a modest cell density in M9GCM medium. Once again, the 
implementation of Module II, and the GapA activity thereof, improved or even restored the growth phenotype 
in the triple mutant. Interestingly, this strain had a >6-fold increase in the specific growth rate when grown 
in semi-synthetic medium, obtaining the highest value among the conditions and strains analyzed in this 
part of the study (Table 5). 
 
Finally, Dpgk and Deno mutants were analyzed to functionally complement missing activities by 
Module II, obtaining similar results as the ones described thus far. In both cases, the growth obtained in 
semi-synthetic medium was very poor, and no growth was detected in M9 minimal medium with glucose. In 
accordance with the results obtained with other glycolytic mutants, the implementation of Module II was 
enough to restore the growth phenotype in glucose in both strains, while the specific growth rate in M9GCM 
medium increased by ca. 3-fold in either case (Table 5). Despite the single complementation analyzed in 
this set of experiments, all the strains under study are provided with additional copies of the rest of glycolytic 
genes in each GlucoBrick module, boosting the channeling of hexoses though the linear EMP pathway. In 
all the cases here, the final cell densities in M9 minimal medium with glucose attained by the recombinants 
carrying either Module I or II of the GlucoBrick platform were comparable to that of WT E. coli BW25113. 
 
Additionally, and in order to corroborate that the changes in the glucose-dependent growth phenotype 
correlated with the enzyme activities encoded in the GlucoBrick platform, the specific activities of some 
enzymes involved in glucose processing were evaluated in vitro in cell-free extracts. Two key steps in the 
EMP pathway, the Glk and Pkf activities, were targeted for this purpose. In the first case, the activity of Glk 
in the glucose-grown Dglk DptsI mutant expressing Module I was 1,370 ± 120 nmol min-1 mgprotein-1 upon 
induction of gene expression with IPTG, representing a ca. 23- and 10-fold increase as compared with the 
same strain carrying the empty vector and WT BW25113 carrying the empty vector, respectively [note that 
some residual Glk activity was observed in the knock-out strain, possibly arising from some other non-
specific hexose kinases (Meyer et al., 1997)]. On the other hand, the implementation and induction of the 
activities encoded in Module I in the DpfkA DpfkB strain resulted in a 10-fold increase in the specific Pfk 
activity (1,080 ± 70 nmol min-1 mgprotein-1) as compared with the same strain carrying the empty pSEVA224 
vector. In contrast, the Pfk activity in WT BW25113 was 751 ± 36 nmol min-1 mgprotein-1. Interestingly, there 
was some residual Pfk activity detected in vitro in the E. coli DpfkA DpfkB mutant (<100 nmol min-1 mgprotein-
1), that could originate from a side activity of an enzyme belonging to the PfkB family of phosphosugar 
kinases [a subset of the large ribokinase superfamily (Park & Gupta, 2008)]. Ribokinase (or another enzyme 
belonging to this family) can possibly phosphorylate F6P to FBP in vitro, which in turn may be due to the 
dilution of an allosteric inhibitor in the assay, as previously described (Chin & Cirino, 2011). 
Chapter 1 
	 76 
 
 
As a summary of the results obtained thus far, it can be safely assumed that the GlucoBrick system is 
a useful tool for the implementation of different glycolytic activities in E. coli strains. The next standing 
question to be answered is how portable this system is, and for the sake of this Thesis, checking its usability 
in different, unrelated bacterial species (i.e., Pseudomonas). 
 
1.3. Portability of the GlucoBrick system: using Modules I and II to engineer glycolysis in 
two different Pseudomonas species 
 
The last few years have witnessed an increase in the development of dedicated genetic tools to manipulate 
Gram-negative bacteria, specifically P. putida (Benedetti et al., 2016; Calero et al., 2016; Martínez-García 
et al., 2011; 2014a,b; Martínez-García & de Lorenzo, 2011; Silva-Rocha et al., 2013). Along this line, the 
GlucoBrick system represents a new standard to implement novel metabolic capabilities in different Gram-
negative bacteria, nested in the main, overarching objective of this Thesis: the rational implementation of a 
linear EMP pathway in P. putida KT2440. In order to elucidate the viability of the GlucoBrick system to bring 
about the activities needed for such task, and also for evaluating the portability of the system in 
Pseudomonas species, the present section describes the use of the platform in P. putida KT2440 and P. 
aeruginosa PAO1. 
 
P. putida and P. aeruginosa are representative members of the genus, with several environmental and 
medical implications, respectively. Both strains use the ED pathway for hexoses breakdown as part of a 
most intricate glucose metabolism (Belda et al., 2016; Berger et al., 2014; Sudarsan et al., 2014; Vicente & 
Cánovas, 1973a,b). Recently, this metabolic complexity was shown to run in a particular architecture in P. 
putida KT2440 (Nikel et al., 2015a), which operates a combination of enzymes belonging to the EMP 
pathway, the ED pathway, and the PP pathway to catabolize glucose via a metabolic device termed EDEMP 
cycle (Fig. 6a). Such metabolic scenario is probably present in other members of the Pseudomonas group 
as well, such as P. aeruginosa. The high degree of metabolic complexity in the glycolysis of these bacteria 
makes it difficult to implement biotechnological approaches based on glucose breakdown. This is the main 
reason for which both P. putida KT2440 and P. aeruginosa PAO1 were adopted as heterologous hosts for 
testing the GlucoBrick platform. Physiological and growth parameters as well as the in vitro activity of key 
glycolytic enzymes were systematically assessed in the resulting strains as indicated below. 
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Figure 6½ Characterization of physiological parameters in recombinant Pseudomonas putida and 
P. aeruginosa strains carrying Module I. (a) Schematic representation of central carbon metabolism in 
Pseudomonas species. Glucose catabolism occurs mainly through the activity of the Entner-Doudoroff (ED) 
pathway, but part of the trioses-P thereby generated are recycled back to hexoses-P by means of the 
EDEMP cycle, that also encompasses activities from the partial Embden-Meyerhof-Parnas (EMP) and 
pentose phosphate (PP) pathways. A set of peripheral reactions can also oxidize glucose to gluconate 
and/or 2-ketogluconate (2KG) before any phosphorylation of the intermediates occurs. Each metabolic 
block is indicated with a different color along with the relevant enzymes catalyzing each step, and the 
EDEMP cycle is shaded in blue in this diagram. The 6-phosphofructo-1-kinase (Pfk) activity, missing in 
most Pseudomonas species, is highlighted with a dashed gray arrow. The abbreviations used for the 
metabolic intermediates are as indicated in the legend to Fig. 4; other abbreviations are as follows: 6PG, 
6-phosphogluconate; KDPG, 2-keto-3-deoxy-6-phosphogluconate; acetyl-CoA, acetyl-coenzyme A; and 
2K6PG, 2-ketogluconate-6-P. (b) Glucose consumption profile and (c) growth curves of P. putida KT2440, 
its Dglk derivative, and P. aeruginosa PAO1, carrying either the control vector (pSEVA224) or pS224·GBI 
(Module I). Glucose consumption is reported as the mean value ± standard deviation from duplicate 
measurements in at least three independent experiments. CDW, cell dry weight. Significant differences (P 
< 0.05, as evaluated by means of the Student's t test) in the pair-wise comparison of a given recombinant 
to the control strain, carrying the empty pSEVA224 vector, are indicated by an asterisk. In the growth 
curves, each data point represents the mean value of the optical density measured at 600 nm (OD600) of 
quadruplicate measurements from at least three independent experiments. The specific growth rates (µ) 
were calculated from these data during exponential growth, and the inset shows the mean values ± 
standard deviations for each strain. 
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The implementation of Module I should boost the extant, partially active EMP pathway in Pseudomonas 
due to the addition of the missing step catalyzed by Pfk. In order to corroborate the consequences of such 
scenario, the overall glucose consumption was evaluated in recombinant P. putida and P. aeruginosa strains 
carrying either an empty pSEVA224 vector or the pS224·GBI plasmid, bearing Module I (Fig. 6b). In both 
cases, the overall rate of glucose consumption was significantly increased by expressing the genes of 
Module I (i.e., 2.5- and 1.5-fold in P. putida KT2440 and P. aeruginosa PAO1, respectively, as compared to 
the strains bearing the pSEVA224 vector). In addition, no major growth deficiencies in terms of final biomass 
densities and specific growth rates (as determined in microtiter-plate cultures) were observed in the strains 
carrying Module I (Fig. 6c). P. aeruginosa PAO1 had a slight reduction in the specific growth rate when 
expressing Module I, but the difference in this parameter as compared to that in the same strain carrying an 
empty vector was not significant.  
 
All the information provided in the previous paragraph indicates that the GlucoBrick system influences 
the metabolic state of the two Pseudomonas species analyzed. In order to clarify if this impact is due to the 
action of the activities encoded by the Module I, the in vitro activities of the enzymes of the preparatory 
phase were evaluated in cell-free extracts obtained from the different Pseudomonas recombinants (Fig. 7). 
First, the specific Glk activity was assessed in strains KT2440 and PAO1 carrying pS224·GBI (Module I) 
and growing on glucose as the sole carbon source, with Km and IPTG added as needed (Fig. 7a). In contrast 
with the situation in E. coli, Pseudomonas species do not possess a PTS system for glucose uptake, and 
the phosphorylation of hexoses is directly catalyzed by Glk (i.e., PP_1011 in P. putida and PA_3193 in P. 
aeruginosa) in the cytoplasm. The native Glk activity in both Pseudomonas species ranged from ca. 89 to 
184 nmol min-1 mgprotein-1 in P. aeruginosa PAO1 and P. putida KT2440, respectively, and this kinase activity 
was boosted by expression of E. coli glk from plasmid pS224·GBI (i.e., a 1.4-fold increase in strain KT2440 
and a remarkable 6.2-fold increase in strain PAO1). Simultaneously, a P. putida Dglk strain was constructed, 
in which the in vitro Glk activity resulted below the detection limit of the assays (and thus, considered 
negligible). However, transforming this glk mutant strain with plasmid pS224·GBI, followed by induction of 
gene expression by adding IPTG, increased the specific kinase activity up to 45 nmol min-1 mgprotein-1 (i.e., a 
100-fold increase in Glk activity) (Fig. 7a).  
 
As indicated before, the missing Pfk activity in several Pseudomonas species (i.e., strains KT2440 and 
PAO1) generates a gap in the EMP pathway, blocking the transformation of F6P into FBP. The introduction 
of Module I was explored in both Pseudomonas species transformed with plasmid pS224·GBI and grown in 
M9 minimal medium containing glucose, Km, and IPTG (Fig. 7b). The in vitro Pfk activity was firstly 
evaluated on both Pseudomonas species transformed with the empty pSEVA224 vector, and the results 
expectedly corroborate the absence of this key glycolytic enzyme in the native biochemical networks (Fig. 
7b). On the other hand, the expression of the genes borne by plasmid pS224·GBI resulted in increased 
levels of Pfk activity, which were similarly high in both P. putida KT2440 and P. aeruginosa PAO1 (i.e., ca. 
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272 and 550 nmol min-1 mgprotein-1, respectively) (Fig. 7b). The change in the Pfk activity brought about by 
heterologous expression of pfkA in P. putida Dglk was somewhat low, but it still represents a 23-fold increase 
as compared to the control strain transformed with an empty vector (Fig. 7b). The differences in terms of 
Pfk activities detected in the WT strain and its Dglk derivative could stem from alterations in the intracellular 
metabolite pools, which may have an influence in the regulation of the PfkA enzyme of E. coli. 
 
 
 
Figure 7½ Biochemical characterization of native and implanted enzyme activities in Pseudomonas 
species. (a) In vitro quantification of the specific (Sp) glucokinase (Glk) activity, which phosphorylates 
glucose to glucose-6-P (G6P) in wild-type (WT) P. putida KT2440 and its Dglk derivative (left panel), and 
WT P. aeruginosa PAO1 (right panel) carrying either the empty pSEVA224 vector or Module I. (b) In vitro 
quantification of the specific (Sp) 6-phosphofructo-1-kinase (PfkA) activity, which converts fructose-6-P 
(F6P) into fructose-1,6-P2 (FBP) in WT P. putida KT2440 and its Dglk derivative (left panel), and WT P. 
aeruginosa PAO1 (right panel) carrying either the empty pSEVA224 vector or Module I. (c) In vitro 
quantification of the specific (Sp) activities of aldolase, glucose-6-P isomerase, and triose phosphate 
isomerase in P. putida KT2440 carrying either the empty pSEVA224 vector or Module I. These three 
activities, combined with Glk and PfkA, constitute the preparatory phase of the Embden-Meyerhof-Parnas 
pathway (i.e., from glucose to glyceraldehyde-3-P). All the strains tested were grown on M9 minimal 
medium added with glucose at 20 mM and cells were harvested in mid-exponential phase for these in vitro 
enzymatic assays. Each bar represents the mean value of the corresponding enzyme activity ± standard 
deviation of quadruplicate measurements from at least two independent experiments. Significant 
differences (P < 0.05, as evaluated by means of the Student's t test) in the pair-wise comparison of a given 
recombinant to the control strain, carrying the empty pSEVA224 vector, are indicated by an asterisk. 
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Additionally, the three remaining activities within the preparatory phase of the EMP pathway (i.e., 
aldolase, glucose-6-P isomerase, and triose phosphate isomerase) were evaluated in vitro in glucose-grown 
P. putida KT2440 carrying either pSEVA224 or pS224·GBI (Fig. 7c). In all cases, the recombinant strains 
carrying Module I presented a significant increase in each enzyme activity. The total aldolase and triose 
phosphate isomerase activities had a 3- and 5-fold increase, respectively, in P. putida KT2440 expressing 
Module I. Under the same conditions, the activity of glucose-6-P isomerase augmented a surprising 43-fold 
with respect to the control experiment. 
 
In light of the results of this part of the study, it is possible to conclude that all the enzymes that comprise 
the preparatory phase of the EMP pathway are active in recombinant P. putida due to the presence of 
Module I of the GlucoBrick platform. This biochemical scenario is expected to trigger a modification of the 
intracellular metabolome of this bacterium. In order to resolve this question, the impact of the GlucoBrick 
platform in the intracellular metabolome of P. putida KT2440 was evaluated under the same growth 
conditions used to analyze in vitro enzyme activities. The intracellular concentration of some critical 
metabolic intermediates was thus measured in glucose-grown P. putida KT2440 carrying either pSEVA224 
or pS224·GBI during exponential growth. The concentration of the first metabolic intermediary after glucose 
phosphorylation (i.e., G6P) and the last intermediate of the preparatory phase of the EMP pathway (i.e., 
GA3P) was assessed by LC-MS (Table 6). According to the hypothesis, both metabolites were observed to 
have an increased abundance in the strains expressing the genes of Module I (i.e., 1.7-fold in the case of 
the hexose-P and 3.2-fold in the case of the triose-P), a further experimental indication that the EMP pathway 
is active in this recombinant strain. Additionally, and a general proxy of the redox status of the cells, the 
concentration of the key redox cofactor NADPH was included in the same set of measurements. The P. 
putida KT2440 derivative expressing Module I showed a 26% reduction in the intracellular content of NADPH 
(Table 6). Although the intracellular concentration of redox cofactors is known to be tightly regulated by 
several biochemical mechanisms, the diminution observed under the experimental conditions evaluated 
here prompts the hypothesis that the recombinant P. putida strain carrying Module I is redirecting glucose 
from the EDEMP cycle to the newly implemented linear glycolytic pathway. This assumption is based in that 
the activity of Zwf reduces NADP+ coupled to the oxidation of G6P into 6PG (Fig. 6a). If P. putida has an 
active EMP pathway, G6P would be channeled into this metabolic route at the expense of Zwf, and the level 
of NADPH stemming from this metabolic conversion would be smaller. Taken together, these targeted 
metabolomic determinations (along with the direct in vitro measurement of enzyme activities) indicate that 
glucose is probably funneled into a linear glycolysis of sorts in P. putida KT2440 when expressing the genes 
within Module I. 
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Table 6½ Metabolomic determinationsa in glucose-grown Pseudomonas putida KT2440 carrying the 
glycolytic genes borne by Module I. 
 
P. putida KT2440 carrying plasmid 
Intracellular content (nmol mgCDW-1) of 
Glucose-6-P Glyceraldehyde-3-P NADPH 
pSEVA224 (empty vector) 52 ± 9 0.39 ± 0.08 43 ± 5 
pS224·GBI (Module I) 89 ± 4 1.23 ± 0.07 32 ± 9 
 
a Cells were grown aerobically in M9 minimal medium added with glucose at 20 mM, harvested during exponential 
growth, and rapidly quenched in liquid N2. Intracellular metabolites were extracted and their concentration 
determined by means of liquid chromatography coupled to mass spectrometry as indicated in Materials and 
Methods. Each parameter is reported as the mean value ± standard deviation from duplicate measurements in at 
least two independent experiments. 
 
Thus far, the results shown expose the ability of the GlucoBrick system to both (i) boost existing 
glycolytic activities and (ii) introduce new metabolic steps in different Gram-negative bacteria. As such, this 
tool looks promising to refactor the central carbon metabolism of P. putida KT2440, the main goal in this 
Thesis. However, this application, which will be fully exploited as indicated in Chapter 4, does not preclude 
the usability of the GlucoBrick platform in other Metabolic Engineering manipulations. In order to evaluate 
the potential of the tool in a production process, the capacity of the GlucoBrick system to enhance the 
production of added-value metabolites (i.e., PHB) from hexoses was analyzed in recombinant strains of E. 
coli. 
 
1.4. Enhancing heterologous PHB production by increasing glycolytic fluxes in recombinant 
E. coli 
 
Polyhydroxyalkanoates are a structurally complex group of biopolymers produced by different bacteria 
(Cabrera Gomez et al., 2012; López et al., 2015; Ruiz et al., 2006). The simplest bacterial 
polyhydroxyalkanoate is PHB, an isotactic polyester composed by 3-hydroxybutyrate units (Anderson & 
Dawes, 1990). PHB is an interesting biopolymer due to its ecofriendly features, such as its easy 
biodegradation by a large number of bacteria, and the oil-independent nature of the industrial production 
process (Suriyamongkol et al., 2007). This biopolymer is synthesized by Cupriavidus necator (formerly 
known as Ralstonia eutropha) using three enzymes (Fig. 8a). The first step in this pathway is catalyzed by 
PhaA (i.e., 3-ketoacyl-coenzyme A thiolase), which condense two acetyl-CoA moieties, yielding 3-
acetoacetyl-CoA. This intermediate is the substrate for PhaB, a NADPH-dependent 3-acetoacetyl-CoA 
reductase (encoded by phaB1). In the final step of this biosynthetic pathway, (R)-(–)-3-hydroxybutyryl-CoA 
units are polymerized to PHB by PhaC, a PHA synthase (encoded by phaC1).  
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E. coli has been traditionally used as a microbial host of the PHB biosynthetic pathway (Leong et al., 
2014), since this microorganism lacks the metabolic machinery for the synthesis and degradation of 
polyhydroxyalkanoates (which makes pathway engineering easier, and the polymer accumulated by the 
recombinants does not get degraded). A problem recursively encountered when attempting to improve the 
yield and productivity of biopolymer in recombinant E. coli strains is that the PHB biosynthetic pathway is 
nested in the core biochemical network of the bacterium (Nikel et al., 2010), not only drawing acetyl-CoA 
coming from the EMP pathway, but also using NADPH as a cofactor (Ruiz et al., 2012), and the PHB 
biosynthetic route also competes with native fermentation pathways (Fig. 8a), e.g., acetate formation from 
acetyl-CoA (Chang et al., 1999). Taking into account this complex metabolic situation, the availability of 
biosynthetic precursors is assumed to be the main bottleneck compromising not only PHB accumulation but 
also bacterial growth in recombinant E. coli. 
 
In order to elucidate if the GlucoBrick system can help mitigating these metabolic bottlenecks, a PHB-
producing E. coli strain was firstly constructed by transforming plasmid pAeT41 (carrying the phaC1AB1 
gene cluster from C. necator) into WT E. coli BW25113. Plasmids pSEVA224 (KmR, empty vector), 
pS438·GBI (SmR, carrying Module I), and/or pS224·GBII (KmR, carrying Module II) were introduced in this 
strain, and growth, polymer accumulation, and acetate excretion were evaluated in LB medium cultures 
added with glucose and the corresponding antibiotics and inducers after 24 h of aerobic growth (Table 7 
and Fig. 8b and c). The separate introduction of Module I and II stimulated both glucose consumption and 
polymer accumulation with respect to the control strain. On the other hand, the glucose consumption 
increased by 4- and 3-fold upon induction of the genes encoded by Module I and II, respectively (Fig. 8b). 
When the two GlucoBricks modules were simultaneously present in the same strain, a 6-fold increment in 
the specific glucose consumption was observed with respect to the control strain. This result points to a 
synergistic effect of the two modules in promoting glucose metabolism through the entire EMP pathway. In 
addition, the increase in the total glucose consumption in this recombinant strain, accompanied with a 
decrease in residual biomass formation (i.e., non-PHB cell material), indicates that the metabolic 
intermediates generated through the EMP pathway are channeled into PHB accumulation (rather than 
biomass formation). As an additional observation, the overexpression of either gapA or glk·pfkA·gapA did 
not perturb the specific growth rates of the recombinants strains. However, the presence of Module I and II 
reduced this parameter by ca. 30%, indicating some sort of metabolic burden due to plasmid maintenance 
(Dvořák et al., 2015). 
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Figure 8½ Enhanced poly(3-hydroxybutyrate) synthesis in recombinant Escherichia coli carrying 
Modules I and II. (a) Three enzymes are necessary for de novo synthesis of poly(3-hydroxybutyrate) (PHB). 
In Cupriavidus necator, from which the cognate genes were harnessed in this study, PHB accumulation 
depends on the sequential activity of a 3-ketoacyl-coenzyme A (CoA) thiolase (PhaA), a NADPH-dependent 
3-acetoacetyl-CoA reductase (PhaB1), and a PHB synthase (PhaC1). PhaA and PhaB1 catalyze the 
condensation of two molecules of acetyl-CoA to 3-acetoacetyl-CoA and the reduction of this intermediate to 
R-(–)-3-hydroxybutyryl-CoA (3-HB-CoA), respectively. PhaC1 polymerizes 3-HB-CoA monomers to PHB by 
releasing one CoA-SH molecule per monomer added. Note that acetyl-CoA can also be used in the major 
fermentation pathway of E. coli, that produces acetate. The main metabolic blocks within the biochemical 
network are identified with different colors in the outline: the Embden-Meyerhof-Parnas (EMP) pathway, red; 
the pentose phosphate (PP) pathway, purple; and the tricarboxylic acid (TCA) cycle and gluconeogenesis, 
green. Abbreviations of metabolic intermediates are as shown in the caption to Fig. 4; other abbreviations 
are as follows: 6PG, 6-phosphogluconate; acetyl-CoA, acetyl-coenzyme A; OAA, oxaloacetate; and 2-OX, 
2-oxoglutarate. (b) Glucose consumption profile and (c) PHB accumulation by E. coli BW25113 carrying 
plasmid pAeT41 (i.e., constitutively expressing the phaC1AB1 gene cluster from C. necator) transformed 
with plasmids carrying the genes or modules indicated (see Table 3 for further details). Cells were grown 
aerobically in LB medium added with glucose at 10 g l-1 for 24 h. Each parameter is reported as the mean 
value ± standard deviation from duplicate measurements in at least three independent experiments. CDW, 
cell dry weight. Significant differences (P < 0.05, as evaluated by means of the Student's t test) in the pair-
wise comparison of a given recombinant to the control strain, carrying the empty pSEVA224 vector, are 
indicated by an asterisk. 
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Table 7½ Growth parameters and polymer synthesis of a PHB-accumulating Escherichia coli straina 
carrying different combinations of glycolytic genes. 
 
Plasmidb rCDWc (g l-1) PHB (g l-1) µ (h-1) 
Specific rate of 
acetate formation 
(mmol gCDW-1 h-1) 
Acetyl-coenzyme A 
content 
(nmol mgrCDW-1) 
pSEVA224 (empty vector) 0.54 ± 0.06 0.21 ± 0.04 0.46 ± 0.03 3.3 ± 0.4 0.43 ± 0.09 
pS438·GBI (Module I) 0.35 ± 0.02 0.43 ± 0.02 0.29 ± 0.03 1.1 ± 0.2 0.75 ± 0.03 
pS224·GBII (Module II) 0.37 ± 0.01 0.61 ± 0.01 0.29 ± 0.01 1.8 ± 0.2 0.59 ± 0.04 
pS438·GBI + pS224·GBII 0.11 ± 0.01 0.35 ± 0.01 0.21 ± 0.02 1.3 ± 0.1 N.D. 
pS424·gapA 0.45 ± 0.02 0.24 ± 0.02 0.44 ± 0.01 2.8 ± 0.3 N.D. 
pS224·GPG (glk·pfkA·gapA) 0.32 ± 0.01 0.72 ± 0.01 0.42 ± 0.02 1.5 ± 0.1 N.D. 
 
a  E. coli BW25113 carrying plasmid pAeT41 (i.e., constitutively expressing the phaC1AB1 gene cluster from 
C. necator) was transformed with the plasmids indicated, and grown aerobically in LB medium added with 
glucose at 10 g l-1 for 24 h. Each parameter is reported as the mean value ± standard deviation from 
duplicate measurements in at least three independent experiments. N.D., not determined. 
b The full description of each plasmid can be found in Materials and Methods section (Table 3). 
c The residual cell dry weight (rCDW) was calculated as the difference between the total CDW and the PHB 
concentration. 
 
A key issue to be considered when designing E. coli-based microbial cell platforms is the so-called 
overflow metabolism, i.e., the spillage of metabolic intermediates into the formation of (often, undesired) by-
products (Han et al., 1992; Nakano et al., 1997). In order to evaluate this phenomenon in the recombinant 
strains constructed here, the specific rate of acetate formation was measured in all recombinant strains 
(Table 7), since this metabolite is known to be the main by-product of aerobic glucose catabolism (Bernal 
et al., 2016). The control strain, E. coli BW25113 carrying pSEVA224, excreted acetate at a rate of 4.8 ± 
0.2 mmol gCDW-1 h-1 when cultured in LB medium containing glucose. All the strains expressing the 
phaC1AB1 gene cluster had a reduced rate of acetate formation (e.g., the strain transformed with both 
Modules I and II had a 73% reduction in this parameter). This is a finding in line with previous observations, 
indicating that the synthesis of PHB overcomes acetate formation in recombinant E. coli (Chang et al., 1999). 
As an additional experimental validation, the intracellular concentration of acetyl-CoA was also analyzed in 
these strains (Table 7), obtaining a positive correlation between PHB formation and the concentration of 
this metabolite. In particular, the expression of the glycolytic genes encoded by Module I or Module II 
significantly increased the availability of this metabolic precursor by 1.7- and 1.4-fold, respectively, as 
compared to E. coli BW25113/pAeT41 + pSEVA224. Since acetyl-CoA is the substrate of the PHB synthesis 
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pathway, the accumulation of polymer can be correlated with the increase in precursor availability, assuming 
that all strains express the phaC1AB1 gene cluster at similar levels. PHB accumulation in the control strain 
reached 25.6 ± 3.7% of the CDW, while the same strain transformed with either Module I or Module II 
attained 53.9 ± 3.1% and 62.9 ± 1.3% of the CDW, respectively (Fig. 8c). The residual CDW of either strain 
under PHB accumulation conditions was similar (Table 7), indicating that neither Module I nor II affected 
biomass formation significantly. Predictably, the expression in the same strain of the Module I and II from 
two independent plasmids resulted in the highest value of PHB accumulation. Such strain accumulated up 
to 72.5 ± 9.8% of the CDW in the form of PHB, representing an increase of ca. 3-fold as compared to E. coli 
BW25113/pAeT41 + pSEVA224. Interestingly, the overexpression of the glycolytic modules did not increase 
the overflow metabolism from acetyl-CoA (i.e., synthesis of acetate). This result indicates that the 
recombinant strains probably rerouted this metabolite to produce PHB at the expense of acetate formation. 
Furthermore, this example of pathway engineering illustrates how the availability of key precursors in central 
carbon metabolism can be channeled into the formation of an added-value product while minimally affecting 
the physiology of the bacterial host. 
 
In an attempt to determine which glycolytic fluxes were determinant in increasing PHB accumulation by 
these recombinants, two extra SEVA plasmids were constructed, in which individual GlucoBrick parts, 
belonging to either Module I or II, are expressed under the transcriptional control of a LacIQ/Ptrc regulatory 
element. Plasmids pS424·gapA and pS224·GPG, carrying glk, pfkA, and gapA [see Materials and Methods 
section (Table 3) for details on the construction] were separately introduced into E. coli BW25113/pAeT41, 
and growth, glucose consumption, and PHB accumulation were tested under the same culture conditions 
indicated in the previous section. While an increase in the flux through GA3P dehydrogenase (i.e., GapA) 
did not result in a significant increase of either glucose consumption or polymer synthesis, the expression 
of the glk·pfkA·gapA synthetic cluster from plasmid pS224·GPG significantly enhanced both parameters 
with respect to the control strain (Fig. 8b and c). PHB accumulation in this recombinant peaked at 66.4 ± 
3.7% of the CDW (although there were no differences in the actual PHB concentration, see Table 7). Yet, 
boosting the glycolytic flux by means of Glk, Pfk, and GapA alone was not enough to reach the highest 
accumulation of PHB observed in the strain bearing both Modules I and II (i.e., the whole complement of 
EMP enzymes). This result may in turn suggest that an appropriate channeling of metabolic intermediates 
from glucose all the way down to acetyl-CoA is only possible if an adequate balance of all the individual 
enzyme activities involved is met. 
 
In summary, the GlucoBrick system has been systematically proved to be a useful tool for the targeted 
implementation of glycolytic capacities in different Gram-negative bacteria. In the context of this Thesis, this 
platform represents the first step to achieve the main objective of the whole project: to refactor central carbon 
metabolism in P. putida KT2440, transforming the native glucose catabolism into a synthetic, predictable 
linear EMP pathway. The next chapters explain in detail the steps followed to complete this ambitious 
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objective that comprises the generation of a suitable P. putida KT2440 glycolytic chassis to accommodate 
the grafted metabolic pathway, while dissecting the biochemical principles coordinating the intricate 
metabolism of this bacterium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
	 87 
IV 
CHAPTER 2 
 
Design and construction of P. putida GC (Glycolytic Chassis): The starting 
point for deep refactoring of central carbon metabolism 
in environmental bacteria 
 
 
 
Background 
 
P. putida KT2440 is an environmental Gram-negative bacterium with a large number of interesting features 
for biotechnological processes. These characteristics include its generally recognized as safe (GRAS) status 
classification (Federal Register. Appendix E, 1982), the high resistance to oxidative stress (Poblete-Castro 
et al., 2012; 2017; Regenhardt et al., 2002), its amenability to genetic manipulations (Lieder et al., 2015; 
Martínez-García et al., 2014a,b; Silva-Rocha et al., 2013), and the availability of different metabolic models 
(Belda et al., 2016; Nogales et al., 2008; Puchałka et al., 2008; Sohn et al., 2010). Accordingly, this 
bacterium is an appealing starting point for a deep metabolic refactoring, such as the simplification of its 
genetic components as an approach to generate a useful metabolic chassis for different applications. 
Glucose metabolism in P. putida (which is based on the ED pathway and the EDEMP cycle) is a remarkable 
example of adaptation to the natural environment, wiring the formation of reducing power (in the form of 
NADPH) and the specific adaptation to environments characterized by harsh conditions. The formation of 
NADPH comes, however, at the cost of ATP synthesis, as the ED pathway yields half the amount of ATP 
as compared to the EMP pathway (Ng et al., 2015). An important number of bioprocesses mediated by cell 
factories in the industry have been described to be dependent on ATP availability (Hara & Kondo, 2015; 
Schuster, 2000). Therefore, the implementation of a linear EMP pathway (where the ATP yield per molecule 
of glucose is higher than that mediated by the ED pathway) could be an interesting approach to improve the 
energy balance in P. putida KT2440. Before considering the actual Metabolic Engineering manipulations 
needed to enable a linear glycolysis in P. putida KT2440, it was necessary to design a genetic chassis to 
host these heterologous enzyme activities. This chassis, named P. putida GC (glycolytic chassis), is based 
in a P. putida KT2440, freed of several native glycolytic activities. The present chapter describes the set of 
deletions introduced in P. putida GC to improve glucose uptake and permit implementation of a linear EMP 
glycolysis. 
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2.1. Streamlining glucose uptake to avoid ATP consumption through the native system of 
P. putida KT2440 
	
2.1.1. Glucose uptake system in P. putida KT2440. P. putida KT2440 can introduce glucose in its central 
carbon metabolism by two different routes (Fig. 9a): (i) phosphorylation in the cytoplasm by Glk, or (ii) 
oxidation in the periplasm to gluconate and/or 2KG through the activity of Gcd and/or Gad (del Castillo et 
al., 2007; 2008; Fuhrer et al., 2005; Latrach-Tlemçani et al., 2008). Glucose uptake into the cytoplasm, 
where Glk is able to phosphorylate glucose, is based on an ABC transport system coupled to OprB porins 
(Fig. 9a). More precisely, the OprB porins [OprB-1 (PP_1019) and OprB-2 (PP_1445)] facilitate the diffusion 
of glucose across the outer membrane (del Castillo et al., 2007; Wylie & Worobec, 1995). Subsequently, 
the ABC transport system captures the glucose from the periplasmic space with the aid of the periplasmic 
sugar-binding protein encoded by the gene gtsA (PP_1015). This complex, composed by the sugar and the 
periplasmic-binding protein (Fig. 9b), interacts with the core of the ABC transporter system encoded by the 
genes gtsB (PP_1016), gtsC (PP_1017), and gtsD (PP_1018) to introduce the carbohydrate into the 
cytoplasm (Schneider, 2001). Taking into account our main goal (i.e., to implement a functional EMP 
pathway with a high ATP yield), it is necessary to have a suitable glucose transport system where energy 
consumption is avoided. This is certainly not the case of the native system to uptake glucose in P. putida 
KT2440, based in an ABC transport system directly correlated with the hydrolysis of ATP. In this chapter, 
removal of the native glucose uptake in P. putida KT2440 is described as the first step to reach the goal of 
generating a P. putida GC strain.      
	
RESULTS 
	 89 
IV 
Figure 9½Glucose uptake in P. putida KT2440. (a)	The scheme depicts the ways that glucose follows to 
enter the central carbon metabolism of P. putida KT2440. The capital letters shown in the picture indicate 
the genes that encode each subunit of the ABC transporter. Abbreviations are as follows: GntT, gluconate 
transporter from the periplasmic space to the cytoplasm; OM, outer membrane; PS, periplasmic space; 
and IM, inner membrane. (b) Genomic context of the genes involved in glucose uptake. The adjacent 
location of the genes with respect to each other is an example of the functional organization within a 
genomic region with a specific role (in this case, glucose uptake); the transcriptional activity of which 
becomes relevant when the bacteria are grown in the presence of glucose (del Castillo et al., 2007).  
 
The elimination of the native glucose uptake activity in P. putida KT2440 is based on two different 
deletion processes: (i) removing the Gcd activity, and (ii) blocking the participation of the glucose ABC 
transporter in hexose uptake. In order to better understand the functional relevance of each element in 
hexose uptake and processing, a set of different mutants was generated in this study. In first place, a Dgcd 
and Dgts mutant strains were separately constructed as indicated in the Materials and Methods section. In 
the case of the Dgts strain, the mutant was generated by a single deletion event that simultaneously 
removed the gtsA, gtsB, gtsC, and gtsD genes. At the same time, a Dgts Dgcd double mutant derivative of 
strain KT2440 was constructed by consecutively entering both deletions (Figs. 10a and b). 
 
 
Figure 10½Growth phenotype characterization of glucose transport mutants. (a) M9 minimal medium 
plates, containing either 20 mM glucose (top panel, plate shown in the left) or 30 mM succinate (top panel, 
plate shown in the right), were seeded with P. putida KT2440 (wild-type), and the mutants Dgcd (PP_1444, 
encoding glucose dehydrogenase), Dgts [DgtsA (PP_1015), DgtsB (PP_1016), DgtsC (PP_1017), and 
DgtsD (PP_1018)], and Dgcd Dgts. (b) Summary of the growth phenotypes of the strains under study           
(“ “ indicates growth, and “ “ indicates that the strain could not grow under the specific conditions tested 
in each case).  
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As indicated in Fig. 9a, P. putida KT2440 is able to introduce glucose in the central carbon metabolism 
by two different ways: oxidation (mediated by Gcd/Gad in the periplasmic space) and/or by phosphorylation 
(mediated by Glk in the cytoplasm). The literature indicates that less than 10% of the hexose enters into 
glucose catabolism via Glk, while the remaining 90% is oxidized by Gcd in the periplasmic space to enter 
into the central carbon metabolism as gluconate (Nikel et al., 2015a). In full accordance with these figures, 
the results displayed in Fig. 10a and b indicate the capacity of P. putida KT2440 to grow in glucose in spite 
of the individual absence of Gcd activity or ABC-mediated transport. The results in this section also 
demonstrate that the only way to obtain a P. putida mutant where glucose uptake is altogether interrupted 
is through the simultaneous elimination of the Gcd activity and the glucose ABC transporter. This strain 
(Dgcd Dgts) constitutes the point of departure to analyze the functionality of an orthogonal glucose transport 
system in P. putida GC, thereby bypassing the intrinsic ATP consumption of the native system. 
 
2.1.2. Recruitment of the glucose facilitator (glf) from Zymomonas mobilis as an alternative transport 
system for P. putida KT2440. Glucose can be introduced into the bacterial cytoplasm by means of different 
transport systems. As previously mentioned, ATP saving is an important principle in various industrial 
bioprocess (Hara & Kondo, 2015). However, glucose transport is generally regulated following a no pain-no 
gain scheme in terms of energy. The cost of glucose uptake in terms of energy expenditure is reflected by 
the three main different models of hexose intake: (i) the PTS system, predominant in Enterobacteria, (ii) 
cation- or proton- linked permeases, and (iii) ABC transporters (Baldwin & Henderson, 1989; Postma et al., 
1993). All these systems use metabolic energy in the form of phosphoenolpyruvate or proton-motive force. 
An interesting exception in terms of mechanism of hexose transport is exemplified by the system of the 
strictly fermentative, Gram-negative bacterium Zymomonas mobilis, where glucose uptake is fulfilled by the 
Glf glucose facilitator encoded by the glf gene (Dimarco & Romano, 1985). Briefly, Glf is an ATP-
independent, low-affinity, and high velocity carrier protein that is able to transport glucose, fructose, and 
xylose (Dimarco & Romano, 1985; Schoberth & de Graaf, 1993). Glf belongs to the group of GLUT proteins 
that comprise members of the major facilitator superfamily of membrane transporters from both prokaryotes 
and eukaryotes (Baldwin, 1993). 
 
Taking into account all the features described above, and assuming the functionality of the Glf-
mediated glucose transport in other Gram-negative bacteria, e.g., E. coli (Nikel & de Lorenzo, 2013b; 
Weisser et al., 1995), this system was selected as a candidate transporter for P. putida GC. As a first step, 
the DNA sequence encoding the Glf transporter (glf, ZMO0366) was edited in silico to eliminate the 
restriction sites incompatible with the sites present in plasmids belonging to the SEVA platform (Martínez-
García et al., 2014a; Silva-Rocha et al., 2013). The Glf module comprises a synthetic RBS followed by the 
glf edited sequence and flanked by EcoRI and KpnI sites. This synthetic DNA cassette was cloned in the 
pSEVA438 vector (pBBR1, SmR/SpR), generating plasmid pS438·glf. This plasmid was used to check 
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whether Glf is able to restore the growth of P. putida KT2440 Dgts Dgcd on glucose as the sole carbon 
source. This plasmid was introduced in the mentioned mutant, and the growth phenotype was tested in M9 
minimal medium plates with 20 mM glucose and proper induction (3-mB at 1 mM). The resulting strain was 
able to grow on glucose, a suitable control to check for the Glf functionality in P. putida KT2440.  
 
Once this experiment was carried out as a proof-of-concept of the heterologous Glf function, the next 
step was the stable insertion of the Glf module the chromosome of P. putida GC. A pBAMD transposon 
vector was designed to deploy the Glf module described above. The Glf-encoding DNA fragment was 
transferred into the mini-Tn5–based vector pBAMD1-2 (giving rise to pBAMD1-2·glf, KmR). After the 
transposon delivery plasmid was amplified in an appropriate E. coli host (E. coli CC118 lpir), a tripartite 
conjugative mating was employed to enter the transposon into the recipient strain (P. putida KT2440 Dgts 
Dgcd). Note that this approach, in which the DNA cargo (devoid of any promoter region) borne by the 
transposon is randomly inserted in the target chromosome, not only enables the stable insertion of the 
module, but it also results in a library of independent insertions expected to display different levels of 
transcription (thereby resulting in different amounts of Glf activity). In this case, the screening of successful 
insertion events was simplified by the fact that, after the exconjugants were plated in M9 minimal medium 
with Km and 0.2% (w/v) citrate (to select P. putida over E. coli), only the clones displaying an adequate level 
of Glf activity are able to grow in M9 medium plates containing glucose as the sole carbon source. In all 
these cases, the successful exconjugants were inoculated in 96-well microtiter plates in M9 minimal medium 
containing 20 mM glucose, and bacterial growth was assessed by measuring the OD600 over time in a 
microtiter plate reader in order to select the exconjugant(s) with the highest specific growth rate (Fig. 11a).  
 
The single-copy insertion of glf from Z. mobilis is able to rescue the growth phenotype of P. putida 
KT2440 Dgcd Dgts in M9 minimal medium with glucose as the sole carbon source (Fig. 11b). Interestingly, 
the specific growth rate of one of the exconjugants selected (i.e., P. putida KT2440 Dgcd Dgts·T) reached 
a similar value to that of the WT strain grown in the same conditions (Fig. 11c). The final cell density was 
likewise similar in the two strains under comparison. Randomly-amplified PCR was used to locate the site 
of insertion of the mini-Tn5 module containing glf in this exconjugant. The insertion mapped in the 120-bp-
long PP_5SE gene. This gene is one out of seven 5S ribosomal RNA genes encoded in the chromosome, 
and an insertion in this position is expected to result in a high rate of gene expression (Ammons et al., 1999). 
In summary, the implementation of a single-copy insertion of glf in the chromosome allows a glucose 
transport-deficient derivative of P. putida to uptake enough glucose to support bacterial growth up to the 
level of the WT strain. 
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Figure 11½Glf functionality in a glucose transport-deficient derivative of P. putida KT2440. (a) The 
scheme depicts the role that Glf plays in glucose uptake of P. putida KT2440 Dgcd Dgts mutant. 
Abbreviations are as follows: OM, outer membrane; PS, periplasmic space; and IM, inner membrane. (b) 
Growth phenotypes of the different strains under study. M9 minimal medium plates containing 20 mM 
glucose were seeded with P. putida KT2440 (wild-type), and the mutants Dgcd Dgts, and Dgcd Dgts·T 
[i.e., Dgcd Dgts with a mini-Tn5 transposon module inserted in the chromosome, carrying the glf gene 
(Transporter)]. (c) Growth curves of P. putida KT2440 and the exconjugant Dgcd Dgts·T on M9 minimal 
medium with 20 mM glucose. Each data point in the growth curve represents the mean value of the OD600 
in quadruplicate measurements from at least three independent experiments. The specific growth rates (µ) 
were calculated from these data during exponential growth, and the inset shows the mean value ± standard 
deviations for each strain.   
 
2.2. The metabolic fate of glucose in P. putida KT2440: A key issue to solve in order to 
implement a functional EMP pathway 
 
High rates of reducing power (i.e., NADPH) regeneration per molecule of glucose are relevant in order to 
counteract different types of environmental stress (Kim & Park, 2014). This evolutive necessity seems to 
have been addressed by the metabolic connectivities of the EDEMP cycle (encompassing activities from 
the ED, EMP, and PP pathways; Fig. 12), where the ED pathway serves as the main glycolytic route while 
the (incomplete) EMP assumes the role of regenerating hexoses-P from trioses-P (Nikel et al., 2015a). On 
top of this metabolic versatility in the core metabolism, many environmental bacteria have branched 
pathways to introduce glucose (del Castillo et al., 2007; 2008; Lessie & Phibbs, 1984). Taking into account 
all these features, the native metabolism of P. putida KT2440 needs to be streamlined and simplified in 
order to implement a linear glycolysis based on the EMP pathway carried by the GlucoBrick system. For 
this reason, one of the main goals in this Thesis was the generation of a set of mutants in which to avoid 
glucose misrouting, a necessary principle to funnel the hexose into a linear glycolysis. More particularly, the 
target metabolic nodes to remove from the central carbon metabolism of P. putida are both hexose 
phosphorylation and oxidation: (i) Glk, (ii) Gcd, and (iii) Gad activities (Fig. 12). 
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Figure 12½Schematic representation of central carbon metabolism in P. putida KT2440. Glucose 
catabolism occurs mainly through the activity of the Entner-Doudoroff (ED) pathway, but part of the trioses-
P thereby generated are recycled back to hexoses-P by means of the EDEMP cycle, that also 
encompasses activities from the Embden-Meyerhof-Parnas (EMP) and pentose phosphate (PP) pathways. 
Note that a set of peripheral reactions can also oxidize glucose to gluconate and/or 2-ketogluconate (2KG) 
before any phosphorylation of the intermediates occurs. Each metabolism block is indicated with different 
color and the EDEMP cycle is shaded in blue in the diagram. Note that 6-phosphofructo-1-kinase (Pfk) 
activity is absent and is indicated as a dashed grey row. The deletions introduced in genes encoding 
metabolic enzymes targeted in this chapter are indicated by a D symbol. The abbreviations used in this 
picture are as follows: G6P, glucose-6-P; F6P, fructose-6-P; FBP, fructose-1,6-P2; DHAP, 
dihydroxyacetone-P; GA3P, glyceraldehyde-3-P; BPG, glycerate-1,3-P2; 3PG, glycerate-3-P; 2PG, 
glycerate-2-P; PEP, phosphoenolpyruvate; Pyr, pyruvate; 6PG, 6-phosphogluconate; KDPG, 2-keto-3-
deoxy-6-phosphogluconate; acetyl-CoA, acetyl-coenzyme A; 2K6PG, 2-ketogluconate-6-P; OM, outer 
membrane; PS, periplasmic space; and IM, inner membrane. 
 
Glucokinase (Glk). The main hexose kinase activity in P. putida KT2440 is encoded by the glk gene, i.e., 
PP_1011 (del Castillo et al., 2007). This enzyme allows P. putida KT2440 to phosphorylate glucose into 
G6P in the cytoplasm. Then, G6P can be transformed into 6PG by the action of the Zwf, the required 
intermediary to introduce glucose in the ED pathway via phosphorylation (Fig. 12). In spite of the fact that 
only 10% of the glucose entering the network is phosphorylated to G6P (Nikel et al., 2015a), we planned to 
remove this native activity from P. putida in or order to facilitate the subsequent implantation of the Glk 
activity from the GlucoBrick system. As indicated in Fig. 13a, this operation avoids any potential interaction 
between such unrelated enzymes [i.e., cellular machinery vs. implanted genetic constructs (Kim & Copley, 
2012)].  
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Figure 13½Characterization of the glk deletion in P. putida KT2440. (a) The scheme depicts the location 
of the glk gene in the chromosome of P. putida KT2440, and the ATP-dependent reaction catalyzed by Glk. 
Note that the STOP codon of the edd gene overlaps with the beginning of the glk coding region. As detailed 
in the Materials and Methods section, the deletion introduced in this locus (indicated with a D symbol in the 
outline) eliminates most of the glk gene without affecting edd. (b) In vitro quantification of the specific (Sp) 
Glk activity in wild-type (WT) P. putida KT2440, and its Dglk and Dgcd mutant derivatives. All the strains 
employed for the in vitro enzymatic assays were grown on M9 minimal medium added with glucose at 20 
mM and cells were harvested in mid-exponential phase to obtain the cell-free extracts. Each bar represents 
the mean value of the corresponding enzyme activity ± standard deviation of quadruplicate measurements 
from at least two independent experiments. Significant differences (P < 0.05, as evaluated by means of the 
Student's t test) in the pair-wise comparison of a given recombinant to the control WT strain are indicated 
by an asterisk. (c) Growth curves of P. putida KT2440 and its Dglk derivative under glycolytic (M9 minimal 
medium with 20 mM glucose) or gluconeogenic (M9 minimal medium with 30 mM succinate) conditions. 
Each data point represents the mean value of the optical density measured at 600 nm (OD600) of 
quadruplicate measurements from at least three independent experiments. The specific growth rates (µ) 
were calculated from these data during exponential growth, and the inset shows the mean values ± 
standard deviations for each strain. 
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The results shown in Fig. 13b indicate that the deletion of the glk (PP_1011) gene results in the loss 
of any detectable Glk activity in P. putida KT2440 (del Castillo et al., 2007). At the same time, the deletion 
of gcd gene does not seem to affect the Glk activity in P. putida KT2440. The growth phenotype of the Dglk 
mutant was also analyzed in order to elucidate its importance in the bacterial fitness in liquid cultures (Fig. 
13c) and in plates (Figs. 17a and b). The results suggest that the absence of the Glk activity is not critically 
important for the overall fitness of the bacterium, maintaining similar values for the specific growth rate (Fig. 
13c), under either glycolytic or gluconeogenic conditions (i.e., growing on M9 minimal medium with 20 mM 
glucose or 30 mM succinate, respectively). 
 
Glucose dehydrogenase (Gcd). The Gcd activity in P. putida KT2440 is executed by the protein encoded 
by the gcd gene, i.e., PP_1444 (del Castillo et al., 2007). This enzyme is an example of inner membrane-
bound glucose dehydrogenase (An & Moe, 2016), that requires the redox cofactor pyrroloquinoline quinone 
(PQQ). Gcd allows P. putida KT2440 to transform glucose into gluconate in the periplasmic space, a rather 
relevant role if one considers that almost 90% of the glucose that enters the central carbon metabolism of 
this bacterium gets oxidized (Nikel et al., 2015a). This transformation of glucose into oxidized products is 
counterproductive for our purposes, as the use of hexoses in peripheral reactions is a competing pathway 
for the intended linear glycolysis (Fig. 12). Elimination of the Gcd activity, the first committed step in the 
oxidation peripheral pathway, was thus of capital importance for the construction of P. putida GC (Fig. 14a). 
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Figure 14½Characterization of the gcd deletion in P. putida KT2440. (a) The scheme depicts the 
location of the gcd gene in the chromosome of P. putida KT2440, and the deletion introduced in this locus 
(indicated with a D symbol in the outline). The relative orientation of gcd (i.e., in the reverse strand) is also 
indicated in the diagram. Note that the oxidation of glucose into gluconate proceeds via the reduction of 
the redox cofactor pyrroloquinoline quinone (PQQ). (b) In vitro quantification of the specific (Sp) Gcd activity 
in wild-type (WT) P. putida KT2440, and its Dglk and Dgcd mutant derivatives. All the strains employed for 
the in vitro enzymatic assays were grown on M9 minimal medium added with glucose at 20 mM and cells 
were harvested in mid-exponential phase to obtain the cell-free extracts. Each bar represents the mean 
value of the corresponding enzyme activity ± standard deviation of quadruplicate measurements from at 
least two independent experiments. Significant differences (P < 0.05, as evaluated by means of the 
Student's t test) in the pair-wise comparison of a given recombinant to the control WT strain are indicated 
by an asterisk. (c) Growth curves of P. putida KT2440 and its Dgcd derivative under glycolytic (M9 minimal 
medium with 20 mM glucose) or gluconeogenic (M9 minimal medium with 30 mM succinate) conditions. 
Each data point represents the mean value of the optical density measured at 600 nm (OD600) of 
quadruplicate measurements from at least three independent experiments. The specific growth rates (µ) 
were calculated from these data during exponential growth, and the inset shows the mean values ± 
standard deviations for each strain. 
 
The gcd deletion altogether eliminated the Gcd activity in the P. putida KT2440, in contrast with the 
WT and Dglk controls, which displayed similar levels of specific Gcd activity (Fig. 14b). In terms of growth 
phenotype (Fig. 14c), the Dgcd mutant was more affected than the previously analyzed Dglk strain (µ = 
0.33 h-1 vs. µ = 0.45 h-1, respectively) when the bacteria were growing in M9 minimal medium with 20 mM 
glucose. This phenotype does not involve a dramatic effect in terms of overall fitness, but it could reflect the 
preference that this bacterium has to metabolize glucose mainly by the oxidative branch (Nikel et al., 2015a). 
Additionally, the results indicated in Fig. 14c demonstrate that the absence of Gcd activity is not revelant 
for growth under gluconeogenic conditions (i.e., in M9 minimal medium with 30 mM succinate). It should be 
noted that, as expected, the accumulation of the Dglk and Dgcd deletions in the same strain prevented P. 
putida KT2440 to grow in glucose (Figs. 17a and b). This phenotype is in accordance with the hypothesis 
that hexose consumption can be blocked by limiting the entrance of glucose into central catabolism through 
both phosphorylation (i.e., Glk) and oxidation (i.e., Gcd).   
 
Gluconate 2-dehydrogenase (Gad). The Gad activity in P. putida KT2440 is carried out by an enzymatic 
complex comprising three different gene products: PP_3382, PP_3383, and PP_3384. More precisely, Gad 
activity is driven by a membrane-bound flavin adenine dinucleotide (FAD)-containing gluconate 2-
dehydrogenase (FAD-GADH). Such FAD-GADH activity has been characterized to some extent in P. 
aeruginosa (Matsushita et al., 1982), allowing us to identify the orthologues in P. putida KT2440. These 
regions have the following features: (i) the largest subunit of the complex is encoded by the PP_3383 gene 
(with a product of 594 amino acids) and comprises the dehydrogenase subunit that contains FAD as the 
prosthetic group, which is covalently bound to the histidine residue of the subunit (McIntire et al., 1985); (ii) 
the middle subunit (with a product of 417 amino acids) is encoded by the PP_3382 gene and contains the 
heme c cofactor, which probably allows the electron transfer from the FAD in the dehydrogenase subunit to 
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the ubiquinone carrier placed in the inner membrane, connecting the oxidation of the substrate with the 
respiratory chain (Matsushita et al., 1994); and (iii) the small subunit (with a product of 246 amino acids) is 
encoded by the PP_3384 gene and it was annotated in silico, only in the case of P. aeruginosa, as a  g 
subunit of the FAD-GADH complex. 
 
In this work, the complete removal of the group of genes PP_3382-4 was done by a single deletion 
event. The pair of genes PP_3382 and PP_3383 have a properly annotated function in the Pseudomonas 
database (Winsor et al., 2016) and in the recent resequencing of the genome of strain KT2440 (Belda et al., 
2016). PP_3384 does not present a clear function in strain KT2440, and it was removed since studies in 
other species support a key role of the product encoded by this gene in sugar oxidation (Arellano et al., 
2010). Additionally, the role of the products encoded by PP_3623 and PP_4232 in the overall Gad activity 
was also evaluated by eliminating the corresponding coding sequences. In the case of PP_3623 (encoding 
a product of 447 amino acids), the in silico annotation describes the product of this gene as the cytochrome 
c subunit of an alcohol dehydrogenase (and likely a sugar dehydrogenase, too). At the same time, PP_3623 
is considered to be a duplication of the PP_3382 gene with a high level of statistical significance. The 
PP_4232 gene (encoding a product of 403 amino acids) has not been assigned any function but is also 
considered to be a duplication of the PP_3382 gene with a high level of statistical significance. For these 
reasons, the deletion of both PP_3623 and PP_4232 was implemented along the elimination of PP_3382-
PP_3384 in order to completely remove the Gad activity in P. putida KT2440 (Fig. 15a). 
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Figure 15½Characterization of the Gad activity removal in P. putida KT2440. (a) The scheme depicts 
the distribution of the hypothetical genes involved in the Gad activity in the chromosome of P. putida 
KT2440, and the biochemical reaction they encode. The relative orientation of the genes in the 
chromosome is likewise indicated. (b) In vitro quantification of the specific (Sp) gluconate 2-dehydrogenase 
(Gad) activity in wild-type (WT) P. putida KT2440, and the mutant strains DPP_3382-4 (which comprises 
the deletions of PP_3382, PP_3383, and PP_3384), DPP_3623, DPP_4232, and Dgad (which comprises 
the deletions from DPP_3382-4, DPP_3623, and DPP_4232). All the strains employed for the in vitro 
enzymatic assays were grown on M9 minimal medium added with glucose at 20 mM and cells were 
harvested in mid-exponential phase to obtain the cell-free extracts. Each bar represents the mean value of 
the corresponding enzyme activity ± standard deviation of quadruplicate measurements from at least two 
independent experiments. Significant differences (P < 0.05, as evaluated by means of the Student's t test) 
in the pair-wise comparison of a given recombinant to the control WT strain are indicated by an asterisk. 
(c) Growth curves of P. putida KT2440 and partial and full mutants blocked in the Gad activity under 
glycolytic (M9 minimal medium with 20 mM glucose) or gluconeogenic (M9 minimal medium with 30 mM 
succinate) conditions. Each data point represents the mean value of the optical density measured at 600 
nm (OD600) of quadruplicate measurements from at least three independent experiments. The specific 
growth rates (µ) were calculated from these data during exponential growth, and the inset shows the mean 
values ± standard deviations for each strain. 
 
The results shown in Fig. 15 shed light on the genotype-to-phenotype wiring of the Gad activity in P. 
putida KT2440. Firstly, the pool of genes involved in the oxidation of gluconate into 2KG could be 
unambiguously identified (Fig. 15b). More precisely, the bulk Gad activity could be traced to the products of 
the PP3382-4 operon; the products encoded by PP_3623 and PP_4232 displaying a marginal influence in 
the Gad activity with a non-statistical significance. On the other hand, the growth phenotype evaluated in 
both liquid medium (Fig. 15c) and plates (Figs. 17a and b) indicated that the Gad activity is largely irrelevant 
in terms of bacterial fitness, since very similar values of specific growth rates were observed in all the 
mutants evaluated under glycolytic (M9 minimal medium with 20 mM glucose) or gluconeogenic (M9 minimal 
medium with 30 mM succinate) conditions (Fig. 15c). In the light of the aforementioned results, the complete 
set of deletions for Gad activity (DPP_3382-4, DPP_3623, and DPP_4232) was introduced in the KT2440 
genetic background in order to avoid glucose misrouting into oxidation pathways in P. putida GC. 
 
2.3. Removing the ED pathway of P. putida KT2440 to establish a linear glycolysis 
 
The ED pathway is the fundamental pillar for glucose catabolism in P. putida KT2440 (Fig. 12), and the only 
way that this bacterium has to consume this hexose due to the absence of a complete, catabolic EMP 
pathway, which is blocked at the level of Pfk (del Castillo et al., 2007; Fuhrer et al., 2005; Latrach-Tlemçani 
et al., 2008; Nikel et al., 2015a; Vicente & Cánovas, 1973a,b). The ED pathway enables P. putida KT2440 
to obtain Pyr and GA3P from glucose, key intermediates in order to regenerate hexoses-P through the 
EDEMP cycle, and also to obtain energy and reducing power by means of the TCA cycle (Nikel et al., 
2015a). Basically, the ED pathway in strain KT2440 is composed by the sequential activity of Edd encoded 
by the edd gene (PP_1010), which transforms 6PG into KDPG; and Eda encoded by the eda gene 
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(PP_1024), which transforms KDPG into Pyr and GA3P. The next step in the stepwise construction of P. 
putida GC was to remove the components of the extant ED pathway (Fig. 16a and b). 
 
 
Figure 16½Interrupting the Entner-Doudoroff (ED) pathway of P. putida KT2440. (a) The two-step ED 
pathway in P. putida KT2440. Abbreviations are as follows: 6PG, 6-phosphogluconate; KDPG, 2-keto-3-
deoxy-6-phosphogluconate; GA3P, glyceraldehyde-3-P; Pyr, pyruvate; Edd, 6-phosphogluconate 
dehydratase; and Eda, 2-keto-3-deoxy-6-phosphogluconate aldolase. (b) The scheme indicates the 
distribution of the genes involved in the ED pathway in the chromosome of P. putida KT2440. Note that for 
both edd and eda there is an overlapping of the corresponding coding regions with adjoining genes (likely 
indicating co-regulation of the members in the gene cluster). The deletions implemented in this study 
(indicated with a D symbol in the outline) are shown in the outline, and do not affect the expression of the 
genes in the vicinity of the target loci. (c) In vitro quantification of the specific (Sp) Edd activity in wild-type 
(WT) P. putida KT2440 and its Dedd mutant derivative. All the strains employed for the in vitro enzymatic 
assays were grown on LB medium and cells were harvested in mid-exponential phase to obtain the cell-
free extracts. Each bar represents the mean value of the corresponding enzyme activity ± standard 
deviation of quadruplicate measurements from at least two independent experiments. Significant 
differences (P < 0.05, as evaluated by means of the Student's t test) in the pair-wise comparison of a given 
recombinant to the control WT strain are indicated by an asterisk.  
 
Fig. 16a indicates that it is possible to block the ED pathway by eliminating the first committed step 
(i.e., Edd). In this case, the deletion of the edd gene prevents P. putida KT2440 to transform 6PG into KDPG, 
as reflected in the in vitro enzymatic assay (Fig. 16c). Given that the Dedd mutant cannot grow on glucose 
as the only carbon source (Figs. 17a and b), the in vitro enzymatic assay of the Edd activity was performed 
in cell-free extracts obtained from LB medium cultures. The Edd activity in P. putida KT2440 grown in LB 
medium was low (approximately 3%) as compared with that in cells grown under strictly glycolytic conditions 
(Nikel et al., 2015a). Even when blocking the Edd step of the ED pathway was enough to prevent the 
glucose-dependent growth of strain KT2440, both Dedd and Deda deletions were introduced in P. putida 
GC to avoid any potential misrouting of central metabolic intermediates. Figs. 17a and b summarize the 
growth phenotypes of all the P. putida KT2440 mutants constructed and described in this chapter under 
both glycolytic and gluconeogenic conditions. 
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Figure 17½Growth phenotype characterization of different glucose catabolism mutants of P. putida 
KT2440. (a)	M9 minimal medium plates, containing either 20 mM glucose (top plate) or 30 mM succinate 
(bottom plate), were seeded with P. putida KT2440 (wild-type), and the mutants Dglk (PP_1011, 
glucokinase), Dgcd (PP_1444, glucose dehydrogenase), Dglk Dgcd, Dgad (which comprises the deletions 
of DPP_3382, DPP_3383, DPP_3384, DPP_3623 and DPP_4232, encoding gluconate 2-dehydrogenase), 
Dedd (PP_1010, 6-phosphogluconate dehydratase), and Deda (PP_1024, 2-keto-3-deoxy-6-
phosphogluconate aldolase). (b) Summary of the growth phenotypes of the strains under study (“ “ 
indicates growth, and “ “ indicates that the strain could not grow under the specific conditions tested in 
each case).	
 
In summary, the gene deletions described above have been considered to construct P. putida GC. In 
all cases, the mutations studied in this chapter are correlated with the assumed loss of function in key 
metabolic steps of the biochemical network of strain KT2440, certifying their functionality in the glycolytic 
chassis.    
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CHAPTER 3 
 
Exploring the role of glucose-6-P isomerase in central carbon metabolism of 
P. putida KT2440 
 
 
 
 
Background 
 
As explained previously, the regeneration of hexoses-P from trioses-P is a key feature of the normal 
metabolic operation of P. putida KT2440. A pivotal player influencing the formation of hexoses-P is glucose-
6-P isomerase (Pgi). In P. putida KT2440, Pgi functions in the direction of G6P formation, unlike the 
traditional role of this enzyme in other bacteria, i.e., catalyzing the conversion of G6P into F6P. Since the 
functioning of this enzyme would oppose the expected carbon flow in the intended EMP-based P. putida 
derivative, this chapter explores the phenotypic and metabolic consequences of blocking the reaction 
catalyzed by Pgi in P. putida KT2440.  
 
3.1. Removing the Pgi activity from P. putida KT2440: a single step to block the EDEMP cycle 
 
As mentioned along this Thesis, P. putida KT2440 bases its central carbon metabolism in the biochemical 
EDEMP cycle. An important role of this metabolic architecture to this end is the recycling of trioses-P into 
hexoses-P employing the (incomplete) EMP pathway as a gluconeogenic route. Pgi participates in such 
cycle as a key point in the whole metabolic sequence, catalyzing the transformation of F6P into G6P (Fig. 
18). The in vivo distribution of metabolic fluxes in glucose-grown P. putida KT2440, analyzed by using 
substrates containing 13C, indicated a significant participation of the Pgi activity in central carbon metabolism 
(Nikel et al., 2015a). The biochemical role of Pgi has been investigated in many bacterial species (Hua et 
al., 2003; Lindner et al., 2013; Sanfélix-Haywood et al., 2011; Toya et al., 2010; Usui et al., 2012), and this 
metabolic node has been targeted for Metabolic Engineering purposes, such as PHB production in 
recombinant E. coli (Kabir & Shimizu, 2003; Shi et al., 1999). In E. coli, the Pgi activity mediates the formation 
of F6P from G6P – a situation that would be considered as the canonical reaction, and Pgi is considered to 
be the key enzyme activity controlling the fate of carbon skeletons, that can be further channeled through 
the EMP pathway or the PP pathway. Considering that Pgi catalyzes the reverse reaction in P. putida, and 
as part of the design of a suitable chassis for deep engineering of central carbon metabolism, the relevance 
of the Pgi-catalyzed step and the effects of removing the enzyme activity thereof on the overall cell 
physiology and metabolism was investigated by adopting a multi-omic approach. 
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Figure 18½ Schematic representation of the EDEMP cycle in P. putida KT2440. Glucose catabolism 
occurs mainly through the activity of the Entner-Doudoroff (ED) pathway, but part of the trioses-P thereby 
generated are recycled back to hexoses-P by means of the EDEMP cycle, that also encompasses activities 
from the Entner-Doudoroff (ED) pathway, the (incomplete) Embden-Meyerhof-Parnas (EMP), and the 
pentose phosphate (PP) pathways. Each metabolic block is indicated with different colors and the EDEMP 
cycle is shaded in blue in the diagram. The deletions introduced in genes encoding metabolic enzymes 
targeted in this chapter are indicated by a D symbol. The abbreviations used in this picture are as follows: 
G6P, glucose-6-P; F6P, fructose-6-P; FBP, fructose-1,6-P2; DHAP, dihydroxyacetone-P; GA3P, 
glyceraldehyde-3-P; Pyr, pyruvate; 6PG, 6-phosphogluconate; and KDPG, 2-keto-3-deoxy-6-
phosphogluconate. 
 
The Pgi activity is encoded in P. putida KT2440 by two different genes: pgi-I (PP_1808) and pgi-II 
(PP_4701). These two genes are annotated as to be a duplication event, and their lengths are exactly the 
same (1,665 nucleotides), each one encoding a protein composed of 554 amino acids. There are minor 
differences in the amino acid sequence of the corresponding polypeptides, which otherwise share an identity 
of 98% (i.e., they contain only 9 amino acid differences). Considering the high degree of homology between 
Pgi-I and Pgi-II, the approach adopted in this chapter was based on the sequential elimination of both genes 
in order to completely remove the participation of Pgi in central carbon metabolism in P. putida KT2440 – 
but also revealing the individual contribution of the two pgi genes in the overall enzyme activity (Fig. 19). 
Fig. 19a indicates the in-frame deletions introduced in the two genomic loci annotated to encode Pgi 
activities in strain KT2440. 
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Figure 19½ Characterization of the Pgi deletions in P. putida KT2440. (a) The scheme depicts the 
location of the pgi genes in the chromosome of P. putida KT2440, and the isomerization catalyzed by 
glucose-6-P isomerase (Pgi). The targeted deletions introduced in these loci (showed with a D symbol in 
the outline) are also indicated. (b) M9 minimal medium plates, containing either 20 mM glucose (plate 
shown in the left) or 30 mM succinate (plate shown in the right), were seeded with P. putida KT2440 (wild-
type), and the single and double mutants Dpgi-I, Dpgi-II, and Dpgi-I Dpgi-II. (c) In vitro quantification of the 
specific (Sp) Pgi activity in wild-type (WT) P. putida KT2440, and its Dpgi-I, Dpgi-II, and Dpgi-I Dpgi-II 
mutant derivatives. All the strains employed for the in vitro enzymatic assays were grown on M9 minimal 
medium added with glucose at 20 mM and cells were harvested in mid-exponential phase to obtain the 
cell-free extracts. Each bar represents the mean value of the corresponding enzyme activity ± standard 
deviation of quadruplicate measurements from at least two independent experiments. Significant 
differences (P < 0.05, as evaluated by means of the Student's t test) in the pair-wise comparison of a given 
recombinant to the control WT strain are indicated by an asterisk. (d) Growth curves of P. putida KT2440 
and partial and full mutants blocked in the Pgi activity under glycolytic (M9 minimal medium with 20 mM 
glucose) conditions. Each data point represents the mean value of the optical density measured at 600 nm 
(OD600) of quadruplicate measurements from at least three independent experiments. The specific growth 
rates (µ) were calculated from these data during exponential growth, and the inset shows the mean values 
± standard deviations for each strain.  
 
As a first step in the phenotypic characterization of the mutant strains, all the strains under study where 
streaked onto M9 minimal medium plates containing two different carbon substrates. Fig. 19b exposes the 
gross growth phenotype for the different combination of Pgi mutations under glycolytic (M9 minimal medium 
with 20 mM glucose) or gluconeogenic (M9 minimal medium with 30 mM succinate) conditions in solid 
culture. No dramatic effect was appreciated in terms of the overall fitness of single or double pgi mutants as 
compared to the WT strain. Nevertheless, the Dpgi-I Dpgi-II double mutant seemed to be more affected than 
the rest of the strains, as it formed smaller colonies on glucose-containing M9 minimal medium (Fig. 19b). 
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The next relevant question was the connection between biochemical activity and macroscopic growth 
effects brought about by eliminating the pgi genes in P. putida. The results shown in Fig. 19c indicate that 
the deletion of a single copy of the pgi gene (either pgi-I or pgi-II) is not enough to completely remove the 
Pgi activity in P. putida KT2440. This result would indicate that the redundancy of Pgi-encoding genes 
ensures functional complementation of the enzyme activity in absence of either gene. Therefore, the only 
way to completely block this reaction is the accumulation of both the Dpgi-I and the Dpgi-II deletions in the 
same strain. At the same time, the results suggest that the participation of Pgi-I in the bulk of the activity is 
smaller than that of Pgi-II. In particular, the simultaneous elimination of Pgi-I and Pgi-II resulted in a 40% 
and an 80% reduction of the total in vitro Pgi activity, respectively. The deletion of both isozymes expectedly 
resulted in a significant (i.e., 96%) reduction of the overall Pgi activity in comparison with the WT strain.  
 
The connection between the in vitro Pgi activity and the bacterial growth phenotypes was quantitatively 
explored by growing the different strains under study in liquid cultures in microtiter-plate cultures (Fig. 19d). 
Glycolytic conditions were adopted for this experiment, as glucose is the key nutrient to evaluate the process 
of hexoses-P regeneration, in which Pgi is expected to play a significant role. The results show that the 
partial Pgi mutants (i.e., Dpgi-I or Dpgi-II) preserved similar specific growth rate values as compared to the 
WT strain. Nevertheless, in the case of the double Dpgi-I Dpgi-II mutant, there was a slight reduction on this 
growth parameter (i.e., 16%) as compared with the WT strain. Interestingly, a significantly protracted lag 
phase was observed for the double mutant, although the final cell densities were almost identical for all the 
strains assayed under glycolytic conditions. 
 
As an additional information, the growth parameters in batchwise, shaken-flask cultures of P. putida 
KT2440 and the double Dpgi-I Dpgi-II mutant were calculated in quantitative physiology experiments, as 
indicated in Table 8. Remarkable differences were observed between the two strains in these experiments. 
In the first place, and similarly to the growth patterns determined in microtiter-plate cultures, the specific 
growth rate value for the Dpgi-I Dpgi-II mutant growing under glycolytic conditions was significantly smaller 
(i.e., 24%) than that of the WT strain. On the other hand, a 1.4-fold higher specific rate of carbon uptake (qs) 
was determined for the Dpgi-I Dpgi-II strain as compared to the WT counterpart. Additionally, the yield of 
biomass on substrate (YX/S) showed the opposite trend, and the Dpgi-I Dpgi-II strain produced almost half 
the amount of biomass per gram of consumed glucose than the WT did. Considering the results of 
quantitative physiology experiments, together with the data shown in Fig. 19, it can be concluded that the 
depletion of the bulk Pgi activity in P. putida K2440 mediates a relevant effect on glucose utilization – both 
in terms of the specific substrate consumption and the fate of the carbon intermediates thereof. At the light 
of the results obtained in this part of the physiological characterization, further experiments were planned to 
unveil the biological function of Pgi in P. putida KT2440. 
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Table 8½Growth parameters of P. putida KT2440 and its Dpgi-I and Dpgi-II mutant derivatives in 
shaken-flask cultures under glycolytic growth conditionsa. 
 
P. putida strain µ (h-1)b qS (mmolglucose gCDW-1 h-1)b YX/S (gCDW gglucose-1)c 
KT2440 (WT) 0.49 ± 0.01 5.93 ± 0.04 0.46 ± 0.03 
Dpgi-I Dpgi-II 0.37 ± 0.02 8.12 ± 0.05 0.25 ± 0.02 
 
a  Cells were grown in M9 minimal medium containing 20 mM glucose as the sole carbon source. All the values shown 
in this Table represent the mean of the corresponding parameter ± standard deviation of quadruplicate 
measurements from at least three independent experiments. 
b  The specific growth rate (µ) and the specific rate of carbon uptake (qs) were obtained during exponential growth by 
linear regression. WT, wild-type; CDW, cell dry weight. 
c  The yield of biomass on substrate (YX/S) was obtained during exponential growth by correlating µ and qs. 
 
3.2. Phenotypic MicroArray™: Global view of the phenotypic consequences of eliminating 
the Pgi activity in P. putida KT2440 
 
Once a suitable full Pgi mutant (i.e., Dpgi-I Dpgi-II) of strain KT2440 was obtained, and its growth patterns 
were thoroughly explored, it was necessary to implement a more general screening method to understand 
what are the biological functions impacted by blocking this activity in P. putida KT2440. As indicated in 
Section 3.1, the full Pgi mutant presents a slight deficiency in the kinetic growth parameters when compared 
with the WT strain, and we explored the overall phenotypic features of such mutant. The use of a high-
throughput screening method was considered to be a useful strategy to simultaneously explore the space 
of possible metabolic, stress resistance, and other phenotypic effects correlated with the absence of the Pgi 
activity. In particular, the BioLog Phenotypic MicroArray™ (PM) technology was employed to this end 
(Bochner, 2009; Bochner et al., 2001). The set-up for this PM analysis was the so-called full array, which 
simultaneously evaluates a set of 20 different plates (i.e., PM1-PM20) to examine diverse carbon, nitrogen, 
phosphorous and sulfur sources, and also to identify the effect of nutrient supplements, osmolytes, different 
pH values, and a large set of chemical compounds (e.g., stressors). The complete report of phenotypes 
observed in the PM assay is presented in Annex 1. The majority of changes involved loss of functions (i.e., 
122 phenotypes were lost, and only 4 phenotypes were gained as compared to the WT strain KT2440), and 
the most conspicuous cases are displayed in Fig. 20. 
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Figure 20½ Phenomic analysis of the Pgi mutation in P. putida KT2440. Selected loss-of-function 
phenotypes of the Pgi (Dpgi-I Dpgi-II) mutant strain as compared to wild-type P. putida KT2440. The 
different compounds (black) are grouped according to their effect (red). In the most relevant cases these 
effects are pooled by their characteristic biological role (bold red). 
 
The results shown in Fig. 20 indicate that the full Pgi mutant is comparatively sensitive to (i) cyclic 
AMP phosphodiesterase inhibitors, (ii) sodium arsenite (a toxic anion), (iii) different types of antibiotics, (iv) 
biofilm inhibitors, and (v) a set of compounds that disrupt the integrity of DNA and the cell membrane. The 
large variety of effects brought about by eliminating Pgi reflects the relevance of this activity in maintaining 
the overall bacterial fitness. In particular, the increased sensitivity to sub-inhibitory concentrations of 
antibiotics and compounds that compromise the cell membrane stability suggested, a priori, a link between 
some of the phenotypes observed for the mutant and the redox status of the cells (e.g., altered NADPH 
availability). The potential link between the redox status of the cells in the absence of Pgi and the PM 
patterns described in Fig. 20 was further explored by taking a closer look at central carbon metabolism in 
P. putida KT2440 (Fig. 18). The perusal of the biochemical network indicates that the elimination of Pgi-I 
and Pgi-II could result in (i) a reduction in the pool of NADPH (since the EDEMP cycle would be blocked, 
and the NADP+-dependent Zwf activity would run short of G6P), and (ii) an increase in the accumulation of 
intracellular F6P (since the EMP pathway would continue feeding this metabolic node from trioses-P). Taking 
into account these hypotheses, and considering the phenomic analysis described above for the Pgi mutant, 
it was possible to sketch a cause-effect relationship as entertained in the next two sections. 
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3.2.1. Decrease of NADPH availability. The EDEMP cycle is a core feature of glucose metabolism in P. 
putida KT2440. The data available in the literature, based on the in vivo carbon flux distribution under 
glycolytic growth conditions, pointed to the Zwf activity as a key step for NADPH regeneration (Nikel et al., 
2015a). In particular, this reaction allows for the reduction of NADP+ into NADPH by means of the oxidation 
of G6P into 6PG. All the attempts to remove the Zwf activity in our laboratory [comprised by three isozymes 
(Zwf, ZwfA, and ZwfB) in strain KT2440] altogether failed, suggesting an important role of this metabolic 
step in central carbon metabolism irrespective of the carbon source used. Note that, in contrast, Zwf 
(represented by a single enzyme) can be removed from bacteria that run a linear glycolysis, such as E. coli 
(Fischer & Sauer, 2003), without significantly affecting growth on glucose. In addition to this background 
information, and in direct connection with the basis of this chapter, the mentioned in vivo carbon flux 
distribution indicated that approximately 47% of the G6P converted to 6PG stems from the Pgi activity via 
cycling. The absence of any Pgi activity would reduce the generation of the carbon substrate for Zwf, thereby 
decreasing the reduction of NADP+ into NADPH (Spaans et al., 2015). As suggested by the phenomic 
analysis in the preceding section, there are several indications that indicate an alteration of the redox state 
in the double Pgi mutant. For example, the mutant showed sensitivity to sodium arsenite, a toxic anion that 
is counteracted by P. putida KT2440 via the products of the ars gene cluster, which includes a NADPH-
dependent quinone reductase encoded by the arsH gene, PP_2715 (Fernández et al., 2014; Páez-Espino 
et al., 2015). On the other hand, the Pgi mutant presented high sensitivity to different DNA harmful agents, 
that could possibly correlate with the shortage of NADPH and a sub-optimal operation of different DNA repair 
and synthesis systems, e.g., the rate of NADP+/NAD+ regeneration are known to indirectly regulate DNA 
repair systems (Mandsberg et al., 2009; Spaans et al., 2015). Other interesting result is the sensitivity of the 
full Pgi mutant to agents that compromise the integrity of cell membranes, especially triclosan [5-chloro-2-
(2,4-dichlorophenoxy)phenol, an inhibitor of lipid synthesis]. Such phenotype exposes the likely impairment 
of cell membrane synthesis and assembly in the Pgi mutant. This phenomenon is supported by the 
necessary oxidation of NADPH in different steps of the fatty acid biosynthesis pathway, e.g., the NADPH-
dependent β-ketoacyl-acyl carrier protein reductase encoded by the fabG gene, PP_1914, in P. putida 
KT2440 (Lai & Cronan, 2004; Yuan et al., 2012). The third line of evidence indicating a redox imbalance in 
the mutant is the high sensitivity of this strain to different types of antibiotics, as observed in other bacterial 
species (Dwyer et al., 2014; Dwyer et al., 2015). From a more general perspective, these phenotypes can 
be also explained in terms of the cell membrane instability discussed above; however, the most relevant 
effects were associated with the treatment with antibiotics that affect the wall synthesis. In this biological 
process, there is an essential participation of the lipid II (a peptidoglycan motif linked to an undecaprenyl 
phosphate), which is considered to be the carrier to transport the peptidoglycan blocks from the cytoplasm 
to the cell wall (Sham et al., 2014). Undecaprenyl phosphate is synthetized by most bacteria using 
isopentenyl as a metabolic precursor (Bouhss et al., 2008). In the case of P. putida KT2440, isopentenyl is 
obtained from Pyr and GA3P following the non-mevalonate (i.e., 2-C-methyl-D-erythritol-4-P/1-deoxy-D-
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xylulose-5-P) pathway, in which various steps actively oxidize NADPH. Finally, many antibiotics are known 
to produce an oxidative burst in the cells in a similar fashion as compounds that damage cell membranes 
and would produce uncoupling of the respiratory chain (Belenky et al., 2015; Dwyer et al., 2014). Since most 
of the biochemical mechanisms that the cells use for the detoxification of reactive oxygen species ultimately 
depend in the intracellular availability of reducing power (Kim & Park, 2014), some of the phenotypes in the 
Dpgi-I Dpgi-II strain would also correlate with a shortage in the availability of reducing power besides the 
specific mechanisms discussed above. In order to experimentally validate these metabolic scenarios, where 
the regeneration of NADPH is compromised in the Dpgi-I Dpgi-II mutant, a set of experiments were designed 
to explore the redox state of the strains under study. These approaches combine physiology experiments, 
based on the effect of an oxidative stressor, with targeted genetic manipulations meant to intensify the redox-
deficient phenotype, and are discussed in Section 3.3. 
 
3.2.2. F6P accumulation. The absence of any Pgi activity would compromise the ability of P. putida KT2440 
to transform F6P into G6P in a biochemical reaction that, in principle, could occur in both directions. The 
literature describes that the prevalent direction in strain KT2440 is F6P → G6P, as part of the characteristic 
EDEMP cycle (Nikel et al., 2015a). Assuming that the PP pathway cannot absorb the bulk of the remaining 
F6P generated by the (now incomplete) EDEMP cycle, deleting pgi-I and pgi-II would probably result in the 
buildup of F6P in the cell. The phenomic analysis indicated a remarkable sensitivity of the Pgi mutant to 
sodium salicylate, a compound known to inhibit biofilm formation in some bacteria. For instance, salicylate 
has been associated with the inhibition of biofilm formation by P. aeruginosa (Prithiviraj et al., 2005). In 
addition, F6P is the metabolic precursor employed by P. aeruginosa PAO1 (and other pseudomonads) to 
synthesize the polysaccharide alginate (Banerjee et al., 1983; Ertesvåg et al., 2017; Franklin et al., 2011; 
Hentzer et al., 2001). The cluster of genes that encode the activities needed to transform F6P in alginate is 
well conserved among pseudomonads, and in the chromosome of P. putida KT2440 it compromises the 
genes algA (PP_1277), algF (PP_1278), algJ (PP_1279), algI (PP_1280), algL (PP_1282), algX (PP_1282), 
algG (PP_1283), algE (PP_1284), algK (PP_1285), alg44 (PP_1286), alg8 (PP_1287), algD (PP_1288), 
and algC (PP_5288). Taking all this information together, it is possible that, in the absence of any Pgi activity, 
the accumulation of F6P may boost alginate formation, a polysaccharide proposed to be synthesized by 
strain KT2440 (Gulez et al., 2014; Nilsson et al., 2011). In order to evaluate this possibility, a simple 
phenotypic test was designed to explore biofilm formation by the Pgi mutants, as indicated in Section 3.4. 
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3.3. Genetic and metabolic perturbations to explore NADPH availability and its relationship 
with oxidative stress resistance in strain KT2440 
 
3.3.1. Role of GntZ in NADPH formation upon the functional interruption of the EDEMP cycle in a 
Dpgi genetic background. From a broad perspective, the experiments discussed so far disclose the 
relationship between central carbon metabolism and the intrinsic adaptation to natural environments by P. 
putida KT2440. In the quest of a suitable metabolic chassis for the implantation of a linear glycolysis (the 
raison d’être of the entire study), the role of Pgi was assessed by eliminating the two genes encoding this 
activity in strain KT2440. The PM analysis of the double mutant pointed to a shortage in the availability of 
NADPH as a possible cause of the many phenotypes observed in this strain. Previous work in our laboratory 
indicates that, besides Zwf, there is another relevant dehydrogenase in central carbon metabolism that can 
support NADPH formation under glycolytic growth conditions (Nikel & Chavarría, 2016; Nikel et al., 2015a). 
6-Phosphogluconate dehydrogenase (GntZ) is considered to be the second most important source of 
NADPH in the upper domain of carbon catabolism after Zwf (Fig. 18). The GntZ activity in P. putida KT2440 
is encoded by the gntZ (PP_4043) gene, and catalyzes the decarboxylating reaction transforming 6PG into 
Ri5P (the first key intermediate of the PP pathway) using NADP+ as the cofactor, thereby obtaining NADPH 
(Fig. 21a). It was then hypothesized that the already compromised redox status of the full Pgi mutant of 
strain KT2440 could be further perturbed by eliminating the GntZ-dependent generation of NADPH. As it is 
the case with other redox regulation processes (Blank et al., 2008; 2010; Nikel et al., 2016b), GntZ is to be 
considered as a metabolic safety valve in strain KT2440, as it does not usually participate in carbon 
catabolism during growth on glucose (i.e., the PP pathway channels <10% of the carbon source under 
normal growth conditions). As a first step in the characterization of the role of this dehydrogenase in a full 
Pgi mutant, an in-frame deletion of gntZ was firstly introduced in strain KT2440 by allelic replacement 
(considering that this gene partially overlaps with zwfB, likely as a part of the same transcriptional unit, Fig. 
21a), and the growth parameters and biochemical features of the mutant were characterized under different 
growth conditions. 
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Figure 21½Characterization of the gntZ deletion in P. putida KT2440. (a) The scheme depicts the 
location of the gntZ gene in the chromosome of P. putida KT2440. Note that there is an overlapping of the 
gntZ coding sequence and the zwfB gene (PP_4042), likely indicating co-regulation of the two genes. The 
deletion implemented in this chapter (indicated with a D symbol in the outline) is shown in the diagram, and 
does not affect the expression of the gene in the vicinity of the target locus. The relative orientation of gntZ 
(i.e., in the reverse strand) is also indicated in the scheme. GntZ catalyzes the decarboxylation of 6PG into 
ribulose-5-P with the concomitant reduction of NADP+. (b) In vitro quantification of the specific (Sp) GntZ 
activity in wild-type (WT) P. putida KT2440 and its DgntZ, Dpgi-I Dpgi-II, and DgntZ Dpgi-I Dpgi-II mutant 
derivatives. All the strains employed for the in vitro enzymatic assays were grown on M9 minimal medium 
added with glucose at 20 mM and cells were harvested in mid-exponential phase to obtain the cell-free 
extracts. Each bar represents the mean value of the corresponding enzyme activity ± standard deviation 
of quadruplicate measurements from at least two independent experiments. Significant differences (P < 
0.05, as evaluated by means of the Student's t test) in the pair-wise comparison of a given recombinant to 
the control WT strain are indicated by an asterisk. (c) Growth curves of P. putida KT2440 and its DgntZ 
derivative combined (or not) with the Dpgi-I Dpgi-II mutations under glycolytic (M9 minimal medium with 20 
mM glucose) conditions. Each data point represents the mean value of the optical density measured at 600 
nm (OD600) of quadruplicate measurements from at least three independent experiments. The specific 
growth rates (µ) were calculated from these data during exponential growth, and the inset shows the mean 
values ± standard deviations for each strain.  
 
The gntZ deletion altogether abolished the GntZ activity in P. putida KT2440, in contrast with the WT 
counterpart and the Dpgi-I Dpgi-II controls, which displayed very similar levels of specific GntZ activity (Fig. 
21b). On the other hand, the growth phenotype was not affected by the elimination of the GntZ activity (Fig. 
21c), and the growth curve of the DgntZ mutant was essentially identical to that of the WT strain in microtiter-
plate cultures. The growth curves expose that the most relevant influence in the growth pattern of the strains 
under study is brought about by the elimination of the Pgi activity (as indicated in Figs. 19d and 21c), in 
which a significant decrease in the specific growth rate values can be appreciated in all the strains carrying 
the Dpgi-I and Dpgi-II deletions – irrespective of the DgntZ mutation. The final cell density was not affected 
by any of the mutations tested, which can be taken as an evidence of a transient metabolic imbalance that 
the cells ultimately manage to deal with. This piece of evidence indicates that GntZ seems to offer no extra 
role in boosting NADPH regeneration in the absence of Pgi. In any case, the still standing question is whether 
the redox phenotype is affected in the Pgi mutant, and this question was tackled by externally imposing 
oxidative stress conditions and evaluating how all the strains under study endure such conditions, as 
indicated in Section 3.3.2. 
 
3.3.2. The metabolic imbalance of the Pgi mutant correlates with a high sensitivity to oxidative stress. 
Taking into account all the experimental observations accumulated thus far, and in order to determine if the 
absence of Pgi activity impacts the intracellular redox state, a set of experiments was designed using 
paraquat (N,N′-dimethyl-4,4′-bipyridinium dichloride) as an oxidative stressor agent. Briefly, this molecule, 
that belongs to the viologen family of redox-active heterocycles, catalyzes the formation of reactive oxygen 
species and has been described to decrease the pool of NADPH (Bus & Gibson, 1984; Shen et al., 2013). 
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The level of resistance to the treatment with paraquat can therefore be adopted as a proxy of the intracellular 
redox status in the cells. As a first attempt, the sensitivity of the strains described in this chapter was 
measured using the top-agar diffusion approach. In this experiment, the different mutants were grown onto 
solid M9 minimal medium with glucose as the carbon source, and a filter paper disc (soaked with 10 µl of 
100 µM paraquat) was placed in the middle of the Petri dish. The growth inhibition zones were determined 
after 24 h of incubation, based on the distance from the filter paper disc to the border of the inhibition halo 
(Figs. 22a and b).  
 
 
 
Figure 22½ Paraquat as an oxidative stressor agent: qualitative characterization of tolerance by Pgi 
and GntZ mutants of P. putida KT2440. (a) M9 minimal medium plates containing 20 mM glucose were 
seeded with P. putida KT2440 (wild-type strain), and the mutants Dpgi-I, Dpgi-II, Dpgi-I Dpgi-II, DgntZ, and 
Dpgi-I Dpgi-II DgntZ. A filter paper disc soaked with 10 µl of 100 µM paraquat was placed in the center of 
the Petri dishes, and the plates were incubated upwards during 24 h. (b) Quantification of the inhibition 
zone radius in wild-type (WT) P. putida KT2440, and its Dpgi-I, Dpgi-II, Dpgi-I Dpgi-II, DgntZ, and Dpgi-I 
Dpgi-II DgntZ mutant derivatives. All the strains employed for this assay were grown on plates of M9 
minimal medium added with glucose at 20 mM with the paraquat test shown. Each bar represents the mean 
value of the corresponding inhibition zones (mm) ± standard deviation from at least three independent 
experiments. Significant differences (P < 0.05, as evaluated by means of the Student's t test) in the pair-
wise comparison of a given recombinant to the control WT strain, are indicated by an asterisk. 
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The results shown in Figs. 22a and b indicate the qualitative effect associated to paraquat treatment 
in strains carrying different combinations of pgi and gntZ deletions. The most relevant result, also supported 
by quantitative statistical analysis (Fig. 22b), suggests an association of the absence of Pgi activity with a 
high sensitivity to paraquat. More precisely, the highest inhibition zone radii were observed in the P. putida 
mutant strains in which the Pgi activity has been completely eliminated (i.e., Dpgi-I Dpgi-II, and Dpgi-I Dpgi-
II DgntZ). At the same time, and in accordance with the physiological experiments reported in Section 3.3.1, 
it was noted that the DgntZ deletion did not influence the oxidative stress resistance profile of the 
corresponding mutant strains, obtaining similar values for the inhibition zones as compared to the WT strain. 
Finally, the highest value of inhibition was associated with the Dpgi-I Dpgi-II DgntZ strain, which would be 
the most compromised strain in terms of NADPH regeneration. With these results in hand, it is possible to 
assume that the bulk of NADPH regeneration in the upper domain of carbon metabolism could be traced to 
the NADP+-dependent Zwf dehydrogenase activity, partially fed by Pgi. In order to contrast the results 
obtained in top-agar tests, the survival ratio of the Dpgi-I Dpgi-II, DgntZ, and Dpgi-I Dpgi-II DgntZ strains 
was evaluated in liquid cultures in the presence of paraquat as indicated in previously published methods 
(Martínez-García et al., 2014d). Survival ratios were expressed as the OD600 values in cultures containing 
paraquat divided by the OD600 value in cultures without the stressor (Fig. 23). 
 
Figure 23½ Stress resistance to paraquat in liquid cultures of P. putida KT2440 carrying different 
combinations of Pgi and GntZ mutations. (a)	Survival ratios for P. putida KT2440 (WT) and the mutants 
Dpgi-I Dpgi-II, DgntZ, and Dpgi-I Dpgi-II DgntZ exposed to paraquat at 10 µM and grown under glycolytic 
(M9 minimal medium with 20 mM glucose) conditions. Each data point represents the survival ratio, 
calculated as the optical density measured at 600 nm (OD600) in cultures containing paraquat divided by 
the OD600 in cultures without the stressor of quadruplicate measurements from at least four independent 
experiments. (b) Survival ratio values at 24 h for wild-type (WT) P. putida KT2440, and its Dpgi-I Dpgi-II, 
DgntZ, and Dpgi-I Dpgi-II DgntZ mutant derivatives. Each bar represents the mean value of the survival 
ratio ± standard deviation of quadruplicate measurement from at least four independent experiments. 
Significant differences (P < 0.05, as evaluated by means of the Student's t test) in the pair-wise comparison 
of a given recombinant to the control WT strain, are indicated by an asterisk. 
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The results shown in Fig. 23a supported previous observations in top-agar experiments. Mutants with 
the double Pgi mutation (i.e., Dpgi-I Dpgi-II) were specially affected by the presence of paraquat, giving 
raise to the lowest survival ratios at the end of the cultivation (Fig. 23b). Interestingly, the WT strain and the 
DgntZ mutant had almost identical curves of survival ratios over time. The rate of decrease in survival ratios 
was comparable among all the strains within the first 5 h of incubation, and from that point onwards, the WT 
strain and the DgntZ mutant reached a minimum value in this parameter at approximately 12.5 h. Both 
strains started to recover afterwards, while the survival ratios for the double Pgi mutant continued to 
decrease attaining a plateau after 18 h, at which point no further changes in survival patterns were observed. 
The final values for the survival ratios were statistically analyzed (Fig. 23b), corroborating that the changes 
were significant in the Dpgi-I Dpgi-II strains. Again, the DgntZ mutant did not suffer a heavy impact in terms 
of survival ratio when treated with paraquat. In summary, and taking into account the data obtained in both 
experiments, it is possible to conclude that the elimination of the Pgi activity compromises NADPH 
regeneration in P. putida KT2440 under glycolytic growth conditions. As indicated in previous sections, the 
other metabolic scenario to be tested in this mutant strain is the availability of F6P.  
 
3.3.3. F6P accumulation and its correlation with biofilm formation in Pgi mutants. The number of 
phenotypic features possibly affected when a key metabolic enzyme activity is removed is rather large – all 
the more if such activity belongs to central carbon metabolism. Apart from suffering a defect in redox 
balance, Pgi mutants of P. putida are expected to be affected in the intracellular availability of metabolic 
precursors. Pgi interconverts F6P into G6P, in principle in either direction (Fig. 18). Previous work from our 
laboratory indicates that the prevalent direction in strain KT2440 is from F6P to G6P (Nikel et al., 2015a). 
For this reason, a possible scenario in the mutant comprises the buildup of F6P since bacteria could not 
complete the gluconeogenic transformation of F6P into G6P catalyzed by Pgi. F6P is involved in a large 
number of cellular functions, and one of them is to be the metabolic precursor for alginate synthesis (Narbad 
et al., 1988). This biopolymer is one of the most studied extracellular polymeric substances (EPS) present 
in the biofilm structure of some Pseudomonas species (Flemming et al., 2007). The synthesis of alginate 
was also described in P. putida KT2440, and it was identified as a useful defense mechanism under 
desiccation stress imposed by mild water limitation (Gulez et al., 2014). Alginate is also proposed to help 
maintaining biofilm stability (Nilsson et al., 2011). With this evidence from the literature, it was possible to 
hypothesize that the buildup of the key precursor F6P in Pgi mutants could correlate with an increase in 
biofilm formation under glycolytic conditions. In order to contrast this hypothesis, an experiment was 
designed to evaluate biofilm formation in different strains of P. putida KT2440 (Fig. 24).  
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Figure 24½ Biofilm formation in P. putida mutants devoid of the Pgi and GntZ activity. (a) The scheme 
depicts the alginate biosynthesis pathway in P. putida KT2440. The genes involved in the formation of the 
building blocks are indicated in the route, and the large number of reactions that participate in 
polymerization of the basic monomer, i.e., guanosine diphosphate (GDP)-mannuronate, have been lumped 
for the sake of clarity.	 (b) Biofilm formation by wild-type (WT) P. putida KT2440, and its Dpgi-I, Dpgi-II, 
Dpgi-I Dpgi-II, DgntZ, and Dpgi-I Dpgi-II DgntZ mutant derivatives. Cells were grown in M9 minimal medium 
with 20 mM glucose in static cultures for 24 h at 30°C, after which the culture broth was removed and 
biofilms were visualized by staining the cells attached to the microtiter plate wells with crystal violet as 
detailed in the Materials and Methods section. The biofilm index values were obtained by normalizing the 
absorbance of crystal violet suspensions at 590 nm (A590) to the bacterial growth in each well, evaluated 
as the optical density measured at 600 nm (OD600). Each bar represents the mean value of the 
corresponding biofilm index ± standard deviation of eight measurements from at least three independent 
experiments. Significant differences (P < 0.05, as evaluated by means of the Student's t test) in the pair-
wise comparison of a given recombinant to the control WT strain, are indicated by an asterisk. 
 
Fig. 24a depicts the alginate synthesis pathway in P. putida KT2440, starting with F6P as the metabolic 
precursor. The first steps within this metabolic route transform F6P into the nucleotide sugar guanosine 
diphosphate (GDP)-mannuronate. This part of the pathway comprises the activities encoded by three genes, 
namely, algA (PP_1277, phosphomannose isomerase and GDP-mannose pyrophosphorylase activity), algC 
(PP_5288, phosphomannomutase), and algD (PP_1288, GDP-mannose dehydrogenase). Subsequently, 
GDP-mannuronate is used as the precursor that is polymerized by the products of the rest of alg genes to 
produce the alginate polymer (Franklin et al., 2011). The results indicated in Fig. 24b support the hypothesis 
correlating the accumulation of F6P with the increment of biofilm formation in a strain devoid of the Pgi 
activity. After 24 h of static incubation, the biofilm formation index increased by ca. 3.5-fold in the strains in 
which the Pgi activity was completely removed (i.e., carrying both the Dpgi-I and Dpgi-II deletions) as 
compared to the parental strain. In the case of partial mutants (either Dpgi-I or Dpgi-II), no differences were 
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appreciated in biofilm formation in comparison with the WT strain. On the other hand, and in accordance 
with the results discussed in previous sections in this chapter, the DgntZ strain had no significant increase 
in biofilm formation when compared with the rest of the strains under evaluation. As a final remark, it should 
be noted that the addition of the DgntZ deletion to the Pgi mutant did not generate any differences in biofilm 
formation in comparison with that in the Dpgi-I Dpgi-II strain. In summary, the standing hypothesis that can 
be drawn from these data is compatible with a metabolic scenario, brought about by eliminating the Pgi 
activity in P. putida KT2440, that promotes the buildup of F6P. Among other phenotypes, this situation 
correlates with an increment in biofilm formation. 
 
3.4. Constraint-based flux analysis as an additional approach to verify substrate availability 
for the NADP+-dependent dehydrogenation catalyzed by Zwf 
 
Flux balance analysis (FBA) is a useful mathematical approach to analyze the flow of different metabolites 
through a metabolic network. P. putida KT2440 is supported by a metabolic model, termed iJN746 (Nogales 
et al., 2008), which can be adopted to predict the fluxes around specific metabolic nodes (La Rosa et al., 
2015). As described in the Materials and Methods section, these genome-scale metabolic models can be 
used to study the absence of different enzyme activities in silico. In our case, the elimination of the Pgi 
activity was simulated paying especial attention to its influence on redox balance. The objective of this 
analysis was to add consistency to the hypothesis developed in the previous sections, in which the absence 
of Pgi activity would result in a decrease of the G6P pool. This scenario would, in turn, lower substrate 
availability for the Zwf activity, decreasing the availability of reducing power (i.e., NADPH). In order to 
corroborate this possibility, the model iJN746 was interrogated to simulate glucose metabolism in WT P. 
putida KT2440 (Fig. 25a) and in the double Dpgi-I Dpgi-II mutant (Fig. 25b). Additionally, the genome-scale 
metabolic model was constrained in order to represent: (i) the in vivo 13C-based metabolic flux analysis for 
glucose-grown P. putida KT2440 (Nikel et al., 2015a), and (ii) the real specific rate of carbon uptake (qS) 
obtained in this Thesis (Table 8). 
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Figure 25½Influence of eliminating the Pgi activity on the distribution of central metabolic fluxes 
evaluated by constraint-based analysis. The scheme depicts the reaction networks in P. putida KT2440 
(WT, left panel) and the Pgi mutant (Dpgi-I Dpgi-II, right panel) during exponential phase in a modelled 
synthetic M9 minimal medium containing glucose as the sole carbon source. The orientation of the arrows 
indicates the assumed direction of the reactions. Significant changes (ca. 2-fold higher) between the Pgi 
strain and WT are indicated in red. Reactions downwards pyruvate are highlighted with a dashed gray 
arrow. All the values for individual fluxes in the diagram were normalized to the specific glucose uptake 
rate (qS, arbitrarily set to 100). The abbreviations used in this picture are as follows: EMP pathway, Embden-
Meyerhof-Parnas pathway; ED pathway, Entner-Doudoroff pathway; PP pathway, pentose phosphate 
pathway; G6P, glucose-6-P; F6P, fructose-6-P; FBP, fructose-1,6-P2; DHAP, dihydroxyacetone-P; GA3P, 
glyceraldehyde-3-P; 6PG, 6-phosphogluconate; KDPG, 2-keto-3-deoxy-6-phosphogluconate; Ri5P, 
ribulose-5-P; R5P, ribose-5-P; X5P, xylulose-5-P; S7P, sedoheptulose-7-P; E4P, erythrose-4-P; BPG, 
glycerate-1,3-P2; 3PG, glycerate-3-P; 2PG, glycerate-2-P; and PEP, phosphoenolpyruvate. 
 
Fig. 25 summarizes the results obtained in the constraint-based analysis adopted to simulate the 
absence of Pgi activity in the central carbon metabolism of P. putida KT2440. It can be assumed that the 
bulk of the influence brought about by the Dpgi-I Dpgi-II deletions is focused on the EDEMP cycle, revealing 
a reduced impact in the carbon fluxes thorugh peripheral reactions. Elimination of Pgi activity results in a 
significant decrease in the flux through Zwf, correlated with a limitation in the availability of G6P. The model 
described a 2.7-fold lower traffic from G6P to 6PG via Zwf. Under these circumstances, the activity of Zwf 
decreases by ca. 63%, affecting the NADPH pool in the cell. Finally, and linked to a lower participation of 
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G6P in the EDEMP cycle, a significant, ca. 2-fold decrease in the fluxes that comprise the gluconeogenic 
arm of the EMP pathway [i.e., fructose-1,6-bisphospatase (Fbp) and fructose-1,6-P2 aldolase (Fda)] can be 
appreciated. Taking into account these results, it can be concluded that NADPH formation (and thus, optimal 
bacterial fitness) is correlated with a proper functioning of the EDEMP cycle. These data substantiate the 
particularity of the P. putida KT2440 metabolism, in contrast with publications that indicate an increase in 
the NADPH balance when the Pgi activity is removed from the biochemical network of E. coli (Canonaco et 
al., 2001; Hua et al., 2003; Kabir & Shimizu, 2003; Shi et al., 1999). 
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CHAPTER 4 
 
Functional replacement of the core carbon metabolism in P. putida: 
establishing a flawless linear glycolysis in strain GC2 
 
 
 
 
Background 
 
The EDEMP cycle-based central carbon metabolism of P. putida KT2440 has probably evolved alongside 
the capability of this bacterium to survive and thrive in the (often adverse) natural environments it inhabits 
(Chavarría et al., 2013; Nikel et al., 2015a). There is no doubt that these capabilities allow P. putida KT2440 
to execute reactions of industrial interest requiring a high redox demand, thanks to the high NADPH yield 
per molecule of glucose stemming from the extant metabolism (Blank et al., 2008; Nikel et al., 2016a; 
Sudarsan et al., 2014). The operation of such metabolic architecture has, however, a downside for the 
application of P. putida as a cell platform in a bioindustry context, which can potentially compromise its wide 
use in biotechnological processes. The metabolic wiring of P. putida, dependent on the ED pathway, leads 
to an intrinsically low ATP yield per molecule of glucose, which can be considered a hindrance in a large 
number of hexose-fueled bioprocess (Hara & Kondo, 2015; Schuster, 2000). Therefore, a deep refactoring 
of the central glucose metabolism was implemented in P. putida KT2440 to boost ATP formation from 
glucose. The strategy adopted in this chapter seeks to completely transform the native core glycolytic 
operation of this bacterium by combining two main approaches: (i) the targeted deletion of genes encoding 
the extant set of glycolytic reactions in order to generate a chassis, termed P. putida GC (glycolytic chassis), 
and (ii) the rational, Synthetic Biology-guided design and implementation of a functional EMP pathway (a 
canonical example of a glycolytic route endowed with high ATP yield) via the GlucoBrick system. 
 
4.1. Implementation of the GlucoBrick system in P. putida GC1: beta-testing phase to allow 
a linear EMP glycolysis 
 
The very idea of completely transforming the identity of central carbon metabolism in whatever living entity 
is not an easy task to accomplish, and there are very few examples of such a systematic endeavor in bacteria 
(Papagianni, 2012). Hexose catabolism is considered to be a vital component of central carbon metabolism 
in many bacterial species, and it could be considered as the metabolic heart of the whole cell biochemistry 
(Nielsen & Keasling, 2016; Raab et al., 2005; Romano & Conway, 1996; Siedler et al., 2012). A beta-testing 
phase was considered as the starting point to successfully achieve the stable implementation of a functional 
EMP pathway in P. putida KT2440. The overall strategy adopted for testing a linear glycolysis in P. putida 
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is summarized in Fig. 26. Against this background, and by following the beta-testing engineering principle, 
the first attempt encompassed the construction of a preliminary version of P. putida GC (termed P. putida 
GC1), with all the essential genetic modifications needed to evaluate the gross consequences of introducing 
an EMP-based glycolysis in Pseudomonas. A similar type of preliminary testing involved the use of the 
GlucoBrick system in a plasmid-based format, as explained below. 
 
4.1.1. Streamlining the central carbon metabolism of P. putida KT2440: design and construction of 
a suitable chassis for the implementation of a linear, EMP-based glycolytic pathway. The first step 
considered in the quest to implement novel metabolic capacities in P. putida was the removal of the relevant 
competing pathways. In other words, it was necessary to functionally block the native system that P. putida 
KT2440 employs to metabolize glucose. In particular, two metabolic and genetic nodes were targeted: (i) 
the competition of pathways for the very hexose substrate (i.e., draining metabolic intermediates away from 
the glycolytic route of interest), and (ii) the interactions between the cellular machinery and the implanted 
genetic construct, i.e., the modules of the GlucoBrick platform (Kim & Copley, 2012). The first of these 
approaches was focused in eliminating the preparatory steps in the consumption of glucose by P. putida 
KT2440, that can occur either via the Glk-dependent phosphorylation of the substrate in the phosphorylative 
branch, or the oxidation of the hexose to organic acids in the periplasmic space in the oxidative branch (Fig. 
26a). Note that this task comprises the in-frame deletions explained in Chapter 2, finally resulting in the 
accumulation of the Dglk, Dgcd, and Dgad (DPP_3382-4, DPP_3623, and DPP_4232) mutations in the 
same P. putida strain. In addition, the ED pathway was blocked by deleting the edd gene (PP_1010, 6-
phosphogluconate dehydratase), encoding the first committed step in the route. The accumulation of all 
these mutations in the WT P. putida KT2440 background resulted in strain P. putida GC1. 
 
4.1.2. Introduction of the genes needed to activate a linear glycolysis in P. putida GC1. The results 
described in Chapter 1, which demonstrated the functional versatility of the GlucoBrick system in different 
Pseudomonas species, set the basis for the activation of an EMP pathway in P. putida GC1. It should be 
mentioned that previous works in our laboratory aimed at restoring a linear glycolytic pathway in P. putida 
KT2440. This objective looks in principle simple, in that the only obvious limitation for this bacterium to 
employ such linear pathway is the absence of a Pfk activity. However, the implementation of this single 
activity in P. putida KT2440 lead to a severely impaired glucose-dependent growth and low resistance to 
oxidative stress (Chavarría et al., 2013). For this reason, and following the reasoning described in Chapter 
1 for the WT strain, the first attempt was the introduction of Module I by transforming plasmid pS224·GBI in 
P. putida GC1 strain (Fig. 26b), in which the genes encoding the enzymes of the preparatory phase within 
the EMP pathway are under transcriptional control of an inducible LacIQ/Ptrc element. The introduction of the 
entire metabolic block allows the circulation of carbon from glucose down to GA3P by connecting the 
corresponding reactions (Fig. 26c), improving metabolic channeling and reducing the creation of potential 
bottlenecks in the biochemical network (Hollinshead et al., 2016). 
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Figure 26½Outline for the beta-testing of a linear glycolysis in P. putida. (a) Genetic profile of the P. 
putida GC1 strain. Note that Dgad represents the accumulation of the individual DPP_3382, DPP_3383, 
DPP_3384, DPP_3623, and DPP_4232 in-frame deletions. (b) Structure of the pS224·GBI plasmid, a 
derivative of vector pSEVA224 bearing Module I from the GlucoBrick system (i.e., encoding the enzymes 
needed for the conversion of glucose into glyceraldehyde-3-P). T0 and T1 indicate transcriptional 
terminators. The IPTG-inducible LacIQ/Ptrc expression system is also indicated in the plasmid map. The 
origin of transfer compatible with the RP4 conjugation machinery is termed oriT. The low-copy-number 
origin of replication compatible with P. putida KT2440 is indicated as oriV(RK2). Note that each gene is 
preceded by a synthetic regulatory element, indicated by a purple circle, composed of a ribosome binding 
site (sequence underlined) and a spacer sequence. The antibiotic-resistance marker, based on kanamycin, 
is shown as KmR. The elements in this scheme are not drawn to scale. (c) Simplified representation of 
central carbon metabolism in P. putida GC1. The activities eliminated in this strain are represented by a 
dashed gray arrow. The biochemical reactions encoded by the genes from the Module I are indicated in 
purple. The abbreviations used in this picture are as follows: G6P, glucose-6-P; F6P, fructose-6-P; FBP, 
fructose-1,6-P2; DHAP, dihydroxyacetone-P; GA3P, glyceraldehyde-3-P; Pyr, pyruvate; 6PG, 6-
phosphogluconate; KDPG, 2-keto-3-deoxy-6-phosphogluconate; OM, outer membrane; PS, periplasmic 
space; and IM, inner membrane. 
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P. putida GC1 transformed with the pS224·GBI plasmid has the full enzymatic complement needed to 
metabolize glucose by means of the EMP pathway, thereby fulfilling the Pfk activity absent in many members 
of the Pseudomonas genus. As indicated in Fig. 27a, and after inducing gene expression in the 
recombinants with a suitable concentration of IPTG (1 mM), P. putida GC1 containing the empty vector (i.e., 
pSEVA224) was unable to grow in M9 minimal medium plates using glucose as the sole carbon source. 
This is the expected growth phenotype for strain GC1, in light of the accumulation of several mutations that 
compromise glucose utilization. In contrast, P. putida GC1 transformed with the pS224·GBI plasmid 
(containing Module I from the GlucoBrick system) was able to grow on glucose under the same culture 
conditions. In other words, the enzyme activities encoded by the pS224·GBI plasmid allow P. putida GC1 to 
metabolize glucose via the EMP pathway (Fig. 27a). The WT strain KT2440 transformed with the empty 
pSEVA224 vector served as a positive control of growth under both glycolytic and gluconeogenic conditions. 
All the strains grew on succinate as the sole carbon source, indicating that the genetic manipulations in 
strain GC1 do not significantly affect bacterial growth through gluconeogenesis. Further characterization of 
the strains at stake in liquid cultures confirmed the growth phenotypes observed in solid media. The results 
shown in Fig. 27b indicate that the specific growth rate of P. putida GC1 transformed with plasmid 
pS224·GBI is smaller (ca. 4-fold decrease) than that of the WT strain containing the empty plasmid in 
glucose cultures. This impaired growth is somewhat expected due to the large number of modifications 
introduced in this strain, including several mutations in its native set of genes encoding components of the 
central carbon metabolism. In addition to the decrease in the specific growth rate, the final cell density was 
also affected in P. putida GC1 transformed with plasmid pS224·GBI (i.e., a 40% reduction of the final OD600 
as compared to that in cultures of P. putida KT2440/pSEVA224). In any case, the glucose-dependent growth 
of the engineered strain served as a proof-of-concept result to further develop a P. putida cell platform based 
on the functional activity of an EMP-based catabolic pathway. 
 
In order to correlate the growth of the engineered strain on glucose with the presence of the enzymes 
encoded by the GlucoBrick genes, the enzyme activity of different key components in the EMP pathway was 
determined in P. putida GC1 transformed with plasmid pS224·GBI. The Glk and Pfk activities, the first 
enzyme in the pathway and the activity missing in P. putida KT2440, respectively, were determined in cell-
free extracts of the relevant strains grown in minimal medium containing glucose (Fig. 27c). In the case of 
Glk, the native activity could be detected in P. putida KT2440 and in E. coli BW25113 carrying the empty 
vector (i.e., pSEVA224), used here as an additional control, upon induction of gene expression with IPTG. 
The native Glk activity in strain KT2440 was almost twice that of WT E. coli. The specific Glk activity was 
also determined in P. putida KT2440 Dglk and in E. coli BW25113 Dglk DptsI (i.e., an E. coli strain 
completely deficient in glucose phosphorylation), carrying the empty plasmid (i.e., pSEVA224) and induced 
with IPTG. Predictably, no significant Glk activity was detected in either mutant. Finally, this phosphorylating 
reaction was analyzed in P. putida GC1 containing plasmid pS224·GBI. The only possible way for this 
bacterium to grow on glucose is linked to the presence of the Glk activity encoded by Module I of the 
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GlucoBrick platform. Indeed, P. putida GC1 carrying plasmid pS224·GBI (and induced with IPTG) has a 
specific Glk activity 129-fold higher than that of the WT strain carrying the empty plasmid (Fig. 27c). This 
high level of enzyme activity can result from unregulated expression of the glk gene, alongside to the extra 
gene copies in the cells due to the expression of Module I in plasmid format (and also from a potentially 
different pattern of enzyme regulation of Glk in a heterologous context). 
 
The specific Pfk activity was assessed in E. coli BW255113 and its DpfkA DpfkB double mutant 
derivative (termed Dpfk in Fig. 27d) carrying the empty vector (i.e., pSEVA224) in IPTG-induced glucose 
cultures. The Pfk activity was determined in these two E. coli strains as a positive and negative control, 
respectively, considering that P. putida KT2440 lacks the Pfk-dependent conversion of F6P into FBP (Fig. 
27d). As expected, the Pfk activity test was positive in the WT E. coli strain in contrast to the very low level 
of activity detected in E. coli Dpfk and in P. putida KT2440 carrying the empty vector (i.e., pSEVA224). In 
the case of P. putida GC1 carrying the pS224·GBI plasmid, it was assumed that the Pfk activity must be 
present as this would be the only way to bestow growth on glucose. The in vitro biochemical determinations 
support this notion, and the P. putida GC1 transformed with the pS224·GBI plasmid (induced with a proper 
concentration of IPTG) had a 32-fold increase in the Pfk activity compared with WT E. coli BW255113 (Fig. 
27d). 
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Figure 27½Physiological and biochemical characterization of the implanted GlucoBrick activities in 
P. putida GC1. (a)	M9 minimal medium plates, containing either 20 mM glucose (left column) or 30 mM 
succinate (right column), were inoculated with P. putida KT2440 (WT) carrying the empty pSEVA224 
vector, and P. putida GC1 carrying either the empty pSEVA224 vector or Module I (pS224·GBI). (b) Growth 
curves of P. putida KT2440 carrying the empty pSEVA224 vector, and P. putida GC1 carrying plasmid 
pS224·GBI on M9 minimal medium with 20 mM glucose, 50 µg ml-1 Km, and 1 mM IPTG in microtiter-plate 
cultures. Each data point in the growth curves represents the mean value of the optical density measured 
at 600 nm (OD600) in quadruplicate measurements from at least three independent experiments. The 
specific growth rates (µ) were calculated from these data during exponential growth, and the inset shows 
the mean value ± standard deviations for each strain. (c) In vitro quantification of the specific (Sp) 
glucokinase (Glk) activity, which phosphorylates glucose to glucose-6-P (G6P) in wild-type (WT) E. coli 
BW25113 and its Dglk DptsI derivative, and wild-type (WT) P. putida KT2440, and its Dglk derivative (left 
panel) carrying the empty pSEVA224 vector. The right panel showed for the same Glk activity the results 
from the P. putida GC1 carrying plasmid pS224·GBI. (d) In vitro quantification of the specific (Sp) 6-
phosphofructo-1-kinase (Pfk) activity, which converts fructose-6-P into fructose-1,6-P2 in wild-type (WT) E. 
coli BW25113 and its DpfkA DpkfB (indicated as Dpfk) derivative, and wild-type (WT) P. putida KT2440 
(left panel) carrying the empty pSEVA224 vector. The right panel shows the Sp Pfk activity for P. putida 
GC1 carrying plasmid pS224·GBI. All the strains employed for the in vitro enzymatic assays were grown 
on M9 minimal medium added with glucose at 20 mM, 50 µg ml-1 Km, and 1 mM IPTG, and cells were 
harvested in mid-exponential phase to obtain the cell-free extracts. Each bar represents the mean value of 
the corresponding enzyme activity ± standard deviation of quadruplicate measurements from at least two 
independent experiments. Significant differences (P < 0.05, as evaluated by means of the Student's t test) 
in the pair-wise comparison of a given recombinant to the control WT strain, are indicated by an asterisk. 
Note that P. putida GC1/pS224·GBI was compared to P. putida Dglk for the Glk activity, and to P. putida 
KT2440 for the Pfk activity.  
 
According to the data gathered so far, the glycolytic activities encoded in Module I of the GlucoBrick 
system allow P. putida GC1 to grow in glucose using a functional EMP pathway. This beta-testing phase 
was thus useful to evaluate the feasibility of the next stage in the deep metabolic refactoring of central 
carbon metabolism. The goal of the second stage is to obtain an upgraded version of P. putida GC1 (i.e., P. 
putida GC2). The construction of this second glycolytic chassis entails the complete elimination of the ED 
pathway (by removing eda, the second gene in the two-step route), and the substitution of the native, ATP-
dependent glucose transport system of P. putida KT2440 by the efficient, energy-independent Glf 
transporter from Z. mobilis. P. putida GC2 will be thus employed as the final platform to stably introduce a 
linear EMP pathway via the GlucoBrick system. At this point of biocatalyst design, all the relevant metabolic 
modules (i.e., the Glf transporter from Z. mobilis, and Modules I and II from the GlucoBrick platform) are 
randomly delivered into the target chromosome as a single copy via mini-Tn5–assisted transposition, as 
explained below. 
 
4.2. P. putida GC2: implementing a stable linear glycolysis based on the EMP pathway 
 
The results obtained in the first part of this chapter support the idea that it is possible to graft a functional 
EMP pathway in a P. putida-based genetic chassis. The beta-testing phase of the project indicated that the 
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engineered bacterium is able to grow on glucose as the sole carbon source by employing a combination of 
part of its endogenous activities and the heterologous activities encoded by Module I of the GlucoBrick 
platform. The second part of the overarching endeavour started with the construction of P. putida GC2, a 
genetically upgraded version of the glycolytic chassis under study. The construction of this multiple-mutant 
P. putida strain comprised the deletion events summarized in Fig. 28a. 
 
4.2.1. Removal of the ED route. In the first place, the ED pathway was completely blocked from P. putida 
GC1, that was already unable to run the ED route due to the targeted elimination of the gene encoding the 
first enzymatic step of the sequence (i.e., Edd). However, and in order to obtain a further reduction in the 
overall complexity of the biochemical network, P. putida GC1 was also depleted of the second (and last) 
activity of the ED pathway by deleting the eda gene (PP_1024, encoding 2-keto-3-deoxy-6-
phosphogluconate aldolase). The experimental approach adopted for introducing this deletion was 
thoroughly explained in Chapter 2. This manipulation is expected to result in an easier-to-manipulate, more 
predictable bacterial host, in which the interaction between the cellular machinery and the implanted genetic 
constructs are reduced (Kim & Copley, 2012; Nielsen et al., 2013).  
 
4.2.2. Elimination of the native glucose transport system. The second manipulation of strain GC1 
involved the native glucose transport system. As mentioned in Chapter 2, glucose uptake in P. putida 
KT2440 is mediated by an ABC transport system that consumes ATP as part of its normal functioning. The 
main goal in the project is to boost the energy balance of P. putida KT2440 under glucose-dependent growth 
conditions. For this reason, and according to the results obtained in Chapter 2, this wasteful native transport 
system was removed from P. putida GC1 by introducing the Dgts mutation. This genetic editing step was 
accomplished by a single deletion event that simultaneously removed the gtsA, gtsB, gtsC, and gtsD genes. 
 
4.3. Design of genetic elements for establishing a stable linear glycolysis in P. putida GC2 
 
The accumulation of the Deda and the Dgts in-frame deletions in P. putida GC1 gave rise to the platform 
strain P. putida GC2. The next stage to develop a set of genetic elements that will allow for an efficient 
expression of all the genes encoding glucose transport and catabolic processing by a linear EMP route. 
Mini-transposon vectors allow for the stable insertion of foreign DNA into the chromosome of many Gram-
negative bacteria (Martínez-García et al., 2011; 2014a; 2017; Martínez-García & de Lorenzo, 2012; Ramos 
et al., 2000). Tn5-derived elements present advantages over their plasmid-based counterparts for the 
introduction and expression of heterologous genes. These features include (i) the maintenance of the 
corresponding transgenes without antibiotic selective pressure, (ii) long-term stability of the constructs and 
reusability of the functional DNA parts, and (iii) the fact that mini-Tn5–based vectors admit cloning and 
chromosomal delivery of considerably long DNA fragments (which would be cumbersome to manipulate in 
other DNA delivery tools). As the transposase-encoding gene tnpA is lost following each transposition event 
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(Reznikoff, 2008), mini-Tn5 vectors can be recursively used in the same microbial host. Since TnpA acts in 
cis (Phadnis et al., 1986), it promotes the insertion of DNA sequences borne by the plasmid irrespective of 
any previous DNA insertions. Martínez-García et al. thoroughly revisited the original mini-Tn5 transposon 
vector concept (Martínez-García et al., 2014a). The functional modules that constitute the vector (including 
the mosaic elements of the Tn5 termini) have been edited to minimize the length of the corresponding DNA 
fragments, improving their functionality and making them entirely modular and exchangeable. The final 
product was the entirely synthetic plasmid construct termed pBAM1 (born-again mini-transposon). This 
design was soon followed by a series of synthetic, modular broad-host-range mini-Tn5 plasmids derived 
from pBAM1. These plasmids, termed pBAMDs vectors (Martínez-García et al., 2014a; 2017), enable the 
possibility of easy cloning and subsequent chromosomal insertion of functional DNA cargoes with three 
different and interchangeable antibiotic resistance markers. Note that this approach, in which the DNA cargo 
borne by the transposon (devoid of any promoter region) is randomly inserted into the target chromosome, 
not only enables the stable insertion of the corresponding genes, but it also results in a library of independent 
insertions expected to display different levels of transcription (Martínez-García et al., 2014a). The elements 
needed to engineer strain GC2 were divided in three independent transposon modules as detailed below, 
and the relevant parts and modules are indicated in Fig. 28b. 
 
4.3.1. Implementation of the glucose facilitator (Glf) from Z. mobilis in strain GC2. The Glf-based 
glucose transporter has been demonstrated in previous sections to be a useful alternative to functionally 
substitute the native hexose transport system of P. putida KT2440. Plasmid pBAMD1-2·glf was designed to 
deliver the glucose transport activity into strain GC2. In this transposon vector, the gene encoding the Glf 
transporter was linked to a synthetic regulatory element that contains an efficient RBS and a short DNA 
spacer sequence (Fig. 28b). The transposition of the glf element also introduces a Km-resistance marker in 
the target chromosome. 
 
4.3.2. Introduction of the EMP pathway activities encoded by Modules I and II of the GlucoBrick 
system. Once the transport of glucose into the bacterial cytoplasm was delegated to the energy-efficient 
Glf transporter, it was necessary to bring about the enzyme activities needed to execute the linear EMP 
pathway in the upgraded glycolytic chassis. P. putida GC2 is not able to use glucose as a carbon source, 
being completely dependent of the catabolic enzymes encoded in the GlucoBrick system. These functional 
elements in Modules I and II were distributed in two independent transposon vectors. Note that the beta-
testing stage described in Section 4.1 of this chapter indicates that Module I would be sufficient to 
complement the glycolytic deficiency of the mutant strains under study. However, the insertion of the second 
module, that contains all the reactions of the pay-off phase of the EMP pathway ensures a correct 
channelling of carbon intermediates, avoiding potential bottlenecks throughout the entire route (Hollinshead 
et al., 2016). In this context, the design comprised the construction of plasmids pBAMD1-4·GBI (Module I) 
and pBAMD1-6·GBII (Module II). As indicated previously for the glf-containing mini-Tn5 transposon, these 
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DNA constructs encompass all the relevant genes of Module I or Module II individually preceded by a 
synthetic regulatory element, containing a RBS and a short DNA spacer sequence (Fig. 28b). These 
regulatory motifs were the only structural feature added to the gene clusters, and no promoter element was 
inserted in the transposons. The insertion of the transposons borne by plasmids pBAMD1-4·GBI and 
pBAMD1-6·GBII also endows a Sm- and a Gm-resistance marker, respectively, in the target chromosome. 
 
 
 
Figure 28½Construction of P. putida GC2 and transposon-based elements used for the stable 
implementation of a linear glycolysis. (a) Genetic profile of the P. putida GC2 strain, indicating the 
deletions implemented to genetically upgrade P. putida GC1. Note that Dgts represents the accumulation 
of the individual DgtsA, DgtsB, DgtsC, and DgtsD in-frame deletions. (b) Schematic structure of the mini-
Tn5−based derivatives of vectors pBAMDs, employed to insert the gene encoding the Glf glucose 
transporter from Z. mobilis (pBAMD1-2·glf), and Module I (pBAMD1-4·GBI) and Module II (pBAMD1-
6·GBII) of the GlucoBrick system in the chromosome of P. putida GC2. ME-I and ME-O, flanking the DNA 
sequence to be delivered into the target chromosome, indicate the position of the two mosaic elements 
recognized by the hyper-active transposase encoded by tnpA. A conditional origin of replication, dependent 
of the p protein [oriV(R6K)], and the origin of transfer (oriT) are also indicated in the outline. Note that each 
gene is preceded by a synthetic regulatory element, indicated by a purple circle, composed of a ribosome 
binding site (sequence underlined) and a short spacer sequence. The antibiotic-resistance markers follow 
the nomenclature: ApR, ampicillin; GmR, gentamicin; KmR, kanamycin; and SmR, streptomycin. The 
elements in this outline are not drawn to scale.   
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Once all the elements needed to implement a linear EMP pathway in the final P. putida strain GC2 
were constructed, a rational strategy was designed to bring the cognate DNA fragments into the target 
chromosome in the correct order. Each mini-transposon was separately delivered in the same P. putida 
GC2 strain in a sequential fashion. The correct order of these individual transposition events facilitated the 
subsequent phenotypic screening to isolate a triple exconjugant strain with the best growth after 
accumulating random insertions of all three transposons in the chromosome. The workflow followed during 
this experimental strategy is detailed in Fig. 29a. 
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Figure 29½Workflow of the construction and selection of P. putida GC2·T·GBI·GBII. (a) Sequential 
transposition events were executed to deliver three separate mini-Tn5 modules carrying all the genetic 
parts needed for efficient glucose transport and a linear, Embden-Meyerhof-Parnas–based glycolytic 
pathway (i.e., glf from Z. mobilis and Modules I and II of the GlucoBrick system, respectively). The relevant 
characteristics of the plasmids used in the construction of P. putida GC2·T·GBI·GBII are detailed in Table 
3 in Materials and Methods. The antibiotic-resistance markers follow the nomenclature: Gm, gentamicin; 
Km, kanamycin; and Sm, streptomycin. (b) Growth curves of P. putida KT2440 and P. putida 
GC2·T·GBI·GBII on M9 minimal medium with 20 mM glucose as the sole carbon source. Each data point 
in the growth curve represents the mean value of the optical density measured at 600 nm (OD600) in 
quadruplicate measurements from at least three independent experiments. The specific growth rates (µ) 
were calculated from these data during exponential growth, and the inset shows the mean value ± standard 
deviations for each strain. 
 
4.3.3. Insertion workflow of different glycolytic modules in P. putida GC2, and phenotypic analysis 
of glucose-using exconjugants isolates. The use of the random insertion approach was selected to obtain 
different levels of gene expression by taking advantage of endogenous promotor regions in the target 
chromosome. P. putida GC2 is unable to grow in glucose due to different mutations accumulated in its 
chromosome, which makes the screening process easier as the trait used for selection was the ability of the 
exconjugants to grow on glucose. In essence, the elements that this strain need to restore its glucose-
dependent growth phenotype are the glucose transporter (Glf, delivered by means of plasmid pBAMD1-
2·glf) and the Glk and Pfk activities encoded by Module I of the GlucoBrick system (borne by plasmid 
pBAMD1-4·GBI). 
 
As indicated in Fig. 29a, the first part of the process was based on a sequential transposition of the 
elements in plasmids pBAMD1-2·glf and pBAMD1-4·GBI, introduced in the recipient strain via triparental 
mating. First, the glf gene was randomly introduced in the chromosome of P. putida GC2 [Fig. 29a(i)]. The 
mating mixture was plated onto M9 minimal medium plates containing 0.2% (w/v) citrate and Km to select a 
diversity of different transposition events enriched in P. putida GC2·T. The letter T stands for insertion of the 
Glf transporter in any given strain. Citrate, a gluconeogenic carbon source, was used in this first stage of 
selection to counterselect for E. coli cells from the triparental mating. The library of insertions in P. putida 
GC2·T was pooled and used in a second triparental mating associated with transposon pBAMD1-4·GBI. 
This transposition event generated P. putida GC2·T·GBI. According to the nomenclature adopted herein, 
GBI stands for insertion of the GlucoBrick Module I in any given strain. The triparental mating mixture was 
plated onto M9 minimal medium plates containing 0.2% (w/v) citrate and Km and Sm in order to select P. 
putida GC2·T·GBI exconjugants. Note that, unlike the parental P. putida GC2·T recipient strain, P. putida 
GC2·T·GBI exconjugants are potentially able to grow on glucose as the sole carbon source as this strain 
carries both glk and pfkA from E. coli. The resulting colonies were then patched onto M9 minimal medium 
plates containing 20 mM glucose, Km, and Sm to discard events that did not restore the growth phenotype 
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under glycolytic conditions [Fig. 29a(ii)]. From these plates, 95 colonies were inoculated in 96-well microtiter 
plates in M9 minimal medium containing 20 mM glucose, and bacterial growth was assessed by measuring 
the OD600 over time in a microtiter plate reader in order to select exconjugants displaying a high specific 
growth rate. Selected colonies were used as the template in randomly-amplified PCRs in order to locate the 
site of insertion of the mini-Tn5 modules containing glf and Module I of the GlucoBrick system. A double 
exconjugant was singled during this screening stage. The glf insertion was mapped to the PP_0841 gene 
(encoding the DNA-binding transcriptional regulator IscR) and Module I was located in the genome 
coordinate 6,005,012 bp (intergenic region between PP_5259 and ydcJ). 
 
The selected P. putida GC2·T·GBI exconjugant with the best growth phenotype on glucose was thus 
employed in a third triparental mating with the pBAMD1-6·GBII construct [Fig. 29a(iii)]. The triparental 
mating mixture was plated onto M9 minimal medium plates containing 0.2% (w/v) citrate, Km, Sm, and Gm 
in order to select for P. putida GC2·T·GBI·GBII. The positive colonies were re-streaked onto M9 minimal 
medium plates containing 20 mM glucose, Km, Sm, and Gm to check that the growth phenotype in glycolytic 
conditions was maintained. From these selection plates, 95 colonies that grew on glucose as the sole carbon 
source were inoculated in 96-well microtiter plates in M9 minimal medium containing 20 mM glucose, and 
bacterial growth was assessed by measuring the OD600 over time in a microtiter plate reader in order to 
select the exconjugant with the highest specific growth rate. In this process, 91 colonies were discarded due 
to very low specific growth rates, and the 4 remaining triple exconjugants that passed this quality control 
step were used as the template in a randomly-amplified PCR to locate the site of insertion of the mini-Tn5 
module containing Module II of the GlucoBrick system [Fig. 29a(iv)]. Two candidates were discarded, due 
to the fact that the insertions ended in potentially problematic genetic loci (i.e., active mobile genetic 
elements that could bring about genetic instability). The two remaining candidates were re-inoculated in 96-
well microtiter plates in M9 minimal medium containing 20 mM glucose, and bacterial growth was again 
assessed by measuring the OD600 over time in a microtiter plate reader. The final candidate, termed P. 
putida GC2·T·GBI·GBII, was selected in this experiment. This strain is a deeply genetically edited P. putida 
KT2440 derivative able to grow on glucose as the carbon source strictly using the grafted EMP pathway. 
The specific growth rate of P. putida GC2·T·GBI·GBII under glycolytic conditions represented a 15% fraction 
of that observed in the original WT strain KT2440 (Fig. 29b). The growth curve of P. putida GC2·T·GBI·GBII 
indicates a possible adaptation process during these conditions, since there were two distinct phases not 
observed for the WT strain, a result that was somehow expected. Apart from the fact that the final glycolytic 
strain has been heavily refactored and the major native pathways for hexose utilization have been removed, 
it should be kept in mind that the regulatory pattern of the grafted metabolic blocks (e.g., temporal activation 
of native promoters controlling gene expression in the transposed elements) remains to be determined. In 
any case, the final cell density attained by the refactored strain in 72-h glucose cultures was very similar to 
that of the WT strain (i.e., 0.41 and 0.52 units, respectively). 
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4.3.4. Biochemical landscape of P. putida GC2·T·GBI·GBII. The preceding sections described the 
genetic refactoring of whole metabolic blocks in P. putida. Fig. 30 depicts the expected glucose metabolism 
in the thereby engineered P. putida GC2·T·GBI·GBII strain. In the first place, the oxidative glucose utilization 
pathway in the periplasm was blocked due to the absence of the Gcd activity (and the oxidations thereafter, 
catalyzed by Gad). On the other hand, the participation of the ED pathway in glucose catabolism was 
prevented by introducing the in-frame Dedd and Deda mutations. In this scenario, the only way for the cells 
to grow in glucose would imply hexose transport by the Glf glucose transporter from Z. mobilis as the very 
first step. Once in the cytoplasm, glucose is phosphorylated into G6P by the Glk activity encoded in the 
inserted Module I. G6P is then transformed into GA3P through the other activities encoded in Module I. In 
this part of the route, the so-called preparatory phase of the EMP pathway, Module I share its reactions with 
the homologous set of endogenous enzymes in the host, with the notable exception of Pfk that is exclusively 
provided by the synthetic construct (Fig. 30). On the other hand, the so-called pay-off phase of the EMP 
pathway comprises the activities that transform GA3P into Pyr. In P. putida GC2·T·GBI·GBII, this part of the 
glycolytic pathway is likely carried out at the same time by the products of the genes encoded in Module II 
and the endogenous enzymes encoded in the chromosome. Finally, the pool of Pyr resulting from the linear 
glycolysis can continue its way to be transformed into acetyl-CoA to enter into the TCA cycle (Fig. 30). 
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Figure 30½Expected glucose metabolism in P. putida GC2·T·GBI·GBII. Glucose uptake in this strain 
takes place through the activity of the Glf transporter from Z. mobilis, since strain GC2 bears the Dgts 
deletion (which erases the native, ATP-dependent transport of glucose). Glucose catabolism through the 
Entner-Doudoroff (ED) pathway is also blocked in this strain due to the Dedd and Deda mutations. 
Oxidative pathways for glucose utilization were likewise suppressed due to the Dgcd and Dgad deletions. 
The non-functional Embden-Meyerhof-Parnas (EMP) pathway is completed by the Pfk activity encoded by 
Module I of the GlucoBrick system. As a result of the above-mentioned deletions, the EDEMP cycle 
(characteristic of the wild-type KT2440 strain) is blocked in this mutant. Each metabolic block is indicated 
with different colours in the scheme, and the deletions introduced in genes encoding any given enzyme 
activity are indicated with a dashed grey arrow. The reactions encoded by the genes from the Module I and 
II are indicated in purple and fuchsia, respectively. The reactions that comprise the preparatory phase and 
the pay-off phase of the EMP pathway are shaded in violet and pink. The abbreviations used in the 
biochemical network are as follows: G6P, glucose-6-P; F6P, fructose-6-P; FBP, fructose-1,6-P2; DHAP, 
dihydroxyacetone-P; GA3P, glyceraldehyde-3-P; Pyr, pyruvate; BPG, glycerate-1,3-P2; 3PG, glycerate-3-
P; 2PG, glycerate-2-P; PEP, phosphoenolpyruvate; 6PG, 6-phosphogluconate; KDPG, 2-keto-3-deoxy-6-
phosphogluconate; OM, outer membrane; PS, periplasmic space; and IM, inner membrane. 
 
Since P. putida GC2·T·GBI·GBII was forced to employ a grafted EMP pathway operating in an entirely 
glycolytic regime (i.e., the opposite role of the partial EMP route naturally found in strain KT2440), a mere 
in vitro characterization, based on assays of enzyme activity, is not sufficient to thoroughly explore the 
metabolic profile of the engineered strain. For this reason, a full 13C-based metabolic flux ratio analysis, 
incorporating quantitative physiology data along the patterns of 13C-distribution in proteinogenic amino acids, 
was tackled to systematically describe the operation of central carbon metabolism in strain GC2·T·GBI·GBII.  
 
4.4. Central carbon metabolism in glucose-grown P. putida GC2·T·GBI·GBII: Quantitative 
physiology parameters and 13C-based metabolic flux analysis 
 
The biochemical pathways involved in glucose catabolism in P. putida (Fig. 31) have been studied in detail 
(del Castillo et al., 2007; Latrach-Tlemçani et al., 2008; Vicente & Cánovas, 1973a), including the description 
of the fate of every metabolite in the upper domain of the biochemical network of strain KT2440 (Nikel et al., 
2015a). P. putida KT2440 mostly uses the peripheral oxidation of glucose into gluconate to feed the 6PG 
node, the first metabolite of the ED pathway. At the same time, this bacterium uses the (partial) EMP 
pathway in a gluconeogenic mode of operation to recycle trioses-P into hexoses-P, with a relatively modest 
contribution of the PP pathway in hexose catabolism. Fig. 31 summarizes all the activities and metabolic 
steps involved in this intricate metabolism and, at the same time, serves as a reference to catalog the 
reactions studied in the 13C-based metabolic flux analysis shown below. 
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Figure 31½Biochemical pathways for glucose catabolism in P. putida KT2440. The entire metabolic 
network was divided in six main metabolic blocks, and they are identified with different colors in the scheme: 
(i) peripheral pathways, that comprise the oxidative transformation of glucose into gluconate and 2-
ketogluconate (including the phosphorylated derivatives of these metabolites); (ii) EMP pathway 
[incomplete, due to the absence of the 6-phosphofructo-1-kinase activity (Pfk), and indicated with a dashed 
grey arrow]; (iii) pentose phosphate (PP) pathway; (iv) ED pathway; (v) the tricarboxylic acid cycle and 
glyoxylate shunt; and (vi) anaplerotic and gluconeogenic bioreactions. Some reactions have been lumped 
to simplify the metabolic map. The complete list of enzymes and isoenzymes catalyzing each reaction is 
shown in the bottom of the scheme. The information indicated in this picture was compiled by the latest 
update (as for June 2017) of the Pseudomonas Genome Database (Winsor et al., 2016) and the 
MicroScope platform (Vallenet et al., 2017). In the cases in which no gene name has been assigned to a 
reaction, the locus tag is indicated in the list. Abbreviations used in this diagram are as follows: G6P, 
glucose-6-P; F6P, fructose-6-P; FBP, fructose-1,6-P2; DHAP, dihydroxyacetone-P; 6PG, 6-
phosphogluconate; KDPG, 2-keto-3-deoxy-6-phosphogluconate; Ri5P, ribulose-5-P; R5P, ribose-5-P; 
X5P, xylulose-5-P; S7P, sedoheptulose-7-P; E4P, erythrose-4-P; GA3P, glyceraldehyde-3-P; 3PG, 
glycerate-3-P; PEP, phosphoenolpyruvate; acetyl-CoA, acetyl-coenzyme A; OAA, oxaloacetate; 2-KG, 2-
ketoglutarate; OM, outer membrane; PS, periplasmic space; and IM, inner membrane. 
 
As a requisite information for 13C-based metabolic flux analysis, the growth parameters of P. putida 
KT2440 and P. putida GC2·T·GBI·GBII were calculated in batchwise, shaken-flask cultures in quantitative 
physiology experiments (Table 9). Important differences were observed between the two strains in these 
experiments. In the first place, and similarly to the growth patterns determined in microtiter-plate cultures, 
the specific growth rate of P. putida GC2·T·GBI·GBII growing under glycolytic conditions was significantly 
smaller (i.e., around one-tenth) than that of the WT strain. The shape of the growth curve for the engineered 
strain in shaken-flask cultures was qualitatively similar to that of strain KT2440, which probably indicates 
that the results of Fig. 29b correlate with deficient oxygenation or agitation in microtiter-plate cultures. On 
the other hand, a 7.6-fold smaller specific rate of carbon uptake (qs) was determined for P. putida 
GC2·T·GBI·GBII as compared to its WT counterpart. Additionally, the yield of biomass on substrate (YX/S) 
showed the same trend but with a smaller difference between the two strains under comparison, and P. 
putida GC2·T·GBI·GBII produced an amount of biomass per gram of glucose approximately 1.4-fold smaller 
than the WT. Considering the results of quantitative physiology experiments, it can be concluded that P. 
putida GC2·T·GBI·GBII is significantly affected in its glucose-dependent growth phenotype. This situation 
was somehow expected since, as indicated in previous sections in this chapter, the expression of the 
inserted gene modules (and, for that matter, any other regulatory pattern) has not been optimized in the 
engineered strain. In any case, the microbial platform obtained herein constituted a proof-of-principle to test 
the functional replacement of central glycolytic pathways, an issue that was further investigated as disclosed 
in the next section. 
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Table 9½Growth parameters of P. putida KT2440 and its P. putida GC2·T·GBI·GBII strain in shaken-
flask cultures under glycolytic growth conditionsa. 
 
P. putida strain µ (h-1)b qS (mmolglucose gCDW-1 h-1)b YX/S (gCDW gglucose-1)c 
KT2440 (WT) 0.49 ± 0.01 5.93 ± 0.04 0.46 ± 0.03 
GC2·T·GBI·GBII 0.048 ± 0.001 0.78 ± 0.02 0.34 ± 0.01 
 
a  Cells were grown in M9 minimal medium containing 20 mM glucose as the sole carbon source. In the case of P. 
putida GC2·T·GBI·GBII, the culture medium was also supplemented with Gm (50 µg ml-1), Km (50 µg ml-1), and Sm 
(80 µg ml-1). All the values shown in this Table represent the mean of the corresponding parameter ± standard 
deviation of quadruplicate measurements from at least three independent experiments. 
b  The specific growth rate (µ) and the specific rate of carbon uptake (qs) were obtained during exponential growth by 
linear regression. WT, wild-type; CDW, cell dry weight. 
c  The yield of biomass on substrate (YX/S) was obtained during exponential growth by correlating µ and qs. 
 
 
The ultimate experiment to characterize and ensure the intended metabolic refactoring in P. putida 
GC2·T·GBI·GBII, involved 13C-based metabolic flux ratio analyses of its central carbon metabolism. In this 
technique, the 13C-labeled carbon source (i.e., glucose) is processed by the enzymes of the central carbon 
metabolism in a way that a significant fraction of the carbon atoms are incorporated into proteinogenic amino 
acids, which exhibit a characteristic labeling patterns to be analyzed by mass spectrometry methodologies 
(Dauner & Sauer, 2000). The labeling pattern of these individual molecules provides information about the 
pathway and carbon skeletons from which these amino acids originated (Sauer, 2006). Then, the fluxes 
through the different metabolic pathways under study can be determined by integrating the relative isotopic 
abundance of metabolic intermediates with stoichiometric metabolic models of the biochemical network 
under study and data obtained from physiological experiments (Zamboni et al., 2005). The in vivo carbon 
flux distribution was thus compared in glucose-grown P. putida KT2440 (i.e., the WT strain) and its deeply 
refactored P. putida GC2·T·GBI·GBII derivative. Mixtures of naturally labeled glucose and either uniformly 
13C-labeled or 13C-labeled in position 1 of the hexose ([U-13C]-glucose and [1-13C]-glucose, respectively) 
were used in shaken-flask cultures of the strains, as indicated in Materials and Methods. Such experimental 
approach was adopted to elucidate the extent of manipulation that the metabolic chassis has been able to 
endure in terms of rerouting its central carbon metabolism. Fig. 32 describes the absolute net fluxes in the 
glucose catabolism network for the strains under study [WT (Fig. 32a) and P. putida GC2·T·GBI·GBII (Fig. 
32b)], in which all the values shown were normalized to the specific glucose uptake rates (Table 9). The 
different metabolic blocks of hexose catabolism and their operation in either strain are explained in the 
sections below. 
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4.4.1. Glucose transport and hexose phosphorylation/oxidation. As a starting point, it should be noted 
that P. putida GC2·T·GBI·GBII transports glucose through the activity of the Glf facilitator of Z. mobilis. As 
indicated before, and considering that the level of expression of the cognate glf module is unknown, the very 
low specific rate of carbon uptake (qS) value of strain P. putida GC2·T·GBI·GBII could stem from a limitation 
in the Glf-mediated internalization of the substrate. According to the data discussed in Chapter 2, the 
accumulation of the Dgcd and Dgad deletions disabled the peripheral reactions (typically run by many 
bacterial members of the Pseudomonas genus) to oxidize glucose into gluconate and/or 2KG. Such 
deletions, in combination with the in-frame elimination of the endogenous gts genes, would completely block 
glucose transport. The results of Table 9 and Fig. 32 demonstrate that Glf is able to functionally complement 
these transport deficiencies in strain GC2·T·GBI·GBII. Interestingly, the WT strain channeled around 90% 
of the internalized glucose through the first step of the periplasmic peripheral pathways of hexose oxidation, 
catalyzed by Gcd. A small fraction (12%) of the thereby generated gluconate was then transformed into 2KG 
by a further oxidation catalyzed by Gad. This finding is consistent with the results recently published for 
glucose-grown strain KT2440 (Nikel et al., 2015a). On the other hand, the inability of P. putida 
GC2·T·GBI·GBII to oxidize or phosphorylate glucose using the native pathways must be compensated by 
the Glk activity brought about by Module I from the GlucoBrick system. As expected, 100% of the substrate 
transported by the engineered bacterium was directly phosphorylated into G6P. This flux was approximately 
10-fold higher than the native glucose phosphorylation flux in P. putida KT2440. 
 
4.4.2. Metabolic origin and fate of G6P and pathways leading to Pyr formation. P. putida KT2440 
phosphorylated approximately 10% of the total transported glucose into G6P, and the G6P node was also 
fed by the Pgi activity (i.e., operating in the gluconeogenic direction), which added an extra 9% fraction to 
the G6P pool with respect to the specific rate of carbon uptake (qS) value. G6P was then transformed into 
6PG by the action of the Zwf activity. The Zwf-catalyzed conversion of G6P into 6PG had similar values in 
both strains, although the metabolic origin of G6P was different in either case. While all the 6PG pool in the 
engineered strain originated from Zwf, in strain KT2440 the 6PG node was also fed by the phosphorylation 
of two oxidized metabolites from the upper peripheral oxidative pathways [i.e., 72% from the phosphorylation 
of gluconate via gluconate kinase (GnuK) and 11% from the reduction of 2-ketogluconate-6-P (2K6PG) via 
2-ketogluconate-6-P reductase (PtxD)]. No G6P formation from F6P was detected in P. putida 
GC2·T·GBI·GBII, and the prevailing direction of the Pgi-catalyzed biochemical step in this strain was entirely 
glycolytic. Furthermore, the biochemical network in the glycolytic chassis mimics the native metabolism of 
E. coli, in that the G6P pool was split in a 22% being channeled into 6PG and the remaining 77% funneled 
into F6P (Fuhrer et al., 2005). This is an additional piece of information that demonstrates that the metabolic 
situation of P. putida GC2·T·GBI·GBII is characterized by a linear glycolytic flux from G6P downwards. 
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As expected, the ED route was completely removed from P. putida GC2·T·GBI·GBII due to the 
introduced Dedd and Deda in-frame deletions. However, the flux values for this pathway were very high in 
the WT strain, and 92% of the total 6PG was channeled downwards through the ED-dependent catabolism. 
The elimination of the ED pathway in the glycolytic chassis lead to a 2.4-fold increase in the traffic via the 
GntZ activity when compared with the WT strain. This result is again very similar to the flux distribution 
expected in glucose-grown WT E. coli (Fuhrer et al., 2005). GntZ catalyzes the conversion 6PG + NADP+ 
→ Ri5P + CO2 + NADPH. The GntZ activity is considered to be the main entry point into the oxidative branch 
of the PP pathway, and usually limits the overall carbon flux through the entire route. Interestingly, the carbon 
fluxes via the PP pathway in P. putida GC2·T·GBI·GBII had very similar values to those reported for E. coli, 
including the non-oxidative branch of the pathway, i.e., TktA and Tal (Fuhrer et al., 2005). 
 
Metabolic fluxes through the EMP pathway were carefully analyzed in P. putida GC2·T·GBI·GBII and 
the WT strain. Consistent with previous findings in our laboratory, the WT strain deployed the (partial) EMP 
route as a gluconeogenic pathway to recycle trioses-P into hexoses-P. However, P. putida GC2·T·GBI·GBII 
channeled 77% of the glucose entering the network via the linear glycolytic EMP pathway encoded by 
Module I and II of the GlucoBrick system. In the glycolytic chassis, 73% of the generated Pyr was obtained 
from the EMP pathway, in contrast with a 49% in the WT strain. In both strains, the so-called pay-off phase 
of the EMP pathway transformed GA3P into Pyr to different extents. In P. putida GC2·T·GBI·GBII, the flux 
through pyruvate kinase (i.e., PEP + ADP + H+ → Pyr + ATP) was 2.5-fold higher than that in the WT 
counterpart.	Pyruvate kinase is a key allosteric enzyme of the EMP route, and, since it catalyzes one of the 
two substrate-level phosphorylation steps that generate ATP, it mediates an important metabolic step in the 
overall objective of the refactoring of P. putida (Emmerling et al., 2002; Zhao et al., 2017). 
 
4.4.3. Anaplerotic pathways, TCA cycle, and glyoxylate shunt. The anaplerotic fluxes from PEP and Pyr 
to oxaloacetate, the fluxes through the TCA cycle, and the fluxes in the glyoxylate shunt (almost zero) were 
very similar in P. putida GC2·T·GBI·GBII and the WT strain. The small differences observed in anaplerosis 
and TCA cycle operativity were not statistically significant, although an increase in the activity of anaplerotic 
pathways would be expected as this is a feature typical of E. coli. Additionally, these routes had similar 
values when they are compared with the information available in the literature not only for P. putida KT2440 
but also other Pseudomonas species, such as P. fluorescens (Chavarría et al., 2012; Fuhrer et al., 2005; 
Nikel et al., 2015a). As expected in P. putida, neither strain had active fermentation pathways, and the 
breakdown of hexoses was entirely oxidative (Fuhrer et al., 2005).  
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Figure 32½In vivo distribution of carbon fluxes under glycolytic growth conditions for P. putida 
KT2440 and P. putida GC2·T·GBI·GBII. In vivo distribution of carbon fluxes obtained from ratio-constrained 
flux balance analysis in cells grown on 13C-labelled glucose. The scheme depicts the flux distribution through 
the biochemical network of (a) P. putida KT2440 (wild-type strain) and (b) P. putida GC2·T·GBI·GBII. All the 
values for individual fluxes in the diagram were normalized to the specific glucose uptake rate (arbitrarily set 
to 100). The ± standard deviations of duplicate measurements from at least three independent experiments 
were calculated using the Gaussian law of error propagation. The arrow line width in each biochemical step 
has been scaled to represent the relative flux percentage. Dashed lines indicate that no significant flux was 
detected in that particular biochemical step under the experimental conditions. The abbreviations employed 
for the different metabolites in the biochemical network and the distribution of the main metabolic blocks 
follow the same principles indicated in Fig. 31. 
 
4.4.4. Impact of the engineered EMP route in the energy and redox balances of P. putida. The 13C-
based metabolic flux analysis allowed us to determine the net fluxes around three key metabolic cofactors 
(ATP, NADH, and NADPH) in order to evaluate the energy and redox state in the strains under study (Fig. 
33). These net fluxes encompass all the reactions generating each of the cofactors and all the reactions at 
which they are consumed. The overall stoichiometry of the ED pathway is glucose + NAD+ + NADP+ + ADP 
+ Pi → 2Pyr + NADH + NADPH + 2H+ + ATP; whereas the stoichiometry of the EMP pathway is glucose + 
2NAD+ + 2ADP + 2Pi → 2Pyr + 2NADH + 2H+ + 2ATP. Considering these overall balances, the proper 
implementation of an EMP pathway in P. putida GC2·T·GBI·GBII should result in an increase in ATP and 
NADH production and, eventually, in a decrease of NADPH generation (due to the elimination of the EDEMP 
cycle). The former hypothesis was already proven correct by the results indicated in Fig. 33, in which the 
ATP formation has increased by approximately 20% in the P. putida GC2·T·GBI·GBII strain as compared 
with the WT counterpart. Even more striking was the value obtained for NADH formation in the engineered 
chassis, representing an increase of 2.5-fold as compared to the WT strain. This result is in line with the 
prediction, since NADH formation (at the expense of NADPH generation) is a key feature of the linear 
glycolysis over the ED pathway. Finally, a small reduction in NADPH formation was observed in P. putida 
GC2·T·GBI·GBII, although the difference with the WT strain was not statistically significant.  
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Figure 33½Net ATP, NADH, and NADPH formation under glycolytic growth conditions for P. putida 
KT2440 and P. putida GC2·T·GBI·GBII. ATP (left panel), NADH and NADPH (right panel) rates of 
formation normalized by the specific rate of glucose uptake (nx/qS) of P. putida KT2440 (WT) and P. putida 
GC2·T·GBI·GBII. Cells were grown aerobically in M9 minimal medium added with glucose at 20 mM, 
harvested during exponential growth, and rapidly quenched with liquid N2. Fluxes were calculated as 
indicated in Materials and Methods. The experimentally determined relative flux ratios (nx) were used to 
obtain net rates as vx = Svformation – Svconsumption. Each bar represents the mean value of the corresponding 
normalized rates (nx/qS) ± standard deviation of duplicate measurements from at least three independent 
experiments. Significant differences (P < 0.05, as evaluated by means of the Student's t test) in the pair-
wise comparison of a P. putida GC2·T·GBI·GBII to the control WT strain are indicated by an asterisk. 
 
As a summary, it was possible to confirm the correct implementation of a functional, linear EMP pathway 
in P. putida KT2440, not only by supplying the activities absent in the extant biochemical network (i.e., Pfk), 
but also by modifying the very structure of central carbon metabolism and the cofactor balance thereof. In 
all, the experimental approach adopted resulted in a heavily refactored derivative of P. putida in which the 
native EDEMP cycle operation was blocked and functionally replaced by a linear glycolytic route.  
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«It is better to debate a question without settling it than to settle a question without debating it» 
Joseph Joubert  
(1754 AC-1824 AC)  
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1. Metabolic Engineering meets Synthetic Biology standards: the GlucoBrick system as a 
tool to implement glycolytic capacities in Gram-negative bacteria 
 
Recombinant DNA technologies have accumulated a considerable history, which resulted in a vast number 
of genetic constructs without a clear classification and structure (Novick et al., 1976). Fortunately, during 
the contemporary era of Systems and Synthetic Biology this situation has been revisited through the 
promotion of the standardization philosophy (Canton et al., 2008). One example of this rationalization is the 
creation of the SEVA plasmid collection, a modular set of standardized plasmid structured for an easy 
combinations of different antibiotics, cargoes (to introduce different genetic modules, such as expression 
systems), and origins of replication (Martínez-García et al., 2014a,b; 2015; 2017; Silva-Rocha et al., 2013). 
Taking inspiration on this standard, and incorporating its rules as a basis for the work discussed in this 
Thesis, part of this study was dedicated to design the GlucoBrick system (Chapter 1). This Metabolic 
Engineering tool comprises a set of glycolytic modules that facilitate the user-friendly implementation of 
EMP pathway activities in different Gram-negative bacteria. 
 
Metabolic Engineering is presented as a key field for different research projects (King et al., 2016; 
Raab et al., 2005; Stafford & Stephanopoulos, 2001; Stephanopoulos, 2012). This burgeoning field is 
considered as the discipline occupied with the directed modification of metabolic pathways for the microbial-
based synthesis of various products (Stephanopoulos, 2012). Usually, the most common scenario for these 
modifications has been focused in peripheral aspects, e.g., the elimination of competing endogenous 
pathways, the optimization of uptake and secretion systems, and the rerouting of small molecules at given 
nodes of the target biochemical network. In contrast, the biochemical core (i.e., central carbon metabolism) 
that fuels the bacterial cell factory is generally taken for granted, and hardly ever touched; i.e., few efforts 
have tackled the refactoring of central enzymatic process in its entirety. Relevant examples of this sort 
include auxotrophic CO2 fixation (Antonovsky et al., 2016) and CH3OH assimilation (Müller et al., 2015) by 
engineered strains of E. coli. Faced with this caveat in the field, and considering that a large number of 
bioprocess are directly connected with the core carbon metabolism [e.g., PHB production and its 
dependency on acetyl-CoA availability (Sharma et al., 2016)], Chapter 1 of this Thesis explored the 
development of the GlucoBrick system. This tool was designed to make the implantation of glycolytic 
modules derived from the EMP pathway in different Gram-negative bacteria easy. All in all, this system 
allows to the user to implement, in a driven-by-demand fashion, the combination of elements (or the entire 
pathway) needed to activate a synthetic EMP pathway inspired in the central carbon metabolism of E. coli. 
In other words, the potential manipulation of the central metabolism is facilitated in a large number of Gram-
negative bacteria in a setup entirely compatible with the SEVA standard. 
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The standardization of a central metabolic process, such as the EMP pathway, cannot be considered 
as a simple copy and paste DNA procedure. The intrinsic regulation of any given metabolic pathway 
increases in complexity at the same time that its connectivity with other regulatory and structural elements 
of the cells increases (Li et al., 2014). This scenario is completely applicable to the EMP pathway, which is 
the main catabolic route in glucose-grown E. coli. For this reason, one fundamental step in the process of 
designing the GlucoBrick system was the elimination of any regulatory elements, in order to make the 
system as independent as possible in terms of regulation when the modules are implanted in the bacterial 
host (i.e., orthogonality). The work developed in order to solve this issue is indicated in the first section of 
Chapter 1 of this Thesis. In this part of the manuscript, the design followed in the assembly of the GlucoBrick 
system, to allow the modular arrangement of its elements to make it compatible with the SEVA standard 
(Silva-Rocha et al., 2013), is also thoroughly described. This structure will facilitate the adaptation of the 
genetic constructs to the necessities of future users, simplifying the tedious task of cloning multiple DNA 
fragments into the proper vector(s). Additionally, the compatibility with the SEVA standard allows this system 
to be cloned in a large number of SEVA-like systems, one of them being the pBAMDs collection of 
transposon vectors (Martínez-García et al., 2014a). This synthetic transposon tool allows for the stable 
insertion of foreign DNA (in our case, the modules of the GlucoBrick system), in the chromosome of the 
desired Gram-negative bacteria. At the same time, the vectors, modules, and elements of the SEVA 
collection are continually evolving and they are regularly updated, conferring new features to the standards 
associated with the platform (Martínez-García et al., 2014b). 
 
The second section of Chapter 1 is focused on demonstrating the functionality of the GlucoBrick 
system in the most widespread model Gram-negative bacterial host, E. coli. Despite the fact that the enzyme 
design brought about by this system was inspired on the glycolytic machinery of this Enterobacterium, the 
large number of modifications introduced in the DNA sequence during the standardization process resulted 
in a different physical and regulatory layout that differs from the original distribution of genes in E. coli. Such 
approach is reminiscent of previous attempts to decompress the regulatory complexity of different biological 
phenomena; e.g., the refactoring of the lytic bacteriophage T7 [resulting in a decrease of ca. 20% of 
infectivity with respect to the WT virus (Chan et al., 2005)], or the refactoring of the nitrogen fixation gene 
cluster from Klebsiella oxytoca [resulting in ca. 57% of N2 fixation as compared to the naturally occurring 
system (Temme et al., 2012)]. The biochemical integrity of the GlucoBrick platform was thus evaluated to 
assess if the different glycolytic elements, after edition and rearrangement, could bring about (or boost) an 
EMP route in the native context from which the genes were taken. The results indicate that the ten genes 
coming from the EMP route in E. coli can be excised from their original environment and still deliver their 
biochemical input in a fashion that equals (and, in some cases, improves) the natural physiology and 
metabolic wiring of the microbial cells; i.e., in a large collection of E. coli glycolytic mutants. 
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Another feature of the GlucoBrick system is its portability. Once the viability of the system was analyzed 
in different E. coli mutants, the capability to boost the efficiency of carbon consumption and distribution was 
tested in other bacterial species. The third section of Chapter 1 thus evaluated this portability in two of the 
most relevant Pseudomonas species, the P. putida KT2440 and P. aeruginosa PAO1. In both cases, it was 
demonstrated that the GlucoBrick system increased glucose catabolism of these bacteria by increasing the 
total glucose consumption. Additionally, the introduction of the Pfk activity in these two Pseudomonas strains 
resulted in actual enzyme activity, taking into account that these bacteria are defective for the Pfk glycolytic 
step. The results showed in this Thesis demonstrate that bridging this glycolytic gap is feasible with the 
introduction of Module I of the GlucoBrick system, and, more importantly, that this manipulation does not 
result in strains with compromised fitness as observed upon introduction of PfkA alone (Chavarría et al., 
2013).  
 
In addition to the results mentioned above, the next step considered in this Thesis was to apply the 
GlucoBrick system in an actual test case in terms of Metabolic Engineering. To this end, the fourth section 
of Chapter 1 illustrated the potential of this glycolytic tool to enhance the production of added-value 
metabolites, with PHB production by recombinant E. coli as an example. Our results showed that the 
presence of the GlucoBrick platform increased the glycolytic activities in a PHB-accumulating recombinant 
E. coli carrying the PHB biosynthetic genes from Cupriavidus necator. As a result of this test, this strain 
accumulated up to ca. 73% of the CDW in the form of PHB (Fig. 8c), and this polymer yield on biomass 
ranks among the highest reported in the literature for batch cultures using glucose as a carbon source 
(Leong et al., 2014; Li et al., 2007). 
 
All these features reveal that the GlucoBrick system is a promising tool to implement novel EMP 
capacities in P. putida KT2440. At the same time, a new standard was made available to the Synthetic 
Biology community (Heinemann & Panke, 2006). This platform constitutes the basic toolbox needed to carry 
out the main goal of this Thesis, i.e., the refactoring of the P. putida KT2440 central carbon metabolism into 
a linear EMP-based glycolytic pathway.  
 
2. Preparing P. putida KT2440 to host a linear EMP pathway: upgrading the potential of 
environmental bacteria as a useful Synthetic Biology chassis 
 
The large number of strategies and tools derived from Synthetic Biology are enabling the rational design of 
genetic circuits, that results in an easy application of metabolic pathways à la carte (Stephanopoulos, 2012). 
The implementation of such circuits must be displayed in the appropriate recipient, thereby providing the 
molecular machinery to make them functional. These biological hosts (or chassis) are based, for instance, 
on bacteria that display a set of useful characteristics in order to be employed in different biotechnological 
purposes (Danchin, 2012). P. putida KT2440 is considered a suitable frame for a robust metabolic chassis 
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(Nikel et al., 2016a; Poblete-Castro et al., 2012; 2017). The complete set of attractive features that support 
this notion was described in detail in the Introduction of this Thesis. P. putida exhibits a remarkable capacity 
to prevent oxidative stress due to an increased NADPH synthesis by the EDEMP cycle (Nikel et al., 2015a). 
Certainly, this is a relevant capacity in different industrial scenarios, such as biofuels production (Liao et al., 
2016), but the native metabolic architecture decreases the capacity of P. putida to be employed in other 
biotechnological activities. In particular, P. putida KT2440 would not excel in processes for which the ATP 
yield on substrate could be the limiting factor [e.g., glutathione (Hara et al., 2009) and succinate biosynthesis 
(Zhao et al., 2016)], as this strain produces half the ATP from glucose molecule as that of a linear glycolysis. 
For this reason, the present Thesis has laid the bases to revert this situation, by functionally replacing the 
native EDEMP cycle with a linear EMP pathway (i.e., bestowing an ATP yield twice as high as the ED 
pathway) empowered by the GlucoBrick platform.  
 
The deep metabolic refactoring in P. putida KT2440 has been made possible through the construction 
of a suitable P. putida GC (glycolytic chassis). This metabolic chassis consists of a P. putida KT2440 
derivative depleted of the most relevant native glycolytic activities. This genomic edition was not designed 
at random, instead, specific metabolic nodes were targeted, thus trying to prepare this bacterium to 
accommodate the implanted EMP activities. Chapter 2 of this Thesis describes the approaches developed 
for the implementation of such genome editing. Basically, the guiding principles followed in this process 
encompassed: (i) improving the glucose uptake system, and (ii) preventing P. putida KT2440 to employ its 
native glycolytic machinery (in particular, the preparatory steps of either phosphorylation or oxidation of the 
hexose).  
 
The result shown in the first section of Chapter 2 analyze the possibility of replacing the native ATP-
dependent ABC glucose transporter of P. putida KT2440 by the energy-efficient Glf transporter from Z. 
mobilis. Firstly, a P. putida mutant (Dgts Dgcd), unable to transport glucose to the cytoplasm and at with the 
oxidative glucose utilization pathway blocked, was generated. This platform strain was employed to evaluate 
if the Glf transporter of Z. mobilis can substitute for the function of the native system in P. putida KT2440. 
The results shown in Fig. 11c of Chapter 2 corroborated this hypothesis, indicating that the Glf facilitator, 
expressed from a single copy in the chromosome, can carry out uptake of glucose into the cytoplasm of P. 
putida KT2440, maintaining the specific growth rate value and the final cell density of the resulting strain at 
similar levels as for the WT strain. These results are in agreement with different publications that employed 
the Glf transporter in different microorganisms to improve the glucose utilization in various biotechnological 
processes, such as biomass production in the cyanobacterium Synechocystis (Ranade et al., 2015) and 
succinate generation in E. coli (Tang et al., 2013). As a conclusion of this part of the Thesis, the Glf transport 
system can be safely added to the set of tools existing to improve the glucose metabolism of P. putida 
KT2440. 
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Once the glucose uptake issue was clarified, the rest of Chapter 2 (sections 2 and 3) detail the 
deletions that comprise the biochemical adaptation of P. putida KT2440 in order to host the implanted linear 
EMP pathway. To address such challenge, P. putida KT2440 must be erased of its native way to metabolize 
glucose, based in the phosphorylation or peripheral oxidation of glucose to be subsequently processed by 
the ED pathway and EDEMP cycle. This approach is useful in order to prevent the interaction between the 
cellular machinery and the genetic constructs to be grafted into P. putida (Kim & Copley, 2012; Nielsen et 
al., 2013), and to avoid the competition for the same substrate by different pathways, i.e., native vs. 
engineered pathway (Tepper & Shlomi, 2010). This sort of biochemical competition is a recurrent problem 
in different Metabolic Engineering approaches. Examples of this issue in the literature include the conditional 
[to optimize isopropanol production (Soma et al., 2014)] or total knock-out [to increment succinate production 
(Kim et al., 2004)] of different central metabolism activities in E. coli, needed to attain an optimal bioprocess 
in terms of carbon distribution. 
 
Taking into account these principles, section 2 of Chapter 2 tackled the elimination of the two entry 
points that P. putida KT2440 employs to metabolize glucose. The objective of this section was the 
elimination of the Glk and Gcd activities in P. putida KT2440 in order to completely erase the first steps of 
hexose processing (del Castillo et al., 2007; Nikel et al., 2015a), delimiting the entering of glucose in the 
central carbon metabolism via phosphorylation mediated by Glk or oxidation mediated by Gcd. The results 
shown in Figs. 17a and b corroborate this hypothesis, displaying the inability of the Dglk Dgcd mutant to 
grow on glucose as a sole carbon source. At the same time, the growth curves on different carbon sources 
indicated that the mutant bacteria can grow without any dramatic consequence. The literature supported the 
information described previously, reporting similar growth characteristics in the same type of P. putida 
KT2440 mutants (Borrero de Acuña et al., 2014; del Castillo et al., 2007), and also in the close relative 
species P. fluorescens (Maleki et al., 2015). Apart from that, the elimination of the Gad activity was analyzed 
as an additional mutation of the oxidative glucose utilization pathway, experimentally tracing the bulk of this 
activity to the PP_3382-PP_3384 gene cluster. This result reveals that the chassis construction process can 
be simultaneously used to increase the knowledge on central carbon metabolism of P. putida KT2440. 
 
With the mutations described in the paragraph above, it was possible to avoid the introduction of the 
bulk of glucose in the central carbon metabolism of P. putida KT2440, consisting of the peripheral oxidation 
of the substrate. However, the results displayed in section 2 of Chapter 2 demonstrated the capacity of this 
bacterium to reroute glucose when this oxidation step was disabled in the presence of a Glk activity in the 
cell, a biochemical scenario that will be found in the glycolytic chassis complemented with the GlucoBrick 
system. For this reason, as an additional control point to generate a more predictable chassis, the elimination 
of the genes involved in the ED pathway was also analyzed. Despite the fact that this pathway is 
compromised to generate precursors due to the mutations described previously, the removal of the Edd and 
Edd activities (the two metabolic elements of the ED pathway in P. putida KT2440) was also considered for 
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the construction of the glycolytic chassis. Through this approach, it was possible to eradicate completely the 
main route for glucose catabolism in this bacterium (Wang et al., 1959). This experimental scenario, in which 
the entire route was removed and not just the first element (i.e., Edd), generated a streamlined strain while 
avoiding unexpected interactions due to the potential presence of latent enzyme activities (i.e., Eda). This 
kind of latent activities, without a potential substrate, can evolve in biological systems generating emergent 
properties that are in turn able to disrupt chassis stability (Miller & Raines, 2004). Taking into account this 
information, the third section of Chapter 2 of this Thesis described the process to remove these activities 
from P. putida KT2440. Predictably, the elimination of either activity (Dedd or Deda) blocked the glucose 
utilization by P. putida KT2440 (Figs. 17a and b), a result in line with the data in the literature for P. putida 
KT2440 (del Castillo et al., 2007; Nikel et al., 2015a) and its close relative P. aeruginosa (Blevins et al., 
1975; Cuskey et al., 1985; Temple et al., 1990). 
 
All the mutations explained in Chapter 2 worked as expected, generating the phenotypes predicted, 
which was demonstrated with the use of different enzymatic assays to expose the successful elimination of 
the activities. This verification process supported the decision of accumulating these mutations in the P. 
putida GC strain with the explicit certainty of removing properly these elements. 
 
3. Understanding P. putida KT2440 glucose metabolism as a key principle to the flawless 
design of P. putida GC: the relevance of blocking the EDEMP cycle 
 
The generation of an appealing chassis is closely related to the level of knowledge of its biological and 
biochemical identity. The metabolism of P. putida KT2440 was revisited from different angles during the last 
few years. Relevant events in this context include the recent revision that received its genome data upon 
resequencing (Belda et al., 2016), the availability of four genome-scale constraint-based metabolic models 
for in silico studies (Belda et al., 2016; Nogales et al., 2008; Puchałka et al., 2008; Sohn et al., 2010), and 
the complete carbon fluxes analysis in glucose cultures of this bacterium by using 13C-labeled substrates 
(Nikel et al., 2015a). All these information sources allow us to predict the capacity of this bacterium to suffer 
different manipulations in its central carbon metabolism, the main goal of the present Thesis. However, 
despite the fact that these studies can draw a general description of this issue, their resolution is not enough 
precise to evaluate a complex biochemical scenario with several simultaneous modifications. For this 
reason, Chapter 3 of this Thesis attempted to shine some light on the possible situation that can emerge 
upon the implementation of a linear EMP route in P. putida KT2440. 
 
Glucose metabolism of P. putida KT2440 has been large explained during this study. As it was 
mentioned before, the native incomplete EMP pathway displayed in this bacterium has a key role in terms 
of recycling trioses-P into hexoses-P. The implementation of a linear EMP pathway in P. putida GC (as it 
was shown in Chapter 4) modified completely the extant biochemical scenario, transforming the native 
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gluconeogenic EMP pathway in a completely glycolytic route. In order to evaluate the consequences of this 
phenomenon, Chapter 3 of this Thesis studied the influence of the Pgi activity in P. putida KT2440. This 
mutation is useful in order to understand the physiological impact that can emerge from the blocking of the 
EDEMP cycle avoiding the transformation of F6P into G6P. As it was described in the first section of Chapter 
3, the Pgi activity is comprised by the addition of the products encoded by the pgi-I and pgi-II genes. 
Additionally, it was demonstrated that the individual contribution of both genes is enough to maintain a 
normal phenotype, just detecting relevant differences in terms of specific growth rate value and specific Pgi 
enzyme activity in the Dpgi-I Dpgi-II double mutant in microtiter-plate cultures with glucose as the carbon 
source (Figs. 19c and d). In the same section, the growth parameters of P. putida KT2440 and its Dpgi-I 
Dpgi-II mutant derivatives in shaken-flask cultures under glycolytic growth conditions identified significant 
differences between both strains (Table 8). First of all, the specific growth rate value decreased (i.e., 24%) 
in the Dpgi-I Dpgi-II mutant compared to the WT strain. At the same time, the utilization of glucose was 
remarkably different between the same strains, with a higher specific rate of carbon uptake (qS) for the Dpgi-
I Dpgi-II mutant. However, the opposite situation was observed in terms of the yield of biomass on substrate, 
indicating that the Dpgi-I Dpgi-II mutant has an impaired ability to transform the consumed glucose into 
biomass.  
 
Once a full Pgi mutant (i.e., Dpgi-I Dpgi-II) of strain KT2440 was analyzed in terms of growth patterns, 
it was necessary to explore the biological consequences of removing the Pgi activity with a more general 
screening method. As it was explained in the second section of Chapter 3, the BioLog Phenotypic 
MicroArray™ (PM) technology was employed to obtain a phenomic analysis of the Pgi deletion in P. putida 
KT2440. Briefly, the results obtained with this high-throughput screening method indicated two scenarios 
where the elimination of Pgi could play a critical role: (i) decreasing the overall NADPH availability, and (ii) 
build-up of F6P. The first one suggests that the blocking of the EDEMP cycle decreases the NADPH 
production. This hypothesis is largely correlated with the results obtained by the PM technology in Chapter 
3. In summary, it was hypothesized that the Pgi mutation reduces the G6P availability coming from the 
isomerization of F6P via the EDEMP pathway (Nikel et al., 2015a). G6P is the substrate of the Zwf activity, 
which concomitantly reduces NADP+ into NADPH. Under this metabolic configuration, the Zwf activity cannot 
obtain enough G6P as the substrate, which lead to decreased levels of NADPH in the mutant. This 
hypothesis was also supported by the results shown in the fourth section of Chapter 3. In this case, the in 
silico simulation obtained for the Pgi mutant by constraint-based flux analysis indicated that the flux via Zwf 
decreased by ca. 63%, compromising the availability of NADPH in the cell. Finally, in order to obtain an 
experimental validation for this scenario, section 3 of Chapter 3 displayed a set of experiments that 
correlated the absence of Pgi activity with a high sensitivity to oxidative stress, and more specifically to the 
presence of the redox stressor paraquat. This compound catalyzes the formation of reactive oxygen species 
and has been described to decrease the pool of NADPH (Bus & Gibson, 1984). For this reason, the results 
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mentioned so far are in agreement with the hypothesis that correlates the Pgi mutation with a diminution in 
the overall NADPH availability (Figs. 22 and 23).  
 
Along with Pgi, we evaluated the role of the GntZ activity in the NADPH regeneration process. As it 
was indicated in the third section of Chapter 3, GntZ is considered to be the second most important source 
of NADPH in the upper domain of carbon catabolism after Zwf. In spite of this situation, the elimination of 
this activity in strain KT2440 had not impact in the redox state of the cells with the same intensity as the Pgi 
mutation did (third section of Chapter 3 and Figs. 22 and 23).  
 
The results discussed previously add consistence to the important physiological role of the EDEMP 
cycle in P. putida KT2440 (Nikel et al., 2015a). The disruption of this pathway involves consequences that 
alter the fitness of this environmental bacterium. Curiously, this scenario has an opposite meaning when it 
applied to the well-known Enterobacterium E. coli. Numerous works have appreciated that the elimination 
of the Pgi activity in E. coli (i.e., Dpgi deletion, since in E. coli there is only one gene encoding Pgi) 
substantially increases the NADPH availability for this bacterial species (Canonaco et al., 2001; Charusanti 
et al., 2010; Hua et al., 2003; Usui et al., 2012). This is possible because E. coli employs mainly a linear 
glycolytic EMP pathway, and when it is disrupted, the bacterium is able to redirect the carbon flux via the 
PP pathway. At the same time, this mutation was employed in order to improve various Metabolic 
Engineering approaches in E. coli, such as PHB synthesis (Shi et al., 1999) and riboflavin production (Lin 
et al., 2014). On the other hand, it is important to appreciate the metabolic context of the pgi genes when 
their role is analyzed in P. putida KT2440 and E. coli. P. putida KT2440 presents a clear duplication of the 
pgi gene. This duplication event can be correlated with the importance of maintaining a suitable level of 
NADPH in strain KT2440, since this cofactor is known to be critical to counteract the oxidative stress 
conditions that environmental bacteria are usually confronted with (Bratlie et al., 2010). The cited example 
exposed the close correlation that exists between the adaptation to the environment and the strategy 
adopted in central carbon metabolism in bacteria thriving in completely different environmental niches. 
 
Finally, the second hypothesis associated to the elimination of Pgi activity is the accumulation of F6P. 
The 13C-based metabolic flux analysis previously performed in glucose-grown P. putida KT2440, as it was 
mentioned before, indicated that this bacterium employed the EMP pathway in a gluconeogenic setup (Nikel 
et al., 2015a). According to this information, the elimination of the Pgi activity can trigger the accumulation 
of F6P coming from the FBP via Fbp, assuming that the PP pathway cannot absorb the bulk of this 
metabolite. The phenomic analysis discussed in the second section of Chapter 3 indicated sensitivity of the 
Pgi mutant to a biofilm-inhibiting compound (i.e., sodium salicylate). In addition to this information, F6P has 
been described as the metabolic precursor employed in different Pseudomonas species to synthesize the 
polysaccharide alginate (Franklin et al., 2011), a component of biofilm formation in some bacteria (Boyd & 
Chakrabarty, 1995; Flemming et al., 2007). At the same time, P. putida KT2440 encodes in its chromosome 
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all the necessary elements to transform F6P into alginate, the alg genes (Gulez et al., 2014; Nilsson et al., 
2011). Additionally, a simple synteny test for the mentioned group of genes showed solid results in 
comparison with the target region of the well-characterized alginate producer P. aeruginosa PAO1 (Vallenet 
et al., 2017). Taking all this information together, it was hypothesized that the presence of the Pgi mutation 
in P. putida KT2440 can result in an increased capacity to produce biofilm. As it was suspected, the absence 
of Pgi activity (i.e., Dpgi-I Dpgi-II strain) conferred a higher capacity (ca. 3.5-fold) to generate biofilm to this 
mutant as compared to the WT strain (third section of Chapter 3 and Fig. 24). As an additional negative 
control, the biofilm formation was evaluated in the DgntZ strain (unrelated to F6P accumulation), obtaining 
similar results compared with the WT strain. Such situation, in which the levels of F6P may have an impact 
on the alginate production, was also described in different Pseudomonas species, such as P. aeruginosa 
(Banerjee, 1989; Banerjee et al., 1983) and recently in P. fluorescens (Ertesvåg et al., 2017; Maleki et al., 
2015). Accumulation of this metabolite is associated with pathogenesis in Gram-positive microorganisms 
(Richardson et al., 2015), and it also correlates with biofilm formation in the nosocomial pathogen 
Staphylococcus epidermidis (Sadykov et al., 2008). It is also relevant to mention the role that biofilm 
formation plays in different P. aeruginosa pathogenic scenarios. This bacterium displays an overproduction 
of alginate that results in an increment in antibiotic resistance (Hentzer et al., 2001). The compendium of 
the information gathered so far highlights the relevant relationship between the regulation of central carbon 
metabolism and physiological adaptations to natural environments. The manipulation of the core bacterial 
metabolism can result in emergent characteristics (i.e., biofilm formation) that can, in turn, give rise to new 
phenotypes during the construction of an appealing microbial chassis.  
 
Blocking the EDEMP cycle via Pgi mutation has provided information that supports the physiological 
importance of this metabolic step in the normal biochemical operation of P. putida KT2440. The disruptions 
mentioned resulted in a redox imbalance condition (i.e., decreasing the NADPH availability) combined with 
an altered biofilm formation patterns (i.e., increasing the biofilm index). This kind of perturbation sets an 
example to predict possible scenarios that can appear during deep refactoring of the glucose central 
metabolism of P. putida KT2440, in which the direction of the carbon flow predominant in the EDEMP cycle 
is expected to be reversed by the implanted EMP pathway. 
 
4. Engineering of P. putida to employ the linear EMP glycolytic pathway 
 
The main goal of the whole project has been the implementation of a functional EMP pathway in P. putida 
KT2440 in order to boost ATP formation from glucose. P. putida KT2440 is unable to fully execute this 
catabolic pathway due to the absence of the Pfk activity (Latrach-Tlemçani et al., 2008). Previous works 
developed in our laboratory attempted to bridge this gap in P. putida KT2440 by complementing the Pfk 
activity encoded by the pfkA gene from E. coli (Chavarría et al., 2013). This preliminary study revealed two 
capital principles to take into account to confront the objectives outlined in this Thesis: (i) the implementation 
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of the PfkA activity alone reduces the tolerance to oxidative stress, and (ii) the addition of this biochemical 
step into the biochemical network of strain KT2440 cannot revert the lack of growth of an ED mutant (i.e., 
eda::mini-Tn5) on glucose. With these notions in mind, it is not feasible to implement a functional EMP 
pathway in P. putida KT2440 through a simple strategy, entailing a simple complementation of the absence 
activity. The previous approach probably failed due to the influence of the EDEMP cycle (Nikel et al., 2015a), 
which sets the EMP pathway in a gluconeogenic fashion to transform part of the trioses-P pool into hexoses-
P. The introduction of the PfkA activity, that enables a glycolytic direction in the carbon flow of E. coli (i.e., 
phosphorylating F6P into FBP, using ATP as the phosphodonor) in a pathway configured in the opposite 
direction resulted in a metabolic unbalance (Fischer & Sauer, 2003), which gives rise to the negative 
phenotypes previously observed (Chavarría et al., 2013). For example, it is possible to correlate the effect 
of introducing the PfkA activity in P. putida KT2440, with the elimination of the Pgi activity in this strain 
(Chapter 3), that increases the sensitivity to oxidative stress due to the reduction in the NADPH pool. In 
both cases, the EDEMP cycle is affected, PfkA actuating as a biochemical barrier that difficult the native 
gluconeogenic setup, and the Pgi mutation directly blocking the assembly of a closed cycle (Portais & Delort, 
2002). All the information available highlights the underlying problem of modifying the central carbon 
metabolism of P. putida KT2440, in which a clear hurdle in terms of interaction between the cellular 
machinery and genetic constructs is imposed by the presence of the EDEMP cycle (Kim & Copley, 2012; 
Nielsen et al., 2013). 
 
The experimental design followed in this Thesis to overcome this situation is summarized in Chapter 
4. The simplification of the biological system rendered the microbial chassis more predictable. As it was 
explained before, the goal of substituting the central glucose utilization pathways presents different types of 
difficulties, one of them being the complex pattern of interactions between the cellular machinery and the 
genetic constructs. This engineering challenge can emerge from different sources, such as the competition 
for the same intermediaries and the cross-regulation effects between the native and implanted activities 
(Kim & Copley, 2012; Nielsen et al., 2013). Taking into account this information, the rational generation of a 
suitable chassis, which was termed P. putida GC (glycolytic chassis), is described in Chapter 4 of this 
Thesis. 
 
Considering the difficulties in pathway engineering identified in previous works, the first section of 
Chapter 4 explains the strategy employed to construct the first version of the P. putida GC (termed P. putida 
GC1). This approach followed the beta-testing engineering principle, in which the set of essential 
modifications needed to check the major consequences of introducing an EMP-based glycolysis in 
Pseudomonas was evaluated. This preliminary version of the chassis is based on a P. putida KT2440 
derivative that accumulated the Dglk, Dgcd, Dgad (DPP_3382-4, DPP_3623, and DPP_4232), and Dedd 
mutations. Briefly, a strain was constructed that (i) is unable to phosphorylate glucose, (ii) cannot employ 
the ED pathway for hexose catabolism, and (iii) is blocked in the use of a set of peripheral glucose utilization 
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reactions (via hexose oxidation). Due to the accumulation of the mentioned deleterious mutations, this strain 
cannot grow on glucose as the sole carbon source. The next step was to evaluate if our strategy of 
substituting the main components in the central carbon metabolism of P. putida KT2440 by a linear EMP 
pathway encoded by the GlucoBrick system was feasible. In order to check this hypothesis, Module I of the 
GlucoBrick system was transformed in the P. putida GC1 employing an inducible expression system in a 
plasmid vector. As it indicated in section 1 of Chapter 4 (Fig. 27), the glucose-dependent growth of P. putida 
GC1 (i.e., the first version of the glycolytic chassis) can be restored with the use of the enzyme activities 
encoded in Module I of the GlycoBrick platform. To the best of our knowledge, this is a first-case example 
of a successful attempt in which a P. putida strain, depleted of the native glycolytic activities used for hexose 
catabolism, can exclusively employ the EMP pathway as a glycolytic activity (Chavarría et al., 2013). 
Additionally, Figs. 27c and d of this Chapter corroborate that this growth phenotype is due to the presence 
of the activities encoded by Module I of the GlucoBrick system through the enzyme activity assays 
implemented for both Glk and Pfk. It should be noted that, under this implanted metabolic scenario, P. putida 
GC1 transformed with Module I of the GlucoBrick system showed a specific growth rate value smaller (ca. 
4-fold decrease) and a 40% reduction of the final OD600 than the WT strain containing the empty plasmid in 
glucose cultures (Fig. 27b). These somehow low values of kinetic and growth parameters are expected due 
to the large number of modifications introduced in this strain, including several mutations in its native set of 
genes for central carbon metabolism and possibly because of metabolic burden due to the presence of the 
plasmid-borne GlucoBrick platform. 
 
The beta-testing protocol was useful to evaluate the feasibility of the approach adopted to construct a 
chassis to host a functional EMP pathway. The positive results previously exposed validated the second 
stage of the deep refactoring attempt. This subsequent step in the design was based on the construction of 
the second version of the P. putida GC, termed P. putida GC2, in which the deletions of the P. putida GC1 
strain are included in addition to the Dgts (DgtsA, DgtsB, DgtsC, and DgtsD) and Deda mutations. This 
upgraded glycolytic chassis was modified in order to eliminate the native ABC glucose transport system 
present in P. putida (that consumes ATP as part of its normal functioning), and also to remove completely 
the ED pathway participation, already blocked with the introduction of the Dedd mutation (Fig. 28a). The 
first modification allowed us to substitute the energy-consuming native glucose transporter by the efficient 
Glf glucose facilitator from Z. mobilis. The validity of this modification was supported by the positive results 
obtained for P. putida KT2440 (displayed in Fig. 11c of Chapter 2), that were already explained in the 
second section of this Discussion. On the other hand, the elimination of Eda activity follows the cited principle 
for good practices in chassis construction, aiming at simplifying the metabolic networks and to prevent any 
unexpected interaction due to the presence of latent enzyme activities (also discussed in the second point 
of this section).  
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Once the metabolic backbone was constructed, the process of sequential stable transposition (based 
on a synthetic mini-Tn5 transposon) was attempted as indicated in Fig. 29a in the third section of Chapter 
4. This strategy was adopted to ensure the efficient implementation of a functional EMP pathway in P. putida 
GC2. The introduction of the Glf transporter, and Modules I and II of the GlucoBrick platform granted a linear 
EMP pathway as indicated in Fig. 30 of Chapter 4. The random nature of the insertion process brought 
about by the Tn5-derived transposition system allowed us to obtain a strain with the desired growth 
phenotype. This clone, termed P. putida GC2·T·GBI·GBII, is the material culmination of the purpose stated 
at the beginning of this Thesis.  
 
 P. putida GC2·T·GBI·GBII contains all the necessary elements to employ the EMP pathway as the 
unique glycolytic route. The physiological parameters indicated in Table 9 (Chapter 4) revealed that the 
specific rate of carbon uptake (qS) and the specific growth rate value for this engineered strain were 
significantly smaller in comparison with the WT strain. However, it must be remarked that the high level of 
genetic and metabolic manipulation introduced in P. putida GC2·T·GBI·GBII, combined with the fact that 
the expression of the inserted modules has not been improved yet, results in sub-optimal growth. This 
microbial platform should be considered as a proof-of-principle to test the functional replacement of central 
glycolytic pathways in environmental bacteria. This issue cannot be analyzed with a simple set of enzyme 
activity assays to corroborate the presence of the EMP pathway and, for this reason, the fourth section of 
Chapter 4 exposes the final (and definite) experimental test to ensure the complete metabolic refactoring 
carried out in P. putida GC2·T·GBI·GBII. In this case, the experimental approach is based on the 13C-based 
metabolic flux ratio analysis of its central carbon metabolism. This powerful methodology is able to 
reconstruct a detailed map that illustrates the different pathways followed by the glucose through the entire 
biochemical network (Sauer, 2006). 
 
As a key outcome of the project, Fig. 32 of Chapter 4 summarizes the distribution of absolute fluxes 
in the glucose catabolism network for the refactorized P. putida GC2·T·GBI·GBII strain as compared with 
its predecessor P. putida KT2440. The results obtained in this part of the Thesis have confirmed the success 
of the metabolic refactoring carried out in P. putida KT2440, breaking down the different metabolic blocks 
where these modifications can be fully appreciated. First, it was demonstrated that the Glf transporter has 
the capacity to functionally complement the hexose transport deficiencies in strain GC2·T·GBI·GBII, 
capturing all the glucose into Glk-dependent phosphorylation (since glucose cannot be oxidized, due to the 
presence of the Dgcd and Dgad mutations). This result is relevant when compared with the metabolic wiring 
in the WT strain, which channeled 90% of glucose via the Gcd-dependent periplasmic oxidation of the 
substrate according to the data obtained in our experiments and previously in the literature (Nikel et al., 
2015a). However, the level of expression and/or activity of Glf must be considered in the future in order to 
improve the general performance of the system, taking into account the low value of specific rate of carbon 
uptake (qS) detected in the glycolytic chassis. The strategy followed in the construction of P. putida 
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GC2·T·GBI·GBII employed random transposition insertions to explore different regulation patterns of the 
gene modules delivered into the chromosome. This approach proved useful for the first proof-of-principle 
attempted in this study, and a fine-tuning regulation for all the genetic elements present in the glycolytic 
chassis is needed to harness the full potential of the EMP-operating P. putida strain. Second, and as a first 
step in the novel implemented EMP pathway, the Glk activity encoded by Module I of the GlucoBrick system 
was able to phosphorylate 100% of the glucose that entered in the cytoplasm employing the exogenous Glf 
transporter. This is the first important point engineered in P. putida GC2·T·GBI·GBII, in which the bulk of 
the glucose in the system was channeled into G6P, in a similar fashion as observed in other bacteria [i.e., 
E. coli (Fuhrer et al., 2005; Hua et al., 2003; Usui et al., 2012)], thereby reverting the natural situation of P. 
putida KT2440, in which only a 10% of the glucose gets phosphorylated by Glk (Nikel et al., 2015a). 
 
Another example of the metabolic reconfiguration in P. putida GC2·T·GBI·GBII as compared with E. 
coli, is the distribution of the fluxes around the G6P node. The G6P pool was split in a 22% being channeled 
into 6PG [a conversion catalyzed by Zwf and 6-phosphogluconolactonase (Pgl)] and the remaining 77% 
funneled into the formation of F6P (a reaction catalyzed by Pgi), in accordance with the values obtained in 
other published studies for E. coli growing under glycolytic conditions (Fuhrer et al., 2005; Hua et al., 2003; 
Usui et al., 2012). Most remarkably, the completely elimination of the ED pathway (comprising by Dedd and 
Deda mutations) has been reflected in the 13C-based metabolic flux ratio analysis, allowing the channeling 
of 6PG into the PP pathway following the same quantitative distribution than in E. coli (Fuhrer et al., 2005; 
Hua et al., 2003; Usui et al., 2012). This modification removed the glycolytic pathway that processes the 
bulk of hexoses in P. putida KT2440 (Nikel et al., 2015a), demonstrating the deep metabolic reconfiguration 
of P. putida GC2·T·GBI·GBII. At the same time, the role of the implanted EMP pathway in the glycolytic 
chassis was dramatically modified, and the genes encoded by Module I of the GlucoBrick system enabled 
the transformation of the native gluconeogenic preparatory phase of P. putida KT2440 into an authentic 
glycolytic pathway.  
 
In terms of EMP pathway implementation, P. putida GC2·T·GBI·GBII channeled a 77% of the glucose 
entering the biochemical network via the linear glycolytic EMP pathway encoded by Module I and II of the 
GlucoBrick system. To be more precise, in the glycolytic chassis 73% of the generated Pyr was obtained 
from the EMP pathway, in contrast with 49% in the WT strain. This boosted flux through the EMP pathway 
resulted in a 2.5-fold higher circulation via pyruvate kinase (i.e., PEP + ADP + H+ → Pyr + ATP). Pyruvate 
kinase is a key allosteric enzyme of the EMP pathway, which catalyzes one of the two substrate-level 
phosphorylation steps that generate ATP. For this reason, and in order to achieve the goal of improving the 
energy status of the glycolytic chassis, stabilizing this step proper is of capital importance for the present 
project. As it was mentioned before, the flux via pyruvate kinase was significantly increased in P. putida 
GC2·T·GBI·GBII. Further enhancement of this key step will comprise the fine-tuning of the activity encoded 
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by Module II of the GlucoBrick system (containing the pykF gene from E. coli), at the same time that the 
participation of the endogenous pyruvate kinases will be thoroughly explored. In E. coli, there are two 
isoenzymes characterized to carry out this activity (i.e., PykA and PykF), displaying remarkable differences 
in terms of absolute activity. For example, the pyruvate kinase specific activity associated to the isoform 
PykF has been reported to be ca. 16-fold higher than that of the PykA counterpart (Ponce et al., 1995). 
When the pykA gene was interrupted, the enzymatic level of the remaining PykF activity increased above 
the levels that would be expected from the addition of both activities separately (Zhao et al., 2017). P. putida 
KT2440 presents a similar scenario, containing two isoenzymes for the same pyruvate kinase activity [i.e., 
PykA (PP_1362) and Pyk (PP_4301)] in its chromosome, and there could be a similar cross-inhibition effect 
as the one reported in E. coli. This is an example of the large number of important points that can be 
regulated in the glycolytic chassis constructed herein in order to further improve its general performance. 
 
Once Pyr is generated in P. putida GC2·T·GBI·GBII, the influence of the genes encoded by Module I 
and II of the GlucoBrick system on downward catabolism started to be less critical. From this metabolic node 
downwards, the side-by-side comparison of the genetic chassis with E. coli is more difficult, due to the 
presence of overflow metabolism in Enterobacteria, in which acetyl-CoA is converted into acetate (Basan et 
al., 2015; Bernal et al., 2016; Fuhrer et al., 2005). On the other hand, P. putida KT2440 and its derivative 
glycolytic chassis metabolize Pyr into acetyl-CoA and the TCA cycle, without any overflow metabolite 
stemming from these metabolic intermediates. The distribution of fluxes in anaplerotic pathways, TCA cycle, 
and glyoxylate shunt were similar in both P. putida GC2·T·GBI·GBII and WT strain. These routes had similar 
flux values when they were compared with the information available in the literature not only for P. putida 
KT2440 but also other Pseudomonas species, such as P. fluorescens (Fuhrer et al., 2005; Nikel et al., 
2015a). As expected for P. putida, neither strain had active fermentation pathways (e.g., formation of lactate 
or ethanol), and the breakdown of hexoses was entirely oxidative (Fuhrer et al., 2005). 
 
Finally, the main goal of this Thesis was evaluated using the data obtained from 13C-based metabolic 
flux ratio analysis. This objective comprised the implementation of a complete EMP pathway in P. putida 
KT2440, as a way to improve the energy efficiency of central carbon metabolism. Fig. 33 clarifies this issue, 
showing an increase in the ATP production of almost 20% for P. putida GC2·T·GBI·GBII compared with the 
WT strain. This kind of approach agrees with the current trend in order to promote metabolic capacities in 
different microbial chassis (Wu et al., 2016), in which ATP generation must be improved via catabolic 
metabolism optimization. This assumption was associated to the limitation presented by the ATP synthase 
system (probably to most obvious target to manipulate ATP formation), which offers limited possibilities in 
terms of manipulation due to the constraints related to cell membrane space, interfering with the proton 
motive force (Eames & Kortemme, 2012). Additionally, as a collateral effect of implementing an EMP 
pathway, the NADH formation increased 2.5-fold as compared to WT strain, bestowing the glycolytic chassis 
with a novel stoichiometry in terms of reducing power. 
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5. Outlook  
 
The metabolic refactoring of the catabolic lifestyle of P. putida KT2440 can be considered to be successfully 
achieved in this Thesis. This is a first milestone to implement not only a functional EMP pathway, but also 
an efficient glycolytic network in this environmental bacterium. From this point on, the possibilities to explore 
in order to fine-tune the central carbon metabolism of this glycolytic chassis are numerous. We are currently 
submitting this strain to an adaptive laboratory evolution process under different pressure agents in order to 
accumulate random mutations in the chassis that would enhance its growth on glucose. This procedure is 
being performed by using an experimental automated turbidostat device designed to avoid biofilm formation 
and push selection of those individual bacteria carrying beneficial variations in terms of growth phenotypes 
(Hansen et al., 2017; Portnoy et al., 2011). Our device was assembled using peristaltic pumps for pumping 
the required operation fluids (namely, a glucose-containing culture medium), and milli-fluidic valves to control 
fluid transport through the whole circuit. The whole assembly is automatically controlled by an ArduinoTM 
automata governed by a Python-guided software program. The different parts of the whole structure were 
generated by demand with the use of a 3D printer. This apparatus, assembled ad hoc, is expected to improve 
the performance of the glycolytic chassis not only by selecting random mutants, but also by evaluating the 
implementation of a direct evolution experiment [i.e., multiplex automated genome engineering (MAGE)] in 
which the desired elements are adjusted, e.g., by setting the RBS and the promoters of the glycolytic genes 
encoded by the GlucoBrick system (Gallagher et al., 2014). Even when the results of such an approach are 
beyond the scope of this Thesis, they are expected to bring about a completely refactored and optimized P. 
putida strain in which the central carbon metabolism is entirely based in the EMP pathway. 
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«I am turned into a sort of machine for observing facts & grinding out conclusions» 
Charles Robert Darwin  
(1809 AC-1882 AC)  
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The work described throughout this Thesis has given rise to the following conclusions: 
 
1. The development of the GlucoBrick system has enabled the à la carte implementation of EMP pathway-
based glycolytic activities into different Gram-negative bacteria. The potential of this standardized genetic 
tool has been exposed by restoring absent glycolytic activities in both E. coli and Pseudomonas species. 
The biotechnological value of the GlucoBrick platform has also been demonstrated by boosting the glucose-
dependent accumulation of the biopolymer PHB in recombinant E. coli strains. 
 
2. The streamlining process conducted in the WT strain KT2440 resulted in a set of P. putida glycolytic 
chassis, specifically designed to host a functional linear EMP pathway. This task has been achieved by 
removing the native glucose uptake system and disabling the endogenous glycolytic routes in this bacterium. 
 
3. The glucose facilitator (glf) of Z. mobilis has been shown to be a promising candidate to substitute the 
native glucose transport system of P. putida KT2440. The use of Glf as a hexose facilitator prevents the 
ATP expenditure associated to the natural glucose uptake system of strain KT2440. Yet, its activity levels 
need further optimization. 
 
4. The disruption of the native glycolytic pathways, by removing the Pgi activity, compromises the overall 
fitness of P. putida KT2440 under glycolytic growth conditions. The impossibility to regenerate G6P from 
trioses-P decreases substrate availability for the Zwf activity, which is in turn reflected in an increased 
sensitivity to oxidative stress due to the diminution of the NADPH pool. Moreover, the elimination of the Pgi 
activity may result in the accumulation of F6P, the metabolic precursor of alginate, thereby increasing the 
biofilm formation capability of P. putida KT2440. 
 
5. The P. putida glycolytic chassis has been used to host a functional linear EMP pathway. Fluxomic 
analyses have demonstrated the successful metabolic refactoring of P. putida KT2440, replacing the natural, 
ED-based catabolic lifestyle by an authentic, energy-efficient EMP glycolytic pathway. 
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El trabajo descrito a lo largo de esta Tesis ha dado lugar a las siguientes conclusiones: 
 
1. El desarrollo del sistema GlucoBrick ha permitido la implementación a la carta de las actividades 
glicolíticas derivadas de la ruta de EMP, siendo posible su utilización en diferentes bacterias Gram-
negativas. El potencial de esta herramienta genética estandarizada ha sido demostrado con el 
restablecimiento de diversas actividades glicolíticas ausentes tanto en E. coli como en diferentes especies 
de Pseudomonas. El valor biotecnológico de esta plataforma se ha demostrado gracias a la detección de 
una mayor acumulación de PHB dependiente de glucosa en diversas cepas recombinantes de E. coli. 
 
2. La edición genética de la cepa silvestre de P. putida KT2440 dio lugar a la obtención de un conjunto de 
chassis glicolíticos, especialmente diseñados para albergar una ruta EMP lineal totalmente funcional. Este 
procedimiento fue posible gracias a la eliminación de los sistemas de transporte y metabolización nativos 
de glucosa en esta bacteria. 
 
3. El transportador de glucosa (glf) de Z. mobilis ha demostrado su capacidad a la hora de sustituir las 
funciones desarrolladas por el sistema nativo de P. putida KT2440. El uso del sistema Glf como 
transportador de hexosas evita el gasto de ATP asociado en el sistema natural de la cepa KT2440. Sin 
embargo, sus niveles de actividad necesitan ser optimizados.  
 
4. La disrupción de las rutas glicolíticas nativas, mediante la eliminación de la actividad Pgi, compromete la 
viabilidad de P. putida KT2440. La incapacidad para generar G6P a partir de triosas-P disminuye la cantidad 
de sustrato disponible para la actividad Zwf. Este escenario conduce a un incremento de la sensibilidad a 
estrés oxidativo, explicada en gran parte por la disminución del NADPH disponible. Además, la eliminación 
de la actividad Pgi podría resultar en una acumulación de F6P, un precursor metabólico de la síntesis de 
alginato, incrementando la formación de biofilm para dicho mutante en P. putida KT2440. 
 
5. La creación del chassis glicolítico basado en P. putida KT2440 ha permitido su utilización como 
hospedador de una ruta lineal funcional de EMP. Los análisis de flujos de carbono mediante marcaje con 
13C han demostrado la refactorización metabólica realizada sobre P. putida KT2440, reemplazando la ruta 
natural basada en ED por una ruta de EMP, más favorable en términos de rendimiento energético. 
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Annex 1. Phenotypic MicroArray™ complete report (P. putida KT2440 vs. P. putida KT2440 Dpgi-1 Dpgi-2) 
Plate Panel Well(s) Respiration ratio Chemical Category 
Phenotypes Gained       
PM07  F06 58 Trp-Ala N-Source, peptide 
PM08  E01 50 Thr-Phe N-Source, peptide 
PM04A C02 72 Phospho-Glycolic acid P-Source, organic 
PM13B H12 61 Tylosin protein synthesis, 50S ribosomal subunit, macrolide 
Phenotypes Lost       
PM20B C06,C07 -105 Atropine acetylcholine receptor, antagonist 
PM20B B02,B03,B04 -247 Orphenadrine anti-cholinergic 
PM20B F09,F10,F11 -224 Pridinol anti-cholinergic 
PM20B B07,B08 -135 D,L-Propanolol beta-adrenergic blocker 
PM17A B01,B02,B03 -191 Salicylate, sodium biofilm inhibitor, anti-capsule agent, chelator, prostaglandin syntetase inhibitor, mar inducer 
PM20B G09,G10 -190 8-Hydroxyquinoline chelator, lipophilic 
PM17A E05,E06,E07 -310 Compound 48/80 cyclic AMP phosphodiesterase inhibitor 
PM17A H06,H07 -93 Caffeine cyclic AMP phosphodiesterase inhibitor 
PM15B D03,D04 -114 Phleomycin DNA damage, oxidation 
PM20B F02,F03 -118 4-Hydroxycoumarin DNA intercalator 
PM20B D01,D02 -105 Proflavine DNA intercalator, inhibits RNA synthesis 
PM18C B06,B07 -126 Pipemidic Acid DNA topoisomerase 
PM20B D07,D08 -122 Ciprofloxacin DNA topoisomerase 
PM11C B11,B12 -116 Lomefloxacin DNA topoisomerase 
PM11C E12 -74 Nalidixic acid DNA topoisomerase 
PM17A A01,A02 -148 D-Serine inhibits 3PGA dehydrogenase (L-serine and pantothenate synthesis) 
PM13B A07,A08 -113 Dequalinium chloride ion channel inhibitor, K+ 
PM17A C01 -76 4-Aminopyridine ion channel inhibitor, K+ 
PM18C G01,G02,G03,G04 -302 Triclosan lipid synthesis, fatty acid inhibitor 
PM20B E06,E07 -216 Dodine (n-Dodecylguanidine) membrane permeability, guanidine, fungicide 
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PM15B A07 -88 Guanidine hydrochloride membrane, chaotropic agent 
PM11C C05,C06,C07 -279 Colistin membrane, cyclic peptide 
PM19  H09,H10 -125 Polymyxin B membrane, cyclic peptide 
PM17A E01,E02 -116 Niaproof membrane, detergent, anionic 
PM18C C01,C02,C03 -266 Poly-L-lysine membrane, detergent, cationic 
PM19  B03,B04 -189 Methyltrioctylammonium chloride membrane, detergent, cationic 
PM12B H09 -71 Dodecyltrimethyl ammonium bromide membrane, detergent, cationic 
PM15B D06,D07 -204 Domiphen bromide membrane, detergent, cationic, fungicide 
PM19  G01 -63 Lauryl sulfobetaine (N-Dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate) membrane, detergent, zwitterionic 
PM20B E09,E10,E11,E12 -216 Hexachlorophene membrane, electron transport 
PM16A C05 -99 Protamine sulfate membrane, nonspecific binding 
PM20B C01,C02,C03 -226 Thioridazine membrane, phenothiazine, efflux pump inhibitor, anti-psychotic 
PM17A D11,D12 -203 Chlorpromazine membrane, phenothiazine, efflux pump inhibitor, anti-psychotic 
PM13B G11,G12 -176 Trifluoperazine membrane, phenothiazine, efflux pump inhibitor, anti-psychotic 
PM20B A01,A02,A03,A04 -338 Amitriptyline membrane, transport 
PM20B H03,H04 -101 Patulin microtubulin polymerization inhibitor, antifungal 
PM03B F11 -63 Uridine N-Source, other 
PM07  B11 -98 Met-Gly N-Source, peptide 
PM06  F03 -94 Gly-Tyr N-Source, peptide 
PM06  C11 -77 Asp-Leu N-Source, peptide 
PM06  E12 -52 Gly-Ser N-Source, peptide 
PM18C F06,F07,F08 -198 Tinidazole nitro compound, oxidizing agent, DNA damage 
PM20B C11,C12 -137 Ornidazole nitro compound, oxidizing agent, DNA damage 
PM18C B09,B10,B11,B12 -205 Azathioprine nucleic acid analog, purine 
PM18C H01,H02,H03,H04 -392 5-Fluoro-5’-deoxyuridine nucleic acid analog, pyrimidine, DNA synthesis 
PM18C B01,B02,B03,B04 -248 Trifluorothymidine nucleic acid analog, pyrimidine, DNA synthesis 
PM09  D01 -86 3% Potassium chloride osmotic sensitivity, KCl 
PM09  D02 -75 4% Potassium chloride osmotic sensitivity, KCl 
PM09  A04 -66 4% NaCl osmotic sensitivity, NaCl 
PM09  E04 -62 4% Sodium formate osmotic sensitivity, sodium formate 
PM09  F03 -82 3% Sodium lactate osmotic sensitivity, sodium lactate 
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PM09  F04 -82 4% Sodium lactate osmotic sensitivity, sodium lactate 
PM10  F05 -102 pH 9.5 + L-Threonine pH, deaminase 
PM10  F02 -93 pH 9.5 + L-Phenylalanine pH, deaminase 
PM10  E11 -65 pH 9.5 + L-Leucine pH, deaminase 
PM10  G01 -65 pH 9.5 + Anthranilic acid pH, deaminase 
PM10  D08 -131 pH 4.5 + 5-Hydroxy-L-Lysine pH, decarboxylase 
PM10  C04 -115 pH 4.5 + L-Serine pH, decarboxylase 
PM10  D04 -115 pH 4.5 + a-Amino-N-Butyric acid pH, decarboxylase 
PM10  C03 -106 pH 4.5 + L-Proline pH, decarboxylase 
PM10  C08 -106 pH 4.5 + L-Valine pH, decarboxylase 
PM10  C05 -101 pH 4.5 + L-Threonine pH, decarboxylase 
PM10  D07 -99 pH 4.5 + D-Lysine pH, decarboxylase 
PM10  C02 -98 pH 4.5 + L-Phenylalanine pH, decarboxylase 
PM10  D06 -92 pH 4.5 + L-Cysteic acid pH, decarboxylase 
PM10  C07 -89 pH 4.5 + L-Citrulline pH, decarboxylase 
PM10  B07 -88 pH 4.5 + L-Glutamine pH, decarboxylase 
PM10  C11 -88 pH 4.5 + L-Homoarginine pH, decarboxylase 
PM10  B04 -87 pH 4.5 + L-Asparagine pH, decarboxylase 
PM10  C01 -81 pH 4.5 + L-Methionine pH, decarboxylase 
PM10  C10 -81 pH 4.5 + L-Ornithine pH, decarboxylase 
PM10  B09 -76 pH 4.5 + L-Histidine pH, decarboxylase 
PM10  B12 -69 pH 4.5 + L-Lysine pH, decarboxylase 
PM10  D10 -66 pH 4.5 + D,L-Diamino-a,e-pimelic acid pH, decarboxylase 
PM10  D11 -66 pH 4.5 + Trimethylamine-N-Oxide pH, decarboxylase 
PM10  D12 -66 pH 4.5 + Urea pH, decarboxylase 
PM10  B02 -62 pH 4.5 + L-Alanine pH, decarboxylase 
PM10  B01 -95 pH 4.5 pH, decarboxylase control 
PM10  A03 -96 pH 4.5 pH, growth at 4.5 
PM10  A04 -81 pH 5 pH, growth at 5 
PM14  H07,H08 -195 Promethazine phenothiazine, anti-cholinergic, anti-psychotic, sedative 
PM19  D09,D10,D11,D12 -209 Phenyl-methylsulfonyl-fluoride (PMSF) protease inhibitor, serine 
PM19  G05,G06,G07,G08 -276 Dihydrostreptomycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM13B E07,E08 -166 Geneticin disulfate (G418) protein synthesis, 30S ribosomal subunit, aminoglycoside 
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PM11C F10,F11 -163 Neomycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM12B D02,D03 -151 Sisomicin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM12B F01,F02 -136 Tobramycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM11C G07,G08 -111 Gentamicin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM12B G01 -77 Spectinomycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM11C H05 -70 Kanamycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM20B A08 -66 Apramycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM16A E01 -63 Streptomycin protein synthesis, 30S ribosomal subunit, aminoglycoside 
PM12B A05,A06,A08 -230 Tetracycline protein synthesis, 30S ribosomal subunit, tetracycline 
PM12B H01 -74 Spiramycin protein synthesis, 50S ribosomal subunit, macrolide 
PM19  H05,H06 -97 a-Monothioglycerol reducing agent, thiol, adenosyl methionine antagonist 
PM19  E01,E02,E03,E04 -188 FCCP respiration, ionophore, H+ 
PM19  F09,F10,F11 -186 Sodium caprylate respiration, ionophore, H+ 
PM19  A05,A06,A07 -169 Gallic acid respiration, ionophore, H+ 
PM20B G06,G07 -157 3,5-Dinitrobenzoic acid respiration, ionophore, H+ 
PM19  C11,C12 -103 trans-Cinnamic acid respiration, ionophore, H+ 
PM13B E11,E12 -148 Ruthenium red respiration, mitochondrial Ca2+ porter 
PM17A D01,D02 -150 Oxycarboxin respiratory enzymes, carboxamide, fungicide 
PM18C G05,G06,G07 -285 3,5- Diamino-1,2,4-triazole (Guanazole) ribonucleotide DP reductase inhibitor 
PM15B H05 -71 Hydroxyurea ribonucleotide DP reductase inhibitor, antifolate (inhibits thymine and methionine synthesis) 
PM18C D01,D02,D03,D04 -253 Sodium Arsenite toxic anion 
PM16A F01 -111 Potassium tellurite toxic anion 
PM11C G09,G10 -109 Potassium tellurite toxic anion 
PM18C E09,E10,E11 -204 Antimony (III) chloride toxic cation 
PM16A G02,G03,G04 -177 Chromium (III) chloride toxic cation 
PM14  D01,D02 -117 Cadmium chloride toxic cation 
PM13B F09 -108 Thallium (I) acetate toxic cation 
PM13B F03,F04 -99 Cesium chloride toxic cation 
PM12B C09 -100 D,L-Serine hydroxamate tRNA synthetase 
PM13B F07,F08 -121 Glycine HCl wall 
PM13B D01,D02,D03,D04 -251 Cefuroxime wall, cephalosporin 
PM17A G11,G12 -116 Cefoperazone wall, cephalosporin 
ANNEXES 
	
190 
	
		
PM15B A11,A12 -106 Cefmetazole wall, cephalosporin 
PM11C H01 -73 Cephalothin wall, cephalosporin 
PM12B A01,A02,A03 -280 Penicillin G wall, lactam 
PM19  F01,F02,F03 -214 Phenethicilllin wall, lactam 
PM12B B02,B03,B04 -171 Oxacillin wall, lactam 
PM12B A09,A10 -108 Carbenicillin wall, lactam 
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